Compartmentalized catalysis by Willemsen, J.S.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/122867
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
  
 
Compartmentalized Catalysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proefschrift 
ter verkrijging van de graad van doctor aan de Radboud Universiteit Nijmegen op gezag van 
de rector magnificus prof. mr. S. C. J. J. Kortmann, volgens besluit van het college van 
decanen in het openbaar te verdedigen op woensdag 8 januari 2014 om 16:30 uur precies  
 
 
 
 
 
 
door 
 
Jorgen Steven Willemsen 
geboren op 12 oktober 1984 
te Wageningen  
 
 
 
 
 
Promotoren: 
Prof. dr. F. P. J. T. Rutjes 
Prof. dr. ir. J. C. M. van Hest 
 
Manuscriptcommissie:  
Prof. dr. A.E. Rowan 
Prof. dr. G. Roelfes (Rijksuniversiteit Groningen) 
Dr. ing. K.M. Bonger 
 
Paranimfen: 
Dr. H. A. van Kalkeren 
F. van der Pijl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The research described in this thesis was financially supported by the NRSC-Catalysis. 
 
 
 
 
Cover picture adapted from: Clipart courtesy FCIT (http://etc.usf.edu/clipart) 
Press: Ipskamp drukkers 
ISBN: 978-94-6259-000-7
- 3 - 
 
Table of contents 
 
1. Introduction – Compartmentalization techniques to overcome 
incompatibility issues in cascade catalysis 
 
5 
2. Ligand synthesis for water-soluble metal catalysts 
 
35 
3. Aqueous reductive amination using a dendritic metal catalyst in a 
dialysis bag 
 
59 
4. Towards homogeneous metal catalysis in a polymersome nanoreactor 
 
73 
5. Potassium formate as a small molecule switch: controlling 
oxidation/reduction behaviour in a two-step sequence 
 
93 
6. A one-pot oxidation/enantioselective oxa-Michael cascade 
 
107 
7. Summary and perspectives (samenvatting en visie) 
 
123 
 Publications 
 
130 
 Curriculum Vitae 131 
 
 
 
 
 
 
 
 
 
 
- 4 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 5 - 
 
1. Introduction – Compartmentalization 
techniques to overcome incompatibility issues in 
cascade catalysis 
 
Abstract 
When multiple chemical transformations in one-pot are combined, higher conversions, less 
by-product formation and shorter reaction times are generally observed. As a consequence, 
less waste is produced and the impact on the environment is lower than in a stepwise 
approach. However, multiple single reactions can generally not be combined without creating 
incompatibility issues. Compartmentalization of the individual reactions is the key strategy to 
overcome such inactivation problems. Incompatible reactions are performed in different 
compartments by keeping the reagents or catalysts in a defined space, while the substrate and 
intermediates can freely diffuse from one compartment to the other. Several methods to create 
compartmentalization have been developed and are discussed in this chapter. 
       
1.1 Cascade reactions & incompatibility issues 
The highly efficient formation of complex molecules in nature can be attributed to 
sophisticated, well-developed reaction sequences. In living cells, production of molecules 
often proceeds via multiple step cascade reactions. A precise control of the reaction sequence 
is achieved by positional assembly or spatial allocation of the responsible enzymes. In 
addition, this strategy suppresses incompatibility issues between the different reactions.
[1],[2]
 
Well-known cyclic reaction sequences in nature are the citric acid cycle,
[3]
 and Calvin cycle.
[4]
 
Examples of complex linear sequences are the fatty acid oxidation,
[5]
 the production of 
vitamin C
[6]
 and the taxol biosynthesis,
[7]
 the latter being a highly active natural product which 
is currently on the market as the cytostatic drug Paclitaxel. The transformations are often 
enantioselective, and the occurrence of undesired side reactions or formation of waste 
products is negligible. Transport of labile reaction intermediates occurs sometimes via 
channels which connect two active sites, called metabolic channeling.
[8]
 Remarkably, the 
- 6 - 
 
separate enzymatic steps do not hamper each other in an undesired way and the biocatalysts 
retain their activity for a prolonged period of time.   
A related strategy in nature to prevent harmful interactions between catalytic systems is by 
compartmentalization. Processes can be separated from each other using different membrane-
based compartments for the formation of intermediate structures. Substrates and products of 
the reactions can easily move between compartments, sometimes via selective membrane 
channels.
[9]
 Another feature of this compartmentalization strategy is that all enzymatic 
reactions, which are in equilibrium, are pushed to one side by the in-situ product removal 
strategy: products are continuously removed from a compartment.
[10]
 In-situ product removal 
is also beneficial if product inhibition of enzymes occurs.  
Based on the efficient results obtained in nature, chemists have applied this knowledge to 
construct one-pot reaction sequences in-vitro.
[11],[12],[13],[14]
 In such cascade processes, steps 
A→B, B→C, C→D etc. happen concurrently so that only one purification step is necessary. 
One-pot reactions are not necessarily cascade reactions however, since reactions in one-pot 
can also be performed subsequently. In other words, some reagents of a next reaction are 
added after completion of the previous reaction. This means that the reactions do not proceed 
simultaneously. Replacing multistep batch wise processes by one-pot procedures increases the 
overall efficiency, as fewer purification steps of intermediate compounds are necessary. In a 
batch wise process, time-consuming and waste-producing purifications are performed 
between individual reactions and multiple purification steps are usually required (Figure 1.1). 
Another advantage is that reactive compounds are generated in-situ and directly reacted into 
another compound, thereby preventing side reactions. Considering the strong points of 
cascade chemistry, it is no surprise that cascade reactions have been proposed to contribute to 
greener chemical processes
[15]
 and that they have continuously received attention of the 
chemical community.
[16]
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Batch wise synthesis Cascade synthesis 
 
 
Figure 1.1 Schematic difference between stepwise and cascade synthesis.
[11]
 Adapted with 
permission from ref. 11. Copyright (2003) American Chemical Society. 
The major challenge in combining multiple chemical transformations is the compatibility of 
the different reagents and catalysts. One approach for a successful reaction sequence is to 
search for two or more compatible reactions. Thus, none of the chemicals present in the 
mixture inhibit another reaction in the sequence. Many combinations of compatible reactions 
have been reported in literature.
[11],[12],[13],[14]
 In a remarkable example described by Orru, an 
eight-component reaction was carried out in a total reaction yield of 24% (Scheme 1.1).
[17]
 
First isocyanide 1 reacted with acetone (2) and amino acid 3. After formation of 7, 
compounds 4, 5 and 6 were added to the same reaction vessel which led to the formation of 
compound 8. After neutralization of the reaction mixture by HCl and addition of benzylamine 
and isobutyraldehyde, compound 9 was obtained. Product formation was only successful after 
a careful design of the reaction sequence. All the reactions proceeded readily in methanol, 
intermediates did not react in an undesired manner and no interfering waste products were 
formed. The strategy that worked here is to perform some reactions in the sequence 
consecutively; transformations went to completion before the next step was initiated.  
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Scheme 1.1 Eight-component one-pot reaction.
[17]
 
Arguably the most impressive compatible cascade to date is the one-pot synthesis of a 
complex precursor of vitamin B12, hydrogenobyrinic acid (11) in 12 enzymatic steps by Scott 
et al. (Scheme 1.2).
[18]
 All enzymes were prepared by overexpression of the specific 
biosynthetic gene of Pseudomonas denitrificans. After concluding that the nine enzymes 
worked separately in their single corresponding step, all enzymes were combined in the 
presence of 5-aminolevulinic acid (10) and the necessary co-factors. Spectacularly, complex 
intermediate 11 was obtained in 20% yield. After four additional chemical steps, vitamin B12 
could be readily prepared.  
 
Scheme 1.2 One-pot multistep synthesis of a vitamin B12 precursor.
[18]
 
Many reactions however, can only be integrated if they fulfill certain requirements. It is 
obvious that the combined reactions should proceed in the same reaction medium and - for 
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aqueous solutions - in a similar pH-window. Generally, combining enzymes with metal 
complexes is problematic, as most metal complexes are not active or even decompose in 
water, while many enzymes are inactive in organic solvents. Furthermore, general problems 
with metal catalysts are poisoning of the metal center by undesired coordination of reactants 
or, if more than one metal catalyst is employed, ligand exchange. Another prerequisite of one-
pot chemistry is that reagents or catalysts of different steps are unreactive to each other but 
only interact with the substrate. The combination of opposing reactions, for example acid- and 
base-catalyzed, or reduction and oxidation reactions poses an additional challenge for one-pot 
chemistry.
[19]
 Some successful combinations have been developed with enzymes in organic 
media,
[20]
 especially in the field of dynamic kinetic resolution,
[12]
 and of water-soluble metal 
catalysts combined with enzymes in aqueous reaction mixtures.
[21],[22]
 However, in general 
most reactions cannot be combined in a one-pot process without encountering problems due 
to incompatibility issues. 
Several techniques have been applied to protect reagents or catalysts in one-pot reactions. 
Generally, like in nature, physical contact between incompatible reagents or catalysts is 
prevented mostly via compartmentalization of the compounds. The incompatible reagents or 
catalysts are confined in the compartment while the substrate and other non-harmful reagents 
can move from one compartment to another. An additional advantage of 
compartmentalization is that catalysts can be selectively recovered from the reaction mixture 
in many cases. In this chapter we will describe different approaches that have been followed 
to overcome compatibility issues between different catalysts in a one-step process, with a 
focus on compartmentalization strategies. We will thereby start with methods to make 
reactions compatible on the macroscale and move to the nanoscale. We will also include those 
methods that until now have only been employed in single catalytic processes, but have the 
potential to be also exploited in cascade reactions.     
 
1.2 Biphasic reaction media 
Biphasic reaction mixtures consist of two non-miscible solvents. Solvents do not mix if the 
intermolecular forces differ sufficiently. A classic example is a water-organic solvent mixture. 
If the products have a different polarity than the reagents and catalysts, the product can be 
easily purified and catalysts and reagents can be obtained from the other phase and reused.
[23]
 
The polarity of catalysts can be manipulated by the immobilization on a support with desired 
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hydrophilicity, resulting in a successful recovery and separation from the reaction products.
[24]
 
Water, which is used in classic biphasic reaction set-ups, has the drawback of being polar and 
reactive towards electrophiles. Therefore, in several studies water is replaced by solvents 
which are also immiscible with organic solvents. An early example was described by Rábai et 
al. in 1994.
[25]
 An adapted rhodium catalyst was used under fluorous biphasic conditions 
(FBC) in a hydroformylation reaction. The catalyst was decorated with fluor-rich alkyl tails, 
thereby enhancing the solubility in the fluorous phase. Contrarily, the substrate had a better 
solubility in the other phase, a hexane/toluene mixture, but still reacted in a catalytic 
hydroformylation (Figure 1.2). After completion of the reaction, the catalyst could be readily 
recovered by separation of the two phases. Other combinations of solvents were developed as 
well, for example ionic liquid-organic solvent,
[26]
 supercritical carbon dioxide-water
[27]
 or 
non-aqueous combinations.
[28]
    
 
Figure 1.2 Schematic representation of biphasic catalysis using a fluorous/organic 
biphasic system.
[25]
 From ref. 25. Reprinted with permission from AAAS. 
The solvents can be considered as two separate (macro)compartments: reagents or catalysts 
may be only soluble in one of the two phases, while substrates have a (moderate) solubility in 
both liquids or react at the interface. York et al. demonstrated the beneficial effects of a 
normally low-yielding pair of reactions when performed in a biphasic medium.
[29]
 A Grubbs-I 
catalyzed ring-closing metathesis reaction was combined with a palladium-catalyzed Heck-
coupling (Scheme 1.3). If all reactants and catalysts were combined in one solvent, product 
formation was observed in poor yield due to poisoning of the ruthenium complex by the 
phosphine ligands of the palladium catalyst. When a fluorinated solvent was added the 
palladium catalyst remained in the fluorous phase while the ruthenium complex was confined 
in the other phase catalyzing the ring-closing metathesis reaction. After completion of the first 
reaction, the mixture was heated, resulting in a monophasic mixture. At this point, the 
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palladium catalyst came in contact with intermediate 13 and reacted towards the desired 
compound 14 in a total reaction yield of 67%. If no fluorous phase was used and the catalysts 
were present from the beginning of the reaction, only 22% of 14 was obtained. 
 
Scheme 1.3 One-pot reaction sequence in a water-fluorous phase mixture.
[29]
 
In addition to metal catalysts, biocatalysts have been applied in biphasic reaction mixtures to 
broaden the scope even further.
[30]
 An impressive number of enzymatic reactions are 
performed under biphasic conditions nowadays. Leitner and coworkers showed the concept of 
macroscale compartmentalization by executing an enzyme-metal catalyst combined cascade 
reaction in a biphasic reaction mixture.
[27]
 Hydrogen peroxide was safely prepared in situ by 
palladium catalysis in supercritical carbon dioxide. This oxidant diffused into the other 
solvent, in which an enantioselective sulfoxidation was catalyzed by chloroperoxidase.  
Microfluidic devices are useful for compartmentalization strategies, via the creation of 
microdroplets.
[31]
 These small compartments are prepared by the dispersion of an aqueous 
solution into oil, resulting in a biphasic system. Enzymes, reagents, metal catalysts or whole 
cells have been enclosed in these droplets. As the aqueous layer is completely enclosed by the 
oil phase encapsulation efficiencies with this technique are quantitative. Stability was ensured 
for prolonged periods and activity was still observed in the droplets. 
Several publications describe the application of the in vitro transcription and translation 
(IVTT) strategy in microdroplets.
[32],[33]
 The first step, the transcription process, involves 
mRNA formation from encapsulated DNA. Next, the mRNA is decoded to produce the 
desired protein during the translation step. High-throughput measurements on protein 
expression and function are possible as large numbers of microscale droplets can be produced 
within short periods of time. Each droplet can be considered as an isolated reaction vessel and 
different reaction conditions can be easily screened. Hence, microdroplets can be used in 
directed evolution technology i.e. the gene is randomly mutated in each droplet in order to 
obtain a large library of different mutated proteins which can have desirable properties.
[34]
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1.3 Membrane reactors & dialysis bags 
Continuous membrane reactors are widely used to achieve compartmentalization, in many 
cases to recover valuable catalysts, either biocatalysts or metal catalysts.
[35],[36]
 In a dead-end 
membrane reactor, the mixture is pumped through a membrane and collected at the end of the 
channel, while in a loop reactor the mixture is continuously circulated (Figure 1.3). Materials 
with dimensions larger than the pore size of the membrane stay in their intended 
compartment, whereas substrates and products can diffuse through the membrane.  
Figure 1.3 Different types of continuous membrane reactors.
[35]
 Reprinted with permission 
from ref 35. Copyright (2002) American Chemical Society. 
From the early 1980’s, Wandrey et al. investigated the possibilities of compartmentalized 
catalysis using membrane technology.
[37] 
In an early example, NAD(H) was covalently bound 
to PEG 10,000 and kept in a compartment of the membrane reactor. Together with formate 
dehydrogenase to regenerate the NAD(H) and leucine dehydrogenase, L-leucine was formed 
in 99.7% yield.
 
 In another example, Cantarella linked two membrane reactors in a serial 
fashion.
[38]
 Although this is not a one-pot process per se, it illustrates the possibilities of 
compartmentalization by membrane reactors for cascade synthesis. Nitrilase was enclosed in 
the first reactor, where 3-cyanopyridine (15) was transformed into nicotinamide (16). This 
intermediate product was transferred to a second reactor, in which amidase catalyzed further 
hydrolysis to nicotinic acid (17) (Scheme 1.4). Enclosing the enzymes in different membrane 
reactors provided the possibility to perform the individual reactions at their optimized 
conditions. The reaction mediated by the unstable nitrile hydratase was therefore conducted at 
5 ºC, while the robust amidase gave the best results at 50 ºC. In addition, the concentration of 
the second reaction was lowered to prevent inhibition by the substrate. This approach resulted 
in two quantitative reactions.     
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Scheme 1.4 Nicotinic acid formation via a two-step enzymatic process.
[38]
 
Decreasing the dimensions of reactors offers some attractive features. In these so-called 
microreactors, heating, cooling and mixing are efficiently accomplished and risks of 
explosions or runaway reactions are negligible. A well-controlled cascade reaction with 
microreactors connected serially was developed by Ley and co-workers. Thus, the necessary 
catalysts and reagents were enclosed in different microreactors and the substrates were passed 
through the separate compartments (Scheme 1.5).
[39]
 The first step was mixing a solution of 
Bestmann-Ohira reagent 18, benzyl azide and an aldehyde with a KO
t
Bu solution, resulting in 
acetylene formation upon heating to 100 °C for 30 minutes. Next, the excess aldehyde, base 
and acidic material were removed by passing the mixture subsequently through three different 
types of functionalized columns (with benzylamine, Amberlyst-15 sulfonic acid and 
Amberlyst-21 dimethylamine, respectively). In a fourth column, a copper catalyst was 
immobilized which catalyzed a Huisgen cycloaddition between the acetylene and azide, 
giving a triazole functionality. Traces of copper were scavenged by a thiourea-functionalized 
column, yielding pure product 19 in 69% yield.  
 
Scheme 1.5 In situ acetylene formation and subsequent Cu-catalyzed Huisgen 
cycloaddition inside a microreactor.
[39]
 © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, 
Weinheim. 
Xia and coworkers published an enzymatic dynamic kinetic resolution performed in a 
continuous-stirred membrane reactor. The reactor consisted of two compartments, separated 
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by a silicone rubber membrane (Figure 1.4).
[40]
 The experiment started with racemic 
Naproxen methyl ester (20). Only the (S)-enantiomer was hydrolyzed by lipase. Because of 
the hydrophobic nature of the membrane, only the unreacted methyl ester was able to migrate 
to the other compartment, where the methyl group was isomerized by solid NaOH. Next, the 
racemic mixture could diffuse back to the other compartment and the (S)-enantiomer was 
again hydrolyzed by lipase. An enantiomeric excess of 96% was achieved in a yield of 60%. 
Without using a membrane, the lipase was destroyed by NaOH, which shows that 
compartmentalization was essential for this reaction to succeed.   
 
Figure 1.4 Dynamic kinetic resolution of Naproxen (21) in a membrane reactor.
[40]
 
Catalysis has also been performed in commercially available dialysis bags. Originally, 
dialysis bags were used to purify materials with dimensions larger than the pore sizes of the 
membranes, in most cases enzymes or polymeric materials. However, as was shown by 
pioneering work of the Whitesides group, enclosure of the biocatalysts in a dialysis bag also 
gives the possibility to remove the enzymes from the reaction medium and reuse them by 
adding the bag to a fresh reaction mixture.
[41]
 Recently, also metal catalysis was performed in 
a dialysis bag. In one example, a copper complex was covalently attached to a dendrimer to 
prevent leakage outside the dialysis bag.
[42]
 Still activity of the dendritic catalyst in a Henry 
reaction was observed and the catalyst could be recycled for seven cycles without a 
significant loss in activity. In another example, palladium was immobilized and showed 
activity in a cross-coupling reaction.
[43]
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1.4 Immobilization on supports  
Incompatible reagents or catalysts can be combined in one-pot after immobilization on a 
support. The insoluble materials can be considered as compartments, so the opposing reagents 
cannot interact with each other, even at relatively high concentrations. The soluble substrate 
however, is able to react subsequently with both reagents, thus entering the different 
“compartments”. This approach is not always applicable. Of course, reagents must remain 
active after immobilization. Secondly, inactivation processes may also proceed in a 
heterogeneous mixture. In 1981, Patchornik et al. found that incompatible reagents could be 
combined in one-pot after immobilization on insoluble polymer supports.
[44]
 In one example 
of the so-called “Wolf and Lamb” reaction, γ-butyrolactone (22) was deprotonated by an 
insoluble trityllithium polymer (Scheme 1.6). Next, the anion reacted with a benzoyl-bearing 
polymer, resulting in benzoylated lactone 24 in 95% over two steps. Without immobilization 
on a polymer, only 31% of the desired compound was obtained. The advantage of this method 
is that the lithium enolate 23 could be immediately trapped with the benzoylation agent. 
Contrarily, in a traditional process the base should be completely consumed before continuing 
with the next step, as it otherwise reacts with the benzoylating agent. However, enolate 23 has 
a limited stability in the presence of lactone 22 as it forms the self-condensated byproduct.   
 
Scheme 1.6 Cascade reaction with two polymer-supported reagents.
[44]
 
In later work, catalysts or reagents that were incompatible under homogeneous conditions 
were also immobilized on magnetic nanoparticles and silica.
[45]
 An additional benefit here was 
that the catalysts could be separately removed from the reaction mixture by applying a 
magnetic field and filtration respectively. Another example involves the preparation of a 
bifunctional silica material containing an acid and base.
[46]
 The two opposing reagents were in 
close proximity but did not neutralize each other.  
McQuade used polymer nanoparticles to achieve compartmentalization in a normally 
incompatible reaction.
[47],[48]
 First, benzaldehyde (25) was reacted into trans-β-nitrostyrene 
(26) under (poly)ethylenimine-catalyzed conditions. Next, a nickel-mediated Michael addition 
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produced desired material 29 (Scheme 1.7). The combination of both catalysts in one-pot 
without any further precautions resulted in only 5% yield. This can be attributed to poisoning 
of the metal catalyst 27 due to coordination of the polymer nitrogen atoms to the nickel. 
Nevertheless, by crosslinking the outer amines of the polymer, nanocapsules were formed. 
The capsule surface appeared impermeable for the metal catalyst, while the starting material 
25 was able to penetrate and react with nitromethane to intermediate 26.   
 
Scheme 1.7 Double catalyzed Michael adduct formation in one-pot.
[47]
 
Fréchet used star polymers to protect acid and base catalysts from neutralization in a 
homogeneous mixture.
[49]
 The acid PTSA and the base DMAP were covalently attached to a 
styrene monomer, which was used in a crosslinking reaction with divinylbenzene and 
nitroxide-functional polystyrene chains to obtain star polymers. Thus, the reactive 
functionalities were located at the core of the materials while the outer part contained 
polystyrene. It was hypothesized that the acidic and basic moieties would have no interaction 
as the reactive centers were unable to physically come in contact with each other (Figure 1.5). 
Indeed, a yield of 65% was obtained in a cascade reaction in which an aldehyde was formed 
after acid-mediated acetal hydrolysis and subsequent base-promoted Baylis-Hillman reaction. 
If the non-adapted catalysts were used, no desired product was obtained. More importantly, 
also reactions in which the acid and base were attached to linear polymers did not yield any 
desired material. This result shows that it was essential to locate the catalytic site in the 
interior of the star polymer.  
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Figure 1.5 Acid- and base-containing star polymers without interaction abilities.
[49]
 © 
2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
Polymer micelles are related to the star polymers described by Fréchet.
[50]
 Polymeric 
amphiphiles self-assemble above the critical micelle concentration under aqueous conditions, 
thereby preventing contact between water and the hydrophobic part of the polymer. 
Nanocompartments are thus formed with an opposite polarity as the solvent. This feature has 
been used to perform organic reactions in aqueous media which were not possible in water 
alone.
[51] 
In addition, enhanced catalytic activities in polymeric assemblies have been 
observed, which can be attributed to high local substrate and catalyst concentrations inside the 
vesicles. For example, Sc(OTf)3-catalyzed aldol reactions inside a micellar vesicle resulted in 
a fivefold increase in product formation.
[52]
 In other research, a rhodium-catalyzed 
hydroformylation showed good yields in the presence of surfactants, while no conversion was 
observed in pure water.
[53]
 Polymer micelles were also used for recycling purposes. An 
encapsulated gold catalyst showed good activity in a cycloisomerization reaction and could be 
recycled by extraction with a metal loss of only 0.1% or less per cycle.
[54]
 Other examples of 
metal catalysis in polymeric micelles reported by the same group consisted of metathesis 
chemistry with a Grubbs catalyst
[55]
 and a palladium-catalyzed Sonogashira coupling.
[56]
 
Enclosing catalysts or reagents in different polymeric micelles or at different locations of the 
micelles would allow performing cascade reactions that are normally incompatible. 
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1.5 Sol-gels 
Sol-gels are glassy or ceramic materials which are prepared from colloidal solutions. 
Generally, sol-gels are formed after hydrolysis of metal alkoxides, resulting in condensation 
into polymeric networks with submicrometer pores. Starting from the middle of the 19
th
 
century, a constant interest in sol-gels led to a broad knowledge about these materials.
[57]
 
Besides applications in for example the field of ceramics and the manufacturing of optical 
elements like lenses and mirrors, sol-gels are applied in (bio)organic chemistry. Because 
numerous papers have appeared about the encapsulation of catalysts in sol-gels,
[58],[59]
 we will 
only discuss some selected examples in which cascade reactions are performed with 
compatibility issues. Between 2000 and 2003, Avnir, Blum and Gelman published about 
combining incompatible reactions in a one-pot system by compartmentalizing the 
incompatible catalysts in sol-gels.
[60],[61],[62],[63]
 One obvious striking combination comprises 
acid-base catalysis. Various acids and bases were successfully entrapped in separate sol-
gels.
[61]
 Next, both gels were added to the same reaction vessel. Ketone 30 was formed via an 
acid-catalyzed pinacol-rearrangement; after diffusion out of the acidic and into the basic gel it 
reacted further by a base-promoted Knoevenagel reaction (Scheme 1.8). No leakage of the 
reagents from the different compartments was observed, which was necessary to perform the 
cascade reaction. 
 
Scheme 1.8 Acid-catalyzed pinacol rearrangement and base-promoted Knoevenagel 
reaction.
[61]
 
In another example, opposing oxidation and reduction reactions were combined. Gelman et al. 
encapsulated pyridinium dichromate, an oxidant, and a metal catalyst capable of performing 
hydrogenations in separate sol-gels.
[64]
 By combining both gels in one-pot, a primary alcohol 
was oxidized to the corresponding aldehyde, which reacted with an amine. Next, the resulting 
imine was reduced by the metal catalyst. Without entrapment of both reagents in different 
compartments, the metal complex was poisoned by the oxidant. 
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1.6 Templated nanocapsules 
Particles with an internal reaction volume can be prepared by the preparation of a permeable 
shell around a sacrificial template. Removal of this temporary core leaves a capsule with a 
hollow interior, which is perfectly suited to perform (bio)catalysis. The most applied method 
for the creation of the shell is the layer-by-layer (LbL) technique, in which multiple thin 
layers are prepared step-by-step, i.e. each layer after the other. As a result of this fabrication 
technique, an excellent control on size, stability and permeability is realized. Furthermore, for 
each layer a different material can be used, as long as the different layers have a reasonable 
interaction to secure binding of the sequential layers.
[65]
 Polyelectrolyte capsules are an 
important class of LbL-particles, which consist of consecutive multiple layers of polyanions 
and polycations.
[66]
 Formation of the layers is possible due to stabilization by electronic 
interactions, which results in a highly permeable membrane.
[67]
 In a representative example, 
the starting point is a colloidal particle, which is encapsulated by negatively charged 
polymers, poly(styrene sulfonate) (PSS) (Figure 1.6). The next step involves addition of the 
positively charged poly(allylamine) (PAH), which binds to the particle due to electrostatic 
interactions. The cycle of absorption of alternating charged polymers is repeated until the 
desired strength and thickness of the layer are achieved. Destruction of the solid core of the 
particle results in a hollow polyelectrolyte capsule. Problems during the preparation are 
mixing of the opposing charged layers, difficulties in removal of the non-bound 
polyelectrolytes and incomplete coverage of the surface, all leading to vesicles with less 
defined and unpredictable properties.  
 
Figure 1.6 Polyelectrolyte capsule formation.
[68]
 © 2004 Wiley-VCH Verlag GmbH & Co. 
KGaA, Weinheim. 
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Besides a great interest in polyelectrolyte nanocapsules for drug delivery purposes,
[69]
 other 
molecules have been entrapped, including enzymes.
[68]
 Because of the intrinsic permeability 
of the shell it is no surprise that polyelectrolyte capsules have been used as nanoreactors, for 
example by Sukhorukov et al.,
[70],[71]
 even in cascade chemistry.
[72]
 A normally incompatible 
dynamic kinetic resolution was successfully performed (Scheme 1.9). Compartmentalization 
of the acidic zeolite was achieved by encapsulation via the layer-by-layer method and the 
nanoreactor was used together with the lipase Candida antarctica Lipase B (CALB). The acid 
catalyzed the racemization of 1-phenylethanol (33). The (R)-enantiomer was selectively 
acetylated by CALB, which afforded 70% of 34 in 87% ee. Without compartmentalization, 
only 41% conversion and 11% ee of the acetylated alcohol 34 were observed, caused by 
enzyme inactivation by the acidic catalyst.   
 
Scheme 1.9 DKR with normally incompatible acidic zeolite and lipase CALB.
[72]
 
A higher level of complexity in compartmentalization was achieved by the group of Möhwald 
with the construction of a vesicle-in-vesicle architecture.
[73]
 The so-called shell-in-shell 
microcapsules are multi-compartment nanoreactors in which two normally incompatible steps 
can be combined within one particle. The preparation of the vesicles started with 
coprecipitation of an enzyme in the presence of magnetite by adding Na2CO3 (Figure 1.7). 
Next, the particles were coated via the LbL technique and a second Na2CO3 precipitation was 
performed at the surface in presence of a second enzyme. At this time, no magnetite was 
added which enables the purification of the desired material from the coproduct, consisting of 
Na2CO3 particles which were formed spontaneously in solution and did not encapsulate the 
previously made LbL particle. Another coating was installed, followed by removal of both 
inorganic supports. The compartments of the microvessels were independently loaded with 
glucose oxidase and peroxidase. In a cascade reaction, enzymatic oxidation of glucose yielded 
H2O2, which was used by peroxidase to produce a highly fluorescent species. A fluorescent 
signal was only observed in the peroxidase compartment of the vesicle. This result shows that 
no leakage of the enzyme occurred and peroxide was able to diffuse from the glucose 
oxidation compartment to the other compartment. This concept was expanded by Bäumler, 
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who encapsulated three enzymes in three different compartments of one single – shell-in-
shell-in-shell – particle.[74]  
 
Figure 1.7 Formation of shell-in-shell microcapsules by Möhwald et al.
[73]
 © 2007 Wiley-
VCH Verlag GmbH & Co. KGaA, Weinheim. 
Related materials are yolk-shell vesicles. These are vesicles with a shell and a heterogeneous 
nanoparticle in the core which however does not utilize the whole inner compartment. An 
early example of a catalytic application has been described by the group of Song.
[75]
 This 
material was prepared using a simple approach starting with the preparation of gold 
nanoparticles, which were coated with silica. In the last step, the metal was partially etched 
away in a controlled manner, leaving empty space between the metallic core and the silica 
shell (Figure 1.8). The particles showed catalytic activity in the reduction of p-nitrophenol by 
NaBH4. The heterogeneous catalyst stayed inside the compartment, while the substrate and 
reducing agent were able to diffuse through the silica shell. 
 
Figure 1.8 Au@SiO2 yolk/shell particle formation.
[75]
 © 2008 Wiley-VCH Verlag GmbH 
& Co. KGaA, Weinheim. 
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An incompatible cascade sequence using yolk/shell particles has been recently reported by 
Yang (Figure 1.9).
[76]
 The core consisted of a basic amine while the outer surface was covered 
with acidic functionalities. The preparation was a combination of the methods depicted in 
Figures 1.7 and 1.8: a sacrificial silica layer was attached to a solid nanoparticle 
functionalized with Boc-protected amines. Next, a thiol-bearing mesoporous silica shell was 
built up around this silica-coated system. After removal of the silica layer, a yolk/shell 
particle was obtained. Next, the amines were deprotected and the thiol groups oxidized to 
SO3H, resulting in particles bearing two opposing catalysts. The particles showed an excellent 
activity in an acid-catalyzed deacetylation followed by a base-promoted Henry condensation. 
Additionally, the material could be recycled with only a slight loss in activity.    
 
Figure 1.9 Compartmentalized cascade reaction in a yolk-shell nanoreactor.
[76]
 © 2012 
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
 
1.7 Liposomes 
Liposomes are vesicles with a bilayer of phospholipids. Due to the amphiphilic nature of the 
phospholipids, nanocompartments with dimensions between 20 and 200 nm are formed in 
water to minimize hydrophobic-hydrophilic interactions. Liposomes have been well-studied 
in the past and current interest focusses on mimicking the living cell,
[77]
 enzyme encapsulation 
and stabilization
[78]
 and drug delivery.
[79]
  
The concept of compartmentalization is nicely illustrated in an example described by 
Moore.
[80]
 ATP was produced in a liposome after incorporation of both ATP synthase and a 
proton pump in the liposomal membrane of the vesicle (Figure 1.10). ATP synthase is a 
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membrane protein with two subunits which is able to produce ATP from ADP and inorganic 
phosphate. Electrons can be transferred through the membrane via the carotene–porphyrin–
naphthoquinone amphiphile after excitation (C-P-Q to C
•+
-P-Q
•-
) and a lipophilic quinone 
(Qs) in an alternating oxidized-reduced form. Upon a pH difference between the two sides of 
the membrane, one of the subunits of the synthase starts to rotate and produces ATP. One of 
the subunits of ATP synthase was embedded inside the lipid membrane of a liposome, while 
the other subunit could freely rotate and hence produce ATP.    
 
Figure 1.10 ATP formation at the surface of a liposome (C
•+
-P-Q
•-
 represents the excited 
amphiphile).
[80]
 Reprinted by permission from Macmillan Publishers Ltd: Nature, ref. 80, 
copyright (1998). 
The production of proteins via the in vitro transcription and translation (IVTT) strategy inside 
these lipid vesicles is another impressive example of a cascade process and an alternative for 
protein formation from cell extracts.
[81]
 The first step, the transcription process, consists of 
mRNA formation from encapsulated DNA. Next, the mRNA is decoded to produce the 
desired polypeptide during the translation. In the group of Yomo, Green Fluorescent Protein 
(GFP) was produced in such a cascade process.
[82]
 First, a gene was expressed to obtain RNA 
polymerase, which transcribed a second gene yielding the GFP. In a second impressive 
example, Libchaber et al. expressed α-hemolysin, a pore-forming protein, inside liposomes 
via the transcription-translation sequence. The in situ prepared protein migrated to the shell 
and formed a membrane channel for nutrients for another protein formation process.
[83]
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Recently, the group of Zasadzinski reported a multicompartment liposome.
[84]
 Large vesicles 
with lipid bilayer were formed in the presence of smaller ones, which yielded liposomes-in-
liposomes or so-called ‘vesosomes’. Encapsulation of a drug inside the vesosomes resulted in 
an enhanced stability in serum. The half-life of ciprofloxacin, a drug often used in drug-
release studies, increased from 10 minutes in single liposomes to 6 hours in vesosomes. This 
can be attributed to the double lipid membrane which has to be crossed instead of a single 
membrane in liposomes. This multicompartment vesicle is a first step towards more complex 
systems and a closer mimic of a natural cell. The multiple organelles in living cells can be 
considered as inner compartments, which are necessary to achieve an efficient metabolism. 
Compartmentalization within one particle will have benefits compared to multiple single 
compartment vesicles in chemical transformations, as intermediates need to travel a shorter 
distance to the next reactive site. 
 
1.8 Polymersomes 
Polymersomes are the synthetic analogues of liposomes and were firstly reported by Discher 
in 1999.
[85]
 Inspired by the self-assembly behavior of natural phospholipids in water, synthetic 
polymeric amphiphiles were added to water and robust vesicles were spontaneously formed. 
Dyes and proteins were successfully encapsulated in those nanocompartments. Polymersomes 
are generally more stable than liposomes, which is attributed to the higher molecular weight 
of the polymers.
[86]
 In addition, properties of polymersomes are better tunable, as many 
different hydrophobic and hydrophilic polymers can be used and the polymers can be 
synthetically adapted.
[87]
 Also the size of the hydrophobic and hydrophilic part and the length 
of the whole polymer have an influence on the thickness, strength and porosity of the vesicle 
membrane. The permeability can be further adapted by insertion of specific proteins in the 
membrane,
[88],[89]
 or by insertion of stimuli-responsive groups,
[90]
 thereby creating semi-
permeable channels. 
Besides proposed biomedical applications of polymersomes as drug carriers,
[91]
 these vesicles 
have been extensively used in compartmentalized catalysis. The polymeric membrane is an 
efficient semi-permeable gate: small molecules can easily enter the compartment, while large 
materials like enzymes or heterogeneous nanoparticles stay inside. Hence, polymersomes 
would be useful to perform cascade reactions with incompatible catalysts, provided that these 
catalysts are unable to cross the membrane. To date, no incompatible reactions have been 
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combined with the aid of polymeric nanoreactors as compartmentalization technique. 
However, some examples of compatible reactions which were combined in a one-pot reaction 
will be discussed to show the concept of compartmentalization via polymersomes. 
In an early and impressive example, Montemagno prepared a multi-enzyme bearing 
polymersome (Figure 1.11),
[92]
 analogously to the liposome example of Moore
[80]
 and 
discussed in the corresponding section. Under the influence of light, protons were 
continuously introduced in the polymersome via the enzyme bacteriorhodopsin (BR), which 
was also installed in the polymeric membrane. A pH difference of almost 0.1 was observed 
between the interior and exterior of the vesicle, which was large enough to produce ATP. In 
the absence of light, no ATP production was detected, showing that it was essential to have 
two active enzymes. This design would have been impossible to conduct without a vesicle. 
However, its function was to create a proton-enriched environment and not to protect 
enzymes from deactivation.               
 
Figure 1.11 BR-ATP synthase-mediated ATP formation based on a proton gradient.
[92]
 
Reprinted with permission from ref. 92. Copyright (2005) American Chemical Society. 
In another example, three enzymes were combined in a one-pot process. Two enzymes were 
installed inside a polymersome: one in the lumen and one in the membrane. The third enzyme 
was first kept outside the polymersome and in later work attached to the membrane surface 
(Figure 1.12).
[93],[94]
 The first enzymatic step comprised a CALB-catalyzed deacetylation of 
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glucose acetate in the membrane of the nanoreactor. Next, the deprotected alcohol was 
selectively oxidized by glucose oxidase (GOx) thereby producing hydrogen peroxide. This 
compound diffused through the membrane and was used in the oxidation of ABTS by the 
surface-attached horse radish peroxidase (HRP), yielding a fluorescent species. This 
combination of enzymes is also active in solution, but it nicely shows the possibility of 
compartmentalization. Hence, the same strategy would be applicable for incompatible 
enzymes or metal catalysts as well.   
 
Figure 1.12 Three-enzyme-mediated cascade reaction with all enzymes attached to one 
polymersome.
[94]
 © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 
To successfully mimic the natural metabolism process in polymeric vesicles, a demand exists 
for multicompartmentalized vesicles.
[95]
 Caruso and co-workers designed liposome-in-
polymersome vesicles, called capsosomes, for nanocarrier purposes.
[96]
 First, a cholesterol-
based polymeric film was formed around silica nanoparticles, which gave a stable absorption 
of phospholipid liposomes. Next, a mixture of a cholesterol-based polymer and a different, 
crosslinkable polymer was assembled around the liposomes. Stable capsules were obtained 
after crosslinking of the outer polymer shell. Although this system was designed for transport 
of the liposome loading, it should also be applicable for cascade catalysis in which each 
catalyzed transformation is performed in a different compartment.    
Nallani prepared polymersomes-in-polymersomes by the formation of the large, outer 
polymersome in the presence of smaller polymersomes.
[97]
 Besides single polymersomes of 
both the large and the small type, polymersomes-in-polymersomes were observed. This 
example of a vesicle with more than one compartment was supported by an experiment with a 
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smart choice of macromolecular dyes: a red and a green fluorescent dye were encapsulated in 
the large and small polymersomes, respectively. Fluorescence microscopy showed either red 
or green emission for the single polymersomes, while the polymersome-in-polymersome 
system showed a yellow emission, indicating that the two dyes are in close proximity of each 
other and that the small polymersomes were indeed encapsulated into the larger ones. In a 
more recent example, Lecommandoux also prepared polymersomes-in-polymersomes.
[98]
 The 
encapsulation of the smaller vesicles into the larger ones was achieved via an emulsion-
centrifugation procedure, leading to a highly efficient method to prepare 
multicompartmentalized vesicles.   
Weitz et al. prepared vesicles which can be seen as two spheres adhering together.
[99]
 
Formation of the multicompartment vesicles was performed in a well-controlled fashion 
(Figure 1.13). First, W/O/W double emulsions with multiple inner water droplets were 
prepared with glass capillary microfluidics. A di-block copolymer stabilized the interfaces 
between the organic solvent and water. Upon evaporation of the oil-phase, the water droplets 
which were initially in the oil-droplet stuck together. Importantly, the polymeric walls 
between the aqueous compartments remained intact, which yielded polymeric capsules with 
multiple compartments. These complex materials would be perfectly suited for cascade 
chemistry, as subsequent incompatible processes can be performed in close proximity of each 
other.        
 
Figure 1.13 Multicompartment formation via a W/O/W double emulsion.
[99]
 © 2011 Wiley-
VCH Verlag GmbH & Co. KGaA, Weinheim. 
In other work of the same group polymersomes were prepared with a triple polymeric 
membrane.
[100]
 Each membrane consisted of the same amphiphile. The 
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multicompartmentalized vesicles were constructed following a step-by-step approach using a 
microfluidic device. 
Very recently, polymersome-stabilized pickering emulsions were reported (Figure 
1.14).
[101],[102]
 These emulsions consist of water droplets in an oil phase, which are stabilized 
by colloidal particles. In one example, catalysis was performed within these 
multicompartmentalized vesicles.
[101]
 To this end, Candida antarctica Lipase B (CALB) was 
encapsulated in either the polymersomes or the water droplets and showed enhanced yields in 
an unfavorable esterification reaction in water. The improved reactivity can be explained by 
the presence of a large hydrophobic medium and small aqueous compartments in which the 
lipase was active. The lipid nature of the product ensured that the molecule stayed only 
shortly in the aqueous vesicle.  
 
Figure 1.14 Polymersome-stabilized pickering emulsions with CALB encapsulated in the 
water droplet (A) or in the polymersomes (B).
[101]
 © 2012 Wiley-VCH Verlag GmbH & Co. 
KGaA, Weinheim. 
 
1.9 Viruses and virus like particles 
Virus-like particles (VLPs) are one of the best defined capsules that have been employed as 
nanoreactors. Generally, the surfaces of these viral cages consist of multiple copies of only 
one or a few different protein subunits, which are assembled in a highly ordered fashion. 
Naturally, virus cages contain genetic material which is brought inside living host cells for 
reproduction of the virus. Release of this material occurs by disassembly of the protein cage, 
followed by reforming the virus particle. Scientists have demonstrated that for some virus 
particles this DNA or RNA could be removed and replaced by other materials like enzymes 
and metal nanoparticles by using a disassembly-assembly strategy that was inspired by 
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nature.
[103]
 Since the genetic information is missing, the protein nanocontainer is referred to as 
a virus-like particle. Inside this nanocontainer catalysts can also be synthesized.
[104]
 Enzyme 
loaded capsules are, besides application in the field of protein carriers,
[105]
 perfectly suited for 
catalysis as the shell of capsules is highly permeable to substrates.
[106],[107] 
The interest in 
using viral nanoreactors has increased over the past years because these compartments can be 
considered as artificial organelles. The content of the capsules is compartmentalized and 
hence protected from the environment.  
 
1.10 Outlook 
The chemical community started to work on cascade reactions because potentially higher 
overall efficiencies can be obtained. Time, costs and waste can be reduced by performing 
reactions in a subsequent manner. Therefore, the search for compatible catalysts and reagents 
to perform multiple steps in one-pot will continue. However, some reactions simply cannot be 
combined, and in such cases compartmentalization is a key technique to overcome 
incompatibilities. The approach to separate harmful catalysts and reagents has been changed 
from a macroscopic to a nanoscopic level since the start of cascade chemistry. In early 
examples, separation was achieved by membrane reactors, via biphasic reaction conditions 
and on heterogeneous supports. Today, the state-of-the-art examples of compartmentalization 
are mainly at the micro- and nanoscale level. Polyelectrolyte capsules, shell-in-shell vesicles, 
liposomes and polymersomes are recent developments in the field of compartmentalization. 
These materials can be considered as mimics of living cells, as they all have an inner 
compartment surrounded with a shell or membrane. Furthermore, (bio)catalysts can be 
encapsulated, which allows to conduct chemical transformations within the artificial cells. 
Due to the small dimensions of the compartments, the path from one catalytic site to another 
is short and subsequent reactions can proceed faster. Hence in the future, academic research 
will most likely mainly focus on nanoscale encapsulation techniques.   
A better imitation of a living cell will enhance the efficiency of cascade reactions. 
Consequently, it is expected that the complexity of nanoreactors will increase. More steps can 
be incorporated in a cascade sequence if multicompartment vesicles are used, which has 
already been shown with shell-in-shell capsules, liposomes and polymersomes. Additionally, 
catalysts can be attached at different locations in or around the vesicle. Another way to obtain 
a closer mimic of a cell is to incorporate selection channels in the membrane. In this way, 
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desired substrates can selectively enter the compartment, while unreactive or harmful 
compounds will not occupy the compartment and inhibit conversion of the substrate. A next 
step would be to navigate substrates to the catalytic site. In previous examples of cascade 
reactions in microcapsules, substrates diffused in random directions and reacted more or less 
‘incidentally’ near the biocatalyst. Navigation of the substrates, for example by mimicking 
metabolic channeling, would definitely enhance the efficiency, as the sequence of 
transformations will proceed faster.     
Until now, the potential of homogeneous metal catalysis has been underestimated in cascade 
chemistry in micro- and nanocapsules. Many metal-catalyzed transformations are difficult to 
achieve by biocatalysts, so the usage of metal catalysts will definitely enhance the synthetic 
opportunities of cascade reactions. A possible explanation for the lack of homogeneous metal 
catalysis in micro- and nanocapsules is that the metal complex should be immobilized on a 
large support to prevent diffusion into another compartment. Furthermore, the metal 
complexes have to be active in aqueous medium, as only a small number of enzymes show 
activity in organic solvents. This puts severe restrictions on the metal complexes that can be 
applied in combination with enzymes. Clearly, more research is required to extend the use of 
homogeneous metal catalysis in aqueous cascade reactions inside microcompartments.   
 
1.11 Thesis outline 
This research has been carried out as part of the program ‘Catalysis Controlled by Chemical 
Design’ of the Dutch National Research School Combination – (NRSC-Catalysis). Our goal 
was to develop catalytic cascade reactions in an aqueous medium, possibly facilitated by 
compartmentalization. Reactions in water were selected since that would allow combinations 
of transition metal complexes with enzymatic reactions in cascade processes.  
Chapter one introduces numerous examples of compartmentalization strategies that have been 
developed over the years. In chapter two, bipyridine and N-heterocyclic carbene (NHC) 
ligands, widely applied in catalysis, were functionalized for immobilization purposes and to 
allow the introduction of water-soluble groups. In chapter three, the modified bipyridine 
ligand was attached to a dendrimer and a metal was coordinated. Due to its expanded size, the 
resulting macrocatalyst stayed in a dialysis bag during a catalytic reductive amination in 
water, showing the concept of aqueous compartmentalized catalysis. In chapter four, our 
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efforts to encapsulate a homogeneous metal catalyst inside a polymersome nanoreactor are 
reported. Approaches involving immobilization on dendritic molecules and on proteins were 
pursued. In chapter five, two catalytic steps, an enzyme-mediated oxidation and a metal 
complex-catalyzed reduction, were combined in one-pot. It is described how a small 
molecule, potassium formate, can act as a switch to stop one process and start the other one.  
The final chapter six describes a laccase/TEMPO-mediated oxidation combined with a 
Michael addition catalyzed by a copper complex, which was immobilized on a DNA template. 
The effect of the presence of the template on compatibility and stereochemistry of the cascade 
reaction was investigated. 
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2. Ligand synthesis for water-soluble metal 
catalysts 
 
Abstract 
In the past decades, the interest in green chemistry has significantly grown in order to reduce 
the environmental impact of chemical processes. The use of green solvents such as water for 
the execution of traditional reactions is in this respect one of the central focus points. Another 
important issue is the recovery of toxic metal catalysts from reaction mixtures. This is 
generally achieved by immobilization on a support which facilitates separation of the catalyst 
after the reaction by filtration. In order to be able to conduct metal-catalyzed cascade 
reactions in water, we have enhanced the water solubility of metal catalysts by installing polar 
functional handles on N-heterocyclic carbene (NHC) and bipyridine ligands, which at the 
same time could be used for immobilization purposes.  
 
2.1 Introduction 
Green chemistry can be described as the performance of chemical processes in such a way 
that the impact on the environment is reduced. Given the societal pressure to decrease the 
environmental burden by chemical manufacturing and to develop sustainable chemical 
processes, green chemistry approaches attract much attention of the global community.
[1],[2]
 
The chemical industry has put a lot of effort in the past decades to implement green chemistry 
in their production processes. For example, hazardous chemicals are increasingly replaced by 
other, non-toxic reagents. Furthermore, the formation of environmentally unfriendly 
byproducts must be prevented as much as possible, while the desired transformations must 
proceed in high yield. To this end, many processes utilizing stoichiometric amounts of 
reagents are developed into catalytic ones, which also leads to a reduction of costs since 
catalysts lower the activation energy of reactions, allowing them to be performed at lower 
temperatures. Importantly, the recovery of (heterogeneous) catalysts is also widely applied in 
industry to reduce costs and the impact of the metals involved on the environment. Another 
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aspect concerning green chemistry is to use environmentally benign solvents. The total impact 
on the environment varies from solvent to solvent,
[3]
 but evidently an excellent green 
chemistry candidate is water. Therefore, currently established organic transformations are 
adjusted to be carried out in aqueous or water-compatible media.
[4]
 Heterogeneous metal 
catalysts have generally a high stability towards water and are readily recovered by filtration. 
However, there are numerous reactions in which homogeneous catalysts outperform their 
heterogeneous counterparts. This is often due to the fact that the relatively stable 
heterogeneous catalysts are difficult to modify, while well-defined homogeneous catalysts are 
more easily optimized to a higher level of selectivity and reactivity. The outcome of 
homogeneous metal-based catalyzed reactions can be adjusted by modifying the coordinating 
ligands of the catalysts. For example, a good selectivity between formation of the linear and 
branched products in hydroformylation reactions is an important target of the chemical 
industry as the functionalization of olefins is a major commercial process.
[5],[6]
 Selectivity can 
be achieved by choosing the proper combination of metal and ligands. This has amongst 
others be extensively studied by van Leeuwen and co-workers, who showed that the ratio 
between branched/linear products could be varied between 6.7 and 80.5, depending on 
different ligand-rhodium combinations in which the bite angle was determined by the 
bidentate ligand (Scheme 2.1).
[7]
  
 
Scheme 2.1 Control of regioselectivity in the hydroformylation of 1-octene (1). 
Furthermore, the enantioselectivity of catalytic processes can be directed by coordination of 
chiral ligands.
[8]
 Well-known examples are BINAP,
[9]
 BOX
[10]
 and TADDOL
[11]
 ligands 
(Scheme 2.2). After coordination to a metal, enantiopure catalysts are obtained which can 
promote reactions in an enantioselective fashion.  
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Scheme 2.2 Examples of widely applied chiral ligands. 
In order to perform chemical processes in an environmental friendly solvent, many 
homogeneous metal catalysts have been developed which are soluble and active in water.
[12]
 
In most cases, the hydrophilicity is increased by the introduction of highly polar substituents 
such as sulfonate,
[13]
 carboxylate
[14]
 or ammonium
[15]
 groups onto the ligands. Furthermore, 
the immobilization onto water-soluble supports such as polyethylene glycol
[16]
 or proteins
[17]
 
has been reported.  
In addition, metal-ligand complexes have also been immobilized on resins
[18]
 or silica gel,
[19]
 
which renders catalyst recovery by filtration possible. For all these modifications it is 
necessary that the ligands are equipped with functional handles. In this chapter we describe 
the introduction of these handles onto N-heterocyclic carbene (NHC), bipyridine and 
terpyridine ligands, three important metal ligands in homogeneous catalysis. Amines, azides, 
alcohols or carbonyl imidazole functionalities were for example introduced. This allows to 
immobilize the catalyst on a support and/or to enhance the water solubility of the 
corresponding metal complexes by the introduction of water-soluble moieties. 
 
2.2 Synthesis of functionalized NHC ligands  
N-Heterocyclic carbenes (NHC) (Scheme 2.3) are widely used as ligands in transition metal 
catalysis, due to the wide range of metals which can be bound to these ligands and the 
excellent stabilization and activation behavior of the metal centers.
[20]
 Syntheses of 
functionalized NHC ligand precursors have been described, which allow straightforward 
attachment of the catalysts to a support. We were especially interested in the introduction of 
hydrophilic moieties onto these NHCs, which we anticipated would result in water-soluble 
metal-NHC complexes.   
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Scheme 2.3 NHC-based metal complexes. 
N-Heterocyclic carbene ligands are generally synthesized via the readily accessible 
corresponding imidazolinium salt. The formation of an NHC-metal complex can either 
proceed spontaneously in the presence of a metal precursor (Scheme 2.4, pathway A) or can 
be achieved by reacting the imidazolinium salt with a strong base and subsequent metal 
precursor addition (Scheme 2.4, pathway B).
[20]
 
 
Scheme 2.4 General NHC-metal complex formation via a spontaneous process (A) or via 
free carbene formation (B). 
2.2.1 Amine-functionalized NHC ligand and subsequent PEGylation 
Amines are reactive nucleophiles which readily attack a wide range of electrophilic groups 
and are therefore perfectly suited for functionalization purposes. In order to introduce an 
amine-functional handle onto NHC-ligand precursors, a reaction sequence was initially 
followed in which a Boc-protected amine was prepared (Scheme 2.5). The sequence started 
with the dibromination of allyl amine (6), yielding compound 7.
[21]
 Next, the mesitylene 
moieties were installed by heating electrophile 7 in neat amino-mesitylene.
[22]
 Desired product 
9 was obtained in a rather moderate yield of 44% as the undesired regioisomer 8 was formed 
as well via intramolecular aziridine formation and subsequent mesitylene attack onto the least 
hindered carbon. The primary amine was readily Boc-protected, which allowed continuing 
with the ring closure in the presence of triethyl orthoformate, yielding the imidazolium salt 11 
bearing a Boc-protected amine group in 84% yield.       
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Scheme 2.5 Synthesis of NHC precursor bearing a Boc-protected amine. 
Next, NHC precursor 11 was deprotected with TFA and after treatment with HCl the 
dichloride salt 12 was obtained in 85% yield (Scheme 2.6). Subsequently, a PEG chain was 
introduced under basic conditions using the NHS-functionalized PEG chain 13. The desired 
product 14a was obtained in pure form after silica gel column chromatography. The presence 
of this hydrophilic polymer was expected to enhance the water solubility of the corresponding 
NHC-metal complexes. The counterion was replaced for the weaker coordinating anion BF4
-
, 
which was anticipated to result in a better coordination to the metal ion of choice.
[23]
 
 
Scheme 2.6 Boc-deprotection and PEG introduction. 
2.2.2 Azide-functionalized NHC ligand 
Sharpless
[24]
 and Meldal
[25]
 independently developed the Huisgen 1,3-dipolar cycloaddition 
into a powerful tool to connect two molecules in a facile and fast orthogonal reaction between 
an azide and an alkyne in the presence of a copper(I) catalyst.
[26]
 Since then, this approach to 
ligate two molecules has become enormously popular and is still applied in numerous 
approaches to conjugate two molecules or materials at will.
[27],[28]
 Alternatively, methods have 
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been developed in which the copper catalyst can be omitted, thereby preventing poisoning of 
biological materials.
[29],[30]
 Hence, azides form ideal candidates as general handles on NHC-
ligands, as they will react with any alkyne-functionalized material. The azide-bearing 
imidazolinium salt 17 was readily obtained in two steps (Scheme 2.7). Firstly, amine 9 was 
treated with diazotransfer reagent 15,
[31]
 yielding the corresponding azide 16 in good yield. 
Subsequent orthoester-induced formation of the desired imidazolinium ring 17 proceeded in 
91% yield. 
 
Scheme 2.7 Azide introduction to NHC-ligand precursor. 
2.2.3 Alcohol-functionalized NHC ligand and subsequent TBS protection 
Alcohols are useful functionalities for the conjugation to a wide variety of supports. The 
moderate nucleophilicity of alcohols can be generally increased by simple deprotonation. In 
addition, an alcohol group can be readily transformed into a leaving group in a single step e.g. 
via mesylation, an Appel reaction
[32]
 or a Mitsunobu reaction.
[33]
 Synthesis of an NHC ligand 
precursor with an alcohol was performed analogously to preparation of amine 12. First, 2,3-
dibromopropanol was reacted with amino-mesitylene,
[22]
 yielding alcohol 19 in moderate 
yield (Scheme 2.8). Next, the imidazolinium salt was produced by heating the product in ethyl 
orthoformate. A subsequent tert-butyldimethylsilyl (TBS) group was installed to prevent side-
reactions during coordination of the ligand to a metal.   
 
Scheme 2.8 Formation of an NHC-ligand precursor bearing a TBS-protected alcohol. 
- 41 - 
 
2.2.4 NHC ligand coordination to ruthenium and iridium 
The Hoveyda-Grubbs-II complex (22) (Scheme 2.9), active in metathesis reactions, is a well-
known example of a metal complex containing an NHC ligand.
[34]
 Another important catalyst 
is iridium-NHC complex 23, which is active in hydrogenation reactions.
[35]
 In this section, we 
describe our efforts to coordinate the functionalized ligands to iridium and ruthenium, thereby 
leading to analogues of these catalysts. 
 
Scheme 2.9 Hoveyda-Grubbs-II catalyst 22 and iridium-NHC complex 23. 
The coordination of the previously described NHC ligands to Hoveyda-Grubbs I complex 24 
should afford a Hoveyda-Grubbs II analogue with enhanced hydrophilicity (Scheme 2.10). 
First, a free carbene was formed in situ by deprotonation of ligand 14b with KHMDS, 
followed by coordination to the metal center.
[23]
 The formation of the desired metal complex 
was observed by 
1
H-NMR, but the complex could not be separated from an unknown side-
product by precipitation or column chromatography. 
1
H-NMR revealed that the impurity was 
not the starting material, and that it contained the isopropoxystyrene ligand. Remarkably, 
comparable chemistry towards HG-II
[36]
 also resulted in a troublesome purification and an 
impure product. Therefore, we decided to continue our research with the formation of iridium-
NHC complexes. 
 
Scheme 2.10 Formation of the water-soluble Hoveyda-Grubbs II analogue 25. 
As a control for the feasibility of this reaction, unfunctionalized ligand 26 was coordinated to 
iridium in 37% yield (Scheme 2.11).
[35]
 Attempts to coordinate the azide-bearing ligand 17 to 
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[Ir(cod)Cl]2 following exactly the same reaction protocol as before failed, probably due to an 
instability of the azide towards carbenes. Contrarily, a successful coordination with ligands 
11, 14a, 20 and 21 was clearly observed by high resolution mass spectroscopy (for a 
representative example, see Figure 2.1). However, NMR revealed that the obtained products 
were complex mixtures of products. Even after purification by column chromatography and 
crystallization, a spectrum was observed of which the resonances could not all be assigned 
(for a representative example, see Figure 2.2). This observation might suggest the presence of 
isomers, but this could not be proven by NMR-measurements in other solvents. Because the 
desired metal complexes could not be isolated in pure form, the formation of functionalized 
metal complexes was continued using other ligands.    
 
Scheme 2.11 NHC ligand coordination to [Ir(cod)Cl]2. 
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Figure 2.1 AccuTOF spectrum of complex 31. 
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Figure 2.2 
1
H-NMR spectrum of complex 31 after purification by column 
chromatography and crystallization. The peak-assignment is a prediction and is based on a 
spectrum of the pure complex 27. 
 
2.3 Synthesis of functionalized 2,2’-bipyridine ligands  
2,2’-Bipyridine ligands are bidentate ligands which can coordinate to a variety of metals 
(Scheme 2.12) and are widely applied in catalysis.
[37],[38],[39],[40]
 Unsurprisingly, many papers 
have appeared about the synthesis of various bipyridine analogues
[41],[42]
 and a broad  range of 
these ligands are commercially available. 
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Scheme 2.12 Bipyridine ligand which coordinates metals in a bidentate fashion. 
2.3.1 Synthesis of a symmetric, silane-functionalized 2,2’-bipyridine 
Initially, a strategy was chosen in which bipyridine ligands were symmetrically functionalized 
in order to be covalently bound to a suitable support. To this end, triethoxysilane groups were 
installed on the bipyridine ligand for immobilization on silica materials.
[19]
 A tetraethylene 
glycol linker was chosen between the ligand and the silane groups to enhance the water 
solubility. We reasoned that the linker would create some distance between the catalytic 
center and the support, in order not to compromise the catalytic behavior. 
 
Scheme 2.13 Introduction of silane groups to 2,2’-bipyridine. 
The synthesis started with full demethylation of 4,4’-dimethoxy-2,2’-bipyridine (33) under 
the influence of hydrobromic acid in 92% yield (Scheme 2.13).
[43]
 Next, azide substituents 
were introduced by a reaction with mesyl-activated ethylene glycol azide 35, which was 
followed by Staudinger reduction to afford the corresponding diamine 37. These amines were 
reacted with (isocyanato)propyltriethoxysilane giving the silane-functionalized bipyridine 38 
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in moderate yield. Next, the silane-bearing ligand was reacted with silica nanoparticles (SNP) 
to explore its immobilization. Thus, ligand 38 was mixed with commercially obtained 10 nm 
sized SNPs in methanol and stirred at 70 °C. Unfortunately, gels were obtained under various 
concentrations, which might be a result of cross-linking of the nanoparticles by the 
bifunctional ligands.   
2.3.2 Synthesis of asymmetric functionalized 2,2’-bipyridine 
Having learned that the bipyridine ligand should be asymmetrically linked to a supporting 
carrier, we turned our attention to the monofunctionalization of the bipyridine system. 
Furthermore, monofunctionalization in principle will lead to a maximal catalyst loading per 
carrier. Therefore, a 1:1 mixture of isopropyl mesylate (39) and tetraethylene glycol azido 
mesylate (35) was reacted with diol 34 (Scheme 2.14), affording a mixture of the desired 
asymmetric bipyridine 40 and the two corresponding symmetrical bipyridines. This mixture 
was separated by column chromatography resulting in 32% isolated yield of pure azide 40. 
Subsequent Staudinger reduction and purification by acid-base extraction afforded the amine-
containing ligand 41 in 96% yield. 
 
Scheme 2.14 Synthesis of the amine-functionalized bipyridine 41. 
The presence of an electrophilic moiety instead of the amine on the asymmetric bipyridine 
ligand would allow connecting to nucleophilic carriers as well. In order to convert the amine 
group present in ligand 41 into an electrophilic handle, it was converted into the 
corresponding reactive carbonyl moiety by reaction with carbonyl diimidazole (CDI) in 
excellent yield (Scheme 2.15).  
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Scheme 2.15 Carbonyl imidazole introduction to bipyridine ligand 41. 
The excellent binding properties of 2,2’-bipyridine ligands to iridium and copper were 
demonstrated by the addition of 1 equivalent [Cp*IrCl2]2
[44]
 and Cu(NO3)2  to ligand 33 
(Scheme 2.16). Clean solutions with a bright yellow and blue color, respectively, were 
observed. The metal complexes were obtained in quantitative yields. Coordination of iridium 
to ligand 41 and of copper and iridium to 42 occurred after ligand immobilization, of which 
the results are described in chapter 3 and 4 respectively.  
 
Scheme 2.16 Metal coordination to bipyridine ligand 33. 
 
2.4 Synthesis of functionalized 2,2’:6’2”-terpyridine ligands 
Because leakage of metal ions from their ligands is one of the major problems of 
homogeneous metal catalysis in water, we explored terpyridine ligands. These are tridentate 
ligands which, coordinate metals stronger than bipyridines.
[45]
 Hence, metal complexes 
bearing a terpyridine ligand are anticipated to be more stable in metal-catalyzed reactions. On 
the other hand, the coordinated metal becomes less electronegative, resulting in a decrease in 
substrate activation.   
In order to immobilize metal complexes bearing a terpyridine ligand, the ligand had to be 
equipped with an amine or carbonyl imidazole functionality. A synthesis route described by 
Ward and co-workers was followed.
[46]
 The synthesis commenced with 4′-chloro-2,2′:6′,2′′-
terpyridine (45), which was reacted with a short amine-functionalized ethylene glycol linker 
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and provided ligand 46 in 94% yield (Scheme 2.17). Analogously to the bipyridine ligand, a 
carbonyl imidazole moiety was attached in a next step, affording the terpyridine ligand with a 
good leaving group. Formation of the corresponding metal complexes is described in chapter 
four.  
 
Scheme 2.17 Introduction of amine and carbonyl imidazole onto a terpyridine ligand. 
 
2.5 Conclusion 
NHC-, bipyridine and terpyridine ligands were modified with functional handles in order to 
immobilize them on a support and/or to equip them with water-soluble moieties. NHC-ligand 
precursors bearing a Boc-protected amine, polyethylene glycol chain, azide, alcohol or TBS-
protected alcohol were successfully synthesized. However, purification of the corresponding 
NHC-metal complexes by column chromatography and crystallization appeared troublesome. 
Contrarily, bipyridine were conveniently prepared and coordinated to either iridium or copper 
to yield the pure complexes. Also the adaption of a terpyridine ligand was achieved in a high 
yield. In order to prevent crosslinking upon immobilization on a solid support it turned out to 
be necessary to use monofunctionalized ligands. An amine was thus introduced in an 
asymmetric fashion, affording bipyridine 14. The amine was furthermore readily converted 
into an electrophilic carbonyl imidazole group. The same strategy was successfully applied to 
obtain the stronger metal binding terpyridine ligand 18. The bipyridine and terpyridine metal 
complexes are applied in research described in this thesis.     
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2.7 Experimental section 
General information: Solvents were distilled from appropriate drying agents prior to use and stored under 
nitrogen. Chemicals were purchased from Sigma-Aldrich and used as received. All reactions were carried out 
under inert atmosphere of dry argon. Reactions were followed with thin layer chromatography (TLC) on silica 
gel-coated plates (Merck 60 F254). IR spectra were recorded on a Thermo Mattson IR 300 FTIR spectrometer. 
NMR spectra were recorded on a Bruker DMX 300 (300 MHz), a Varian 400 (400 MHz) or a Bruker Avance III 
500 (500 MHz) spectrometer. Chemical shifts are given in ppm with respect to tetramethylsilane (TMS) as 
internal standard. Coupling constants are reported as J-values in Hz. Flash column chromatography was carried 
out using Silicycle SilicaFlash P60 gel (40–63 µm). High resolution mass spectra were recorded on a JEOL 
AccuTOF (ESI), or a MAT900 (EI, CI, and ESI). Low resolution mass measurements were recorded on a 
Thermo LCQ Advantage Max. ICP-MS measurements were taken on a Thermo Fisher Scientific Xseries I 
quadrupole machine. Compound 15 was prepared according to a literature description.
[31]
 
ICP-MS sample preparation: An aliquot of 25 μL sample was added to 500 μL HNO3 and heated at 80 °C for 
3h, after which the sample was diluted to 10.00 mL.  
2,3-Dibromopropan-1-propylamine hydrogen bromide salt (7): Allylamine (16.0 mL, 213 mmol) was added 
to a 48 wt% solution of HBr in H2O (30.0 mL, 245 mmol, 1.1 equiv.) at 0 °C at such a rate that the temperature 
did not exceed 20 °C. Bromine (11.2 mL, 219 mmol, 1.0 equiv.) was then added at such a rate that the 
temperature remained between 15 and 30 °C. The solvent was removed in vacuo and the product was 
precipitated from cold methanol. The precipitate was isolated by vacuum filtration and rinsed with cold 
methanol, yielding 48.4 g of the pure product as a white solid (162 mmol, 76%). 
1
H NMR (400 MHz, CD3OD): 
δ = 4.51 (dddd, J = 9.6, 8.6, 4.7, 3.2 Hz, 1H), 4.00 (dd, J = 11.0, 4.7 Hz, 1H), 3.85 (dd, J = 11.0, 8.6 Hz, 1H), 
3.69 (dd, J = 14.0, 3.2 Hz, 1H), 3.33 (dd, J = 14.1, 9.6 Hz, 1H). 
13
C NMR (125 MHz, D2O): δ = 46.4, 44.2, 32.9. 
N,N’-Dimesitylpropane-1,2,3-triamine (9): Amine 7 (4.99 g, 16.8 mmol) was added to 2,4,6-trimethylaniline 
(30 mL, 213 mmol, 12.7 equiv.) and the mixture was stirred at 120 °C overnight. The reaction mixture was 
allowed to cool to rt and dissolved in a 1:1 diethyl ether / 15% aqueous NaOH solution. The organic layer was 
washed with H2O and brine (2×). The organic fraction was dried over MgSO4, filtered and concentrated in 
vacuo. Vacuum distillation was used to partially remove 2,4,6-trimethylaniline. The product was further purified 
by column chromatography (MeOH/DCM, 1:99 to 1:9 with 0.1% Et3N), yielding 2.37 g of the pure product as a 
brown oil (7.28 mmol, 44%). 
1
H NMR (300 MHz, CDCl3): δ = 6.77–6.81 (m, 4H), 3.36–3.47 (m, 1H), 3.15 (dd, 
J = 11.8, 5.7 Hz, 1H), 2.81–2.95 (m, 3H), 2.28 (s, 6H), 2.19–2.22 (m, 12H). 13C NMR (75 MHz, CDCl3): δ = 
143.6, 141.9, 131.5, 130.9, 129.9, 129.8 129.6, 129.0, 58.7, 51.6, 45.0, 20.6, 20.6, 19.3, 18.4. 
tert-Butyl 2,3-bis(mesitylamino)propylcarbamate (10): Triamine 9 (1.00 g, 3.08 mmol) and Boc2O (672 mg, 
3.08 mmol, 1.0 equiv.) were dissolved in 30 mL DCM. The solution was cooled to 0 °C and DMAP (39 mg, 0.32 
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mmol, 0.1 equiv.) was added. The reaction mixture was allowed to stir at 0 °C for 30 minutes prior to warming 
to rt, followed by stirring for an additional 2h. The reaction mixture was washed with H2O (2×) and brine (2×). 
The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by 
column chromatography (EtOAc/heptane 1:4), yielding 1.02g of the pure product as a white solid (2.39 mmol, 
78%). 
1
H NMR (400 MHz, CDCl3): δ = 6.76–6.82 (m, 4H), 4.97 (br. s, 1H), 3.43 (dt, J = 12.2, 6.2 Hz, 2H), 3.25 
(dd, J = 8.9, 5.0 Hz, 1H), 3.09 (dd, J = 12.2, 5.4 Hz, 1H), 2.86 (dd, J = 12.3, 4.8 Hz, 1H), 2.17–2.25 (m, 18H), 
1.44 (s, 9H). 
13
C NMR (75 MHz, CDCl3): δ = 143.6, 141.5, 131.6, 131.2, 130.1, 129.9, 129.6, 129.0, 57.2, 51.0, 
43.5, 28.5, 20.7, 19.2, 18.5. 
4-((tert-Butoxycarbonylamino)methyl)-1,3-dimesityl-4,5-dihydro-1H-imidazol-3-ium chloride (11): 
Carbamate 10 (0.950 mg, 2.23 mmol), NH4Cl (126 mg, 2.35 mmol, 1.05 equiv.) and HC(OEt)3 (5.57 mL, 33.5 
mmol, 15.0 equiv.) were combined and stirred at 120 °C overnight. The mixture was allowed to cool to rt and the 
product was precipitated from diethyl ether. The precipitate was isolated by vacuum filtration and rinsed with 
ether yielding 0.89 g of the pure product as a white powder (1.89 mmol, 84%). 
1
H NMR (400 MHz, CDCl3): δ = 
8.31 (s, 1H),  6.99 (d, J = 4.9 Hz, 4H), 4.84–5.00 (m, 1H), 5.44 (m, 1H), 4.51 (t, J = 12.2 Hz, 1H), 3.77 (m, 1H), 
3.38–3.50 (m, 1H), 2.57–2.22 (m, 18H), 1.37 (s, 9H). 13C NMR (75 MHz, CDCl3): δ = 140.5, 140.3, 134.7, 
134.1, 133.9, 130.3, 129.8, 129.4, 128.2, 62.7, 55.1, 41.0, 27.8, 20.6, 20.5, 18.3, 18.1. 
4-(Aminomethyl)-1,3-dimesityl-4,5-dihydro-1H-imidazol-3-ium chloride hydrogen chloride salt (12): 
Imidazolium salt 11 (859 mg, 1.82 mmol) was dissolved in 10 mL DCM. TFA (340 μL, 4.58 mmol, 2.5 equiv.) 
was added dropwise and the reaction was stirred at rt overnight. Afterwards, a second portion of TFA (340 μL, 
4.58 mmol, 2.5 equiv.) was added dropwise and after 30 minutes, the reaction mixture was stirred at 60 °C for 
6h. The solvent was removed in vacuo and the product was coevaporated with toluene (3×), yielding the pure 
product as the TFA salt. After addition of a 2M HCl solution (10 mL) and evaporation of the solvent in vacuo, 
628 mg of the pure product was obtained as the dichloride salt (1.54 mmol, 85%). 
1
H NMR (400 MHz, D2O): δ 
= 8.74 (s, 1H), 7.06 (s, 2H), 7.02 (s, 2H), 5.10–5.23 (m, 1H), 4.73 (t, J = 12.1 Hz, 1H), 4.36 (dd, J = 12.7, 8.5 
Hz, 1H), 3.60 (dd, J = 13.0, 10.3 Hz, 1H), 3.24 (dd, J = 13.0, 3.0 Hz, 1H), 2.15–2.33 (m, 18H). 13C NMR (75 
MHz, D2O): δ = 160.2, 141.1, 140.9, 135.4, 134.9, 134.7, 129.8, 129.5, 129.1, 127.3, 66.1, 60.2, 54.8, 39.7, 19.6, 
17.1, 16.6, 16.3. IR (ATR): 3411, 2951, 2360, 1625, 1482, 1263, 610 cm
-1
. HRMS (ESI) calcd. for C22H30N3 
(M
+
) 336.2439, found 336.2433. 
Me[ethylene glycol]22OSu (13): Me[ethylene glycol]22OH (2.00 g, 2.00 mmol) and N,N’-disuccinimidyl 
carbonate (781 mg, 3.05 mmol, 1.5 equiv.) were dissolved in 20 mL anhydrous acetonitrile at rt. Next, Et3N (416 
μL, 3.00 mmol, 1.5 equiv.) was added dropwise at 0 °C. The reaction mixture was allowed to warm to rt 
overnight. H2O was added to the mixture and the product was extracted with DCM (3×). The combined organic 
layers were washed with brine and an aqueous 0.1 M HCl solution (3×). The organic layer was dried over 
MgSO4, filtered and concentrated in vacuo, yielding 2.02 g of the pure product as an orange solid (1.77 mmol, 
88%). 
1
H NMR (400 MHz, CDCl3): δ = 4.44–4.50 (m, 2H), 3.75–3.81 (m, 2H), 3.62–3.68 (m, 84H), 3.38 (s, 
3H), 2.84 (s, 4H). 
13
C NMR (75 MHz, CDCl3): δ = 168.6, 72.1, 71.0, 70.7, 70.4, 68.5, 59.2, 25.6. I  (AT ): 
3574, 2865, 2359, 1740, 1097 cm
-1
. 
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1,3-Dimesityl-4-[ethylene glycol]22-4,5-dihydro-1H-imidazol-3-ium chloride (14a): Et3N (1.40 mL, 10.1 
mmol, 9.0 equiv.) was added dropwise to a solution of imidazolium salt 12 (459 mg, 1.12 mmol) and 
Me[ethylene glycol]22OSu (13) (1.28 g, 1.12 mmol, 1.0 equiv.) in 50 mL anhydrous acetonitrile at rt. The 
solution was stirred at 30 °C overnight. The solvent was removed in vacuo, toluene was added and the mixture 
filtered. The residue was purified by column chromatography (MeOH/DCM, 0:1 to 3:17) yielding 1.13 g of the 
pure product as an orange oil (0.81 mmol, 72%). 
1
H NMR (400 MHz, D2O): δ = 8.59 (s, 1 ), 7.01 (s, 4 ), 5.10 
(m, 1H), 4.52 (t, J = 12.1 Hz, 1H), 4.08–4.18 (m, 1H), 3.93 (m, 2H), 3.55 (m, 88H), 3.25 (s, 3H), 2.13–2.30 (m, 
18H). 
13
C NMR (75 MHz, D2O): δ = 157.4, 140.7, 140.2, 134.7, 129.6, 129.5, 129.3, 129.2, 128.7, 70.5, 69.1, 
68.9, 68.3, 63.9, 61.8, 57.5, 53.7, 41.4, 19.6, 17.3, 16.9, 16.3, 16.1. IR (ATR): 1855, 1362, 1327, 1692, 1623, 
1251, 1109, 603 cm
-1
. 
1,3-Dimesityl-4-[ethylene glycol]22-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate (14b): A solution of 
imidazolium salt 14a (206 mg, 0.148 mmol) in 2 mL DCM was added to a solution of AgBF4 (58.9 mg, 0.302 
mmol, 2.0 equiv.) in 2 mL MeO  at rt. The mixture was stirred at rt for 2h, ﬁltered and concentrated in vacuo. 
The product was purified by column chromatography (MeOH/DCM 1:9) yielding 148 mg of the pure product as 
an orange oil (0.102 mmol, 69%). 
1
H NMR (400 MHz, CDCl3): δ = 7.94 (s, 1 ), 7.01 (s, 1 ), 6.99 (s, 3 ), 6.10 
(t, J = 5.9 Hz, 1H), 5.17–5.28 (m, 1H), 4.43–4.59 (m, 1H), 4.11–4.16 (m, 2H), 3.64 (m, 88H), 3.38 (s, 3H), 2.28–
2.44 (m, 18H). 
13
C NMR (75 MHz, CDCl3): δ = 158.5, 157.4, 141.2, 141.0, 135.5, 134.8, 131.0, 130.4, 129.9, 
128.6, 72.0, 70.6, 70.5, 69.3, 64.7, 63.1, 59.1, 55.5, 41.9, 21.2, 21.2, 18.6, 18.2, 17.7. IR (ATR): 3542, 2867, 
1626, 1252, 1095 cm
-1
.  
3-Azido-N,N’-dimesitylpropane-1,2-diamine (16): Imidazole-1-sulfonyl azide hydrochloride (15) (77.4 mg, 
0.37 mmol, 1.2 equiv.) was added to a suspension of triamine 9  (100 mg, 0.31 mmol), K2CO3 (116 mg, 0.84 
mmol, 2.7 equiv.) and CuSO4.5H2O (0.49 mg, 3.08 μmol, 0.01 equiv.) in 1.5 mL methanol. The reaction mixture 
was stirred at rt for 45 minutes. The solvent was removed in vacuo, H2O was added and the solution was 
acidified with concentrated HCl and extracted with EtOAc (3×). The combined organic fractions were dried over 
MgSO4, filtered and concentrated in vacuo. The residue was purified by column chromatography (DCM) 
yielding 89 mg of the pure product as a colourless oil (0.25 mmol, 83%). 
1
H NMR (400 MHz, CDCl3): δ = 6.82 
(s, 2H), 6.81 (s, 2H), 3.52 (dt, J = 7.5, 3.1 Hz, 2H), 3.42 (dd, J = 12.8, 5.9 Hz, 1H), 3.33 (br. s, 2H), 3.21 (dd, J = 
12.2, 5.5 Hz, 1H), 2.94 (dd, J = 12.1, 6.2 Hz, 1H), 2.21–2.28 (m, 18H). 13C NMR (75 MHz, CDCl3): δ = 143.3, 
140.9, 131.8, 131.5, 130.0, 130.0, 129.6, 129.3, 56.4, 53.4, 50.8, 20.7, 20.6, 19.0, 18.4. IR (ATR): 3366, 2913, 
2856, 2298, 1482, 1442, 1228, 853 cm
-1
. HRMS (ESI) calcd. for C21H30N5 (M+H
+
) 352.2501, found 352.2499.  
4-(Azidomethyl)-1,3-dimesityl-4,5-dihydro-1H-imidazol-3-ium chloride (17): Azide 16 (93.8 mg, 0.27 
mmol), NH4Cl (16.9 mg, 0.32 mmol, 1.2 equiv.) and HC(OEt)3 (0.8 mL, 4.8 mmol, 18.0 equiv.) were combined 
and heated to 120 °C for two hours. The solution was allowed to cool to rt and the product was precipitated from 
diethyl ether. The precipitate was isolated by filtration and rinsed with diethyl ether yielding 97 mg of the pure 
product as a brown solid (0.24 mmol, 91%). 
1
H NMR (400 MHz, CDCl3): δ = 8.57 (s, 1 ), 6.99 (m, 4 ), 5.65 
(ddt, J = 10.8, 8.0, 2.6 Hz, 1H), 5.03 (t, J = 12.5 Hz, 1H), 4.33 (dd, J = 12.5, 8.0 Hz, 1H), 4.21 (dd, J = 14.0, 3.0 
Hz, 1H), 3.58 (dd, J = 13.9, 2.3 Hz, 1H), 2.28–2.49 (m, 18H). 13C NMR (75 MHz, CDCl3): δ = 158.7, 141.0, 
140.9, 135.6, 135.4, 135.2, 131.0, 130.6, 130.3, 128.1, 63.4, 54.0, 50.2, 21.2, 21.1, 19.1, 18.0 ppm. IR (ATR): 
3392, 2920, 2109, 1625, 1269 cm
-1
. HRMS (ESI) calcd. for C22H28N5(M
 +
) 362.2344, found 362.2345. 
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N,N’-Dimesityl-2,3-diamino-1-propanol (19): To 2,3-dibromo-1-propanol (18) (10.02 g, 46.0 mmol) was 
added 2,4,6-trimethylaniline (16.09 g, 119.0 mmol, 2.6 equiv.) and the mixture was stirred at 120 °C overnight. 
The reaction mixture was allowed to cool to rt and was subsequently diluted with DCM. An aqueous 15% NaOH 
solution was added, the organic and aqueous layers were separated and the organic layer was washed with H2O. 
The organic fraction was dried over MgSO4, filtered and concentrated in vacuo. The product was purified by 
column chromatography (EtOAc/pentane 1:4 to 1:2), yielding 6.22 g of the pure product as an orange solid (19.1 
mmol, 42%). 
1
H NMR (300 MHz, CDCl3): δ = 6.83 (ddd, J = 5.7, 1.2, 0.6 Hz, 4H), 3.97 (dd, J = 11.0, 2.8 Hz, 
1H), 3.85 (ddd, J = 11.0, 4.2, 1.1 Hz, 1H), 3.54 (br. s, 2H), 3.41 (tdd, J = 5.0, 3.5, 2.8 Hz, 1H), 3.24 (ddd, J = 
11.9, 5.2, 1.2 Hz, 1H), 2.98 (dd, J = 12.0, 3.9 Hz, 1H), 2.03–2.27 (m, 18H). 13C NMR (75 MHz, CDCl3): δ = 
142.7, 141.9, 132.5, 131.0, 130.6, 129.9, 129.6, 128.9, 65.9, 57.1, 52.3, 20.7, 20.6, 19.0, 17.9. 
4-(Hydroxymethyl)-1,3-dimesityl-4,5-dihydro-1H-imidazol-3-ium chloride (20): A mixture of alcohol 19 
(2.04 g, 6.24 mmol), NH4Cl (399 mg, 7.45 mmol, 1.2 equiv.) and HC(OEt)3 (18.5 mL, 111 mmol, 17.8 equiv.) 
was stirred at 120 °C for 2h. Next, the reaction was allowed to cool to rt and the product was precipitated twice 
from Et2O. The precipitate was isolated by vacuum filtration yielding 1.77 g of the pure product as a white solid 
(4.74 mmol, 76%). 
1
H NMR (400 MHz, CDCl3): δ = 7.72 (s, 1H), 6.95–7.02 (m, 4H), 6.50 (t, J = 6.4 Hz, 1H), 
5.32 (dd, J = 12.0, 6.4 Hz, 1H), 4.78–4.84 (m, 1H), 4.39 (t, J = 12.0 Hz, 1H), 4.04 (ddd, J = 13.2, 6.0, 2.0 Hz, 
1H), 3.45–3.62 (m, 1H), 2.50 (s, 6H), 2.22–2.62 (m, 12H) . 13C NMR (75 MHz, CDCl3): δ = 157.9, 140.8, 140.6, 
137.0, 134.6, 130.7, 130.5, 130.4, 130.3, 129.7, 128.7, 66.5, 58.3, 53.0, 21.2, 21.1, 18.5, 18.2. IR (ATR): 3250, 
2919, 2190, 1626, 1481, 1270, 1216, 728 cm
-1
. HRMS (ESI) calcd. for C22H29N2O (M
+
) 337.2279, found 
337.2296. 
4-((tert-Butyldimethylsilyloxy)methyl)-1,3-dimesityl-4,5-dihydro-1H-imidazol-3-ium chloride (21): A 1 M 
solution of TBSCl in DCM (650 μL, 0.65 mmol, 1.2 equiv.) was dropwise added to a solution of imidazolium 
salt 20 (201 mg, 0.54 mmol) and imidazole (56.3 mg, 0.83 mmol, 1.5 equiv.) in 4.5 mL DCM. The reaction 
mixture was stirred for 23h at rt. To promote the slow reaction, DMAP (17.9 mg, 0.15 mmol, 0.3 equiv.) was 
added and the mixture was stirred for another 24h at rt. Water was added and the organic fraction was washed 
with H2O (3×) and brine. The product was dried over MgSO4, filtered and concentrated in vacuo. The product 
was purified by column chromatography (MeOH/DCM 1:9), yielding 63 mg of the pure product as a white solid 
(0.13 mmol, 24%). 
1
H NMR (400 MHz, CDCl3): δ = 9.20 (s, 1 ), 6.96 (s, 4 ), 5.38 (tt, J = 9.3, 2.4 Hz, 1H), 
4.88 (t, J = 12.0 Hz, 1H), 4.31 (dd, J = 11.4, 9.3 Hz, 1H), 3.85 (dd, J = 12.1, 2.7 Hz, 1H), 3.74 (dd, J = 12.1, 2.2 
Hz, 1H), 2.27–2.50 (m, 18H), 0.88 (s, 9H), 0.07 (d, J = 1.0 Hz, 6H). 13C NMR (75 MHz, CDCl3): δ = 160.0, 
140.7, 140.4, 136.1, 135.4, 130.6, 130.5, 130.2, 128.7, 65.4, 60.2, 52.4, 26.1, 21.2, 21.1, 19.1, 18.7, 18.3, -5.2, -
5.3 ppm. IR (ATR): 3379, 2953, 2926, 2856, 2175, 1625, 1462, 1251, 1121, 1003, 838, 729 cm
-1
. HRMS (ESI) 
calcd. for C28H43N2OSi (M
+
) 451.3144, found 451.3140. 
Ir(cyclooctadiene)[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]Cl (27): Imidazolium salt 26 (50.0 
mg, 0.15 mmol, 1.9 equiv.) was dissolved in deoxygenated 3.0 mL anhydrous THF. A 1 M solution of KO
t
Bu in 
T F (165 μL, 0.17 mmol, 2.2 equiv.) was added at rt. The reaction mixture was stirred for 10 min at rt. Then, 
[Ir(cod)Cl]2 (50.6 mg, 0.075 mmol) in 1.5 mL anhydrous, deoxygenated THF was added and the mixture stirred 
at 80 °C for 1h. The solvent was removed in vacuo and the residue was purified by column chromatography 
(EtOAc/heptane 1:4), yielding 35.1 mg of the pure product as a yellow solid (0.055 mmol, 37%). 
1
H NMR (400 
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MHz, CDCl3): δ = 6.98 (s, 2 ), 6.94 (s, 2 ), 4.07–4.12 (m, 2H), 3.87–3.93 (m, 4H), 3.05–3.09 (m, 2H), 2.55 (s, 
6H), 2.35 (s, 6H), 2.32 (s, 6H), 1.55–1.70 (m, 4H), 1.20–1.38 (m, 4H). 13C NMR (75 MHz, CDCl3): δ = 207.4, 
138.2, 137.9, 136.3, 135.3, 129.9, 128.5, 83.8, 51.9, 51.6, 33.5, 28.8, 21.2, 20.0, 18.6. IR (ATR): 2910, 2360, 
2339, 1263, 734, 668 cm
-1
. 
4,4’-Dihydroxy-2,2’-bipyridine (34): To a solution of 4,4'-dimethoxy-2,2'-bipyridine (33) (5.0 g, 23.1 mmol) in 
400 mL of a 3:1 AcOH/H2O mixture was added HBr (33% in AcOH, 40.5 mL, 231 mmol, 10 equiv.). The 
mixture was refluxed for 47h. The mixture was allowed to cool to room temperature and concentrated in vacuo. 
The residue was dissolved in 250 mL water and the acidic solution was basified by adding a 25% ammonium 
hydroxide solution. A white precipitate was formed, which was removed by filtration. Adding more hydroxide to 
the suspension led to a clear solution. Addition of aqueous concentrated HCl led to a white precipitate, which 
was filtered and combined with the first filtrate. The product was dried under high vacuum, affording 3.99 g 
(23.1 mmol, 92%) of a white powder. 
1
H NMR (D2O + NaOH, 300 M z): δ = 7.96–7.85 (m, 2H), 6.88–6.93 (m, 
2H), 6.38 (dd, J = 5.7, 2.1 Hz, 2H). 
13
C NMR (D2O + NaOH, 75 M z): δ = 174.4, 156.9, 149.0, 115.0, 112.7. I  
(ATR): 3209 (br), 3044 (br), 2859, 2772, 1597, 1523, 1467, 1402, 1225 cm
-1
. 
Tetraethylene glycol azido mesylate (35): A solution of tetraethylene glycol (17.8 mL, 103 mmol) in 200 mL 
THF was cooled to 0 °C, followed by the dropwise addition of MsCl (8.37 mL, 108 mmol, 1.05 equiv.) in 20 mL 
THF and Et3N (40 mL, 288 mmol, 2.8 equiv.). The mixture was allowed to warm to room temperature and was 
stirred for an additional 2 h. The reaction mixture was filtered and concentrated in vacuo, yielding a colorless oil. 
The product was dissolved in 400 mL MeOH and NaN3 (33.5 g, 515 mmol, 5 equiv.) was added. The reaction 
mixture was refluxed overnight. The mixture was allowed to cool to room temperature, filtered and concentrated 
in vacuo. Brine was added, and the product extracted with DCM (4×). The organic fractions were dried over 
MgSO4 and concentrated under reduced pressure. The product was purified by column chromatography on silica 
(DCM/MeOH 1:99 to 4:96), yielding 9.16 g (41.8 mmol, 41%) of a colorless oil as the pure desired alcohol 
intermediate (35a). 
1
H NMR (300 MHz, CDCl3): δ = 3.69 (m, 2H), 3.66–3.62 (m, 10H), 3.60–3.54 (m, 2H), 
3.39–3.32 (m, 2H), 2.79 (br s, 1H). 13C NMR (75 MHz, CDCl3): δ = 72.4, 70.6, 70.6, 70.5, 70.3, 69.9, 61.6, 50.6. 
IR (ATR): 3420 (br), 2863, 2098, 1290, 1234, 1095, 931 cm
-1
.  
To a solution of azide 35a (9.16 g, 41.8 mmol) in 160 mL THF was added dropwise a solution of MsCl (4.20 
mL, 54.3 mmol, 1.3 equiv.) in 20 mL THF at 0 °C. Next, a solution of Et3N (21.5 mL, 155 mmol, 3.7 equiv.) in 
20 mL THF was added dropwise. The mixture was allowed to warm to room temperature and stirred for 2.5h. 
Solids were removed by filtration and the mixture concentrated under reduced pressure. The residue was 
dissolved in DCM, washed with a 1M HCl solution and the acidic layer extracted with DCM. The combined 
organic fractions were washed with brine, dried over MgSO4 and concentrated under reduced pressure, yielding 
12.4 g (41.7 mmol, 100%) of a yellow oil. 
1
H NMR (300 MHz, CDCl3): δ = 4.41–4.33 (m, 2H), 3.80–3.73 (m, 
2H), 3.71–3.61 (m, 10H), 3.44–3.32 (m, 2H), 3.06 (s, 3H). 13C NMR (75 MHz, CDCl3): δ = 77.1, 70.7, 70.6, 
70.0, 69.3, 69.0, 50.7, 37.7. IR (ATR): 2919, 2872, 2098, 1355, 1173, 1104, 931, 797 cm
-1
. 
Bis-4-4’(tetraethylene glycol azido)-2,2'-bipyridine (36): To a solution of mesylate 35 (987 mg, 3.32 mmol, 
2.5 equiv.) in 15 mL acetone was added K
2
CO
3
 (734 mg, 5.31 mmol, 4 equiv.), 18-crown-6 (88 mg, 0.33 mmol, 
0.25 equiv.) and 2,2'-bipyridine-4,4'-diol (34) (250 mg, 1.33 mmol). The mixture was refluxed for 40h and 
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allowed to cool to room temperature. Solids were removed by filtration and the solvent by evaporation under 
reduced pressure, DCM was added and the solution washed with a 1M NaOH solution. The crude product was 
purified by column chromatography on silica (MeOH/DCM 1:99 to 1:19), yielding 490 mg (0.83 mmol, 62%) of 
a yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 8.45 (d, J = 6.4 Hz, 2H), 7.97 (d, J = 6.4 Hz, 2H), 6.86 (dd, J = 
5.6, 2.8 Hz, 2H), 4.30 (t, J = 4.8 Hz, 4H), 3.90 (t, J = 4.8 Hz, 4H), 3.75–3.65 (m, 20H), 3.37 (t, J = 4.8 Hz, 4H). 
13
C NMR (75 MHz, CDCl3): δ = 166.0, 157.9, 150.2, 111.6, 106.8, 71.0, 70.8, 70.8, 70.8, 70.1, 69.5, 67.6, 50.8. 
IR (ATR): 2867, 2098, 1584, 1566, 1454, 1285, 1139 cm
-1
. HRMS (ESI): calcd. for C26H38N8O8Na (M+Na
+
) 
613.2710, found 613.2697. 
Bis-4,4’-(tetraethylene glycol amino-2,2'-bipyridine (37): To a solution of azide 36 (400 mg, 0.677 mmol) in 
15 mL THF was added PPh
3
 (444 mg, 1.69 mmol, 2.5 equiv.). The mixture was stirred at 70 °C overnight. A few 
drops of water were added and the mixture stirred at 70 °C for 2h. The mixture was allowed to cool to room 
temperature, an aqueous 2M HCl solution was added and the solution was washed with DCM. The organic layer 
was extracted with a 2M HCl solution. The combined aqueous extracts were basified with a 2M NaOH solution 
and the product was extracted with DCM (3×). The organic phases were washed with brine, dried over MgSO4 
and concentrated by rotary evaporation, yielding 300 mg (0.558 mmol, 88%) of the product which also contained 
some triphenylphosphine oxide. The mixture was used in a next reaction without further purification. 
1
H NMR 
(300 MHz, CDCl3): δ = 8.45 (d, J = 5.7 Hz, 2H), 7.97 (d, J = 2.7 Hz, 2H), 6.86 (dd, J = 5.7, 2.7 Hz, 2H), 4.30 (t, 
J = 4.5 Hz, 4H), 3.90 (t, J = 4.5 Hz, 4H), 3.76–3.60 (m, 16H), 3.50 (t, J = 5.4 Hz, 4H), 2.85 (t, J = 5.4 Hz, 4H), 
1.65 (br s, 4H). 
13
C NMR (75 MHz, CDCl3): δ = 165.9, 157.8, 150.2, 111.5, 106.7, 73.4, 71.0, 70.7, 70.3, 69.4, 
67.5, 41.8. IR (ATR): 2872, 1588, 1437, 1303, 1100, 1061 cm
-1
. HRMS (ESI): calcd. for C26H42N4O8Na 
(M+Na
+
) 561.2900, found 561.2872.  
Bis-4-4’(1-tetraethylene glycol(3-(3-(triethoxysilyl)propyl)urea))-2,2'-bipyridine (38): To a solution of 
amine 37 (176 mg, 0.327 mmol) in 6 mL THF was added (isocyanato)propyltriethoxysilane (283 μL, 1.144 
mmol 3.5 equiv.). The mixture was stirred at rt for 3h. The product was concentrated under reduced pressure and 
purified by column chromatography on silica (DCM/MeOH, 99:1 to 9:1), yielding 221 mg of a colorless oil 
(0.214 mmol, 66%). 
1
H NMR (300 MHz, CDCl3): δ = 8.45 (d, J = 5.4 Hz, 2H), 7.96 (d, J = 2.4 Hz, 2H), 6.86 
(dd, J = 5.7, 2.4 Hz, 2H), 5.05 (t, J = 5.4 Hz, 2H), 4.94 (t, J = 5.4 Hz, 2H), 4.30 (t, J = 4.5 Hz, 4H), 3.90 (t, J = 
4.5 Hz, 4H), 3.82–3.72 (m, 16H), 3.68–3.64 (m, 4H), 3.58–3.62 (m, 8H), 3.52 (t, J = 5.1 Hz, 4H), 3.36–3.31 (m, 
4H), 3.16–3.09 (m, 4H), 1.62–1.52 (m, 4H), 1.19 (t, J = 7.2 Hz, 18H), 0.63–0.58 (m, 4H). 13C NMR (75 MHz, 
CDCl3): δ = 165.9, 158.6, 157.8, 150.3, 111.6, 106.8, 71.0, 70.8, 70.5, 70.5, 70.2, 69.5, 67.5, 58.5, 43.0, 40.4, 
23.8, 18.4, 7.8. IR (ATR): 3317, 2971, 2923, 2884, 1636, 1584, 1562, 1100, 1078 cm
-1
. HRMS (ESI): calcd. for 
C46H84N6O16Si2Na (M+Na
+
) 1055.5380, found 1055.5371.  
Isopropyl mesylate (39): To a mixture of i-PrOH (10.0 mL, 131 mmol, 1.5 equiv.) and Et3N (12.1 mL, 87 
mmol, 1 equiv.) in 75 mL DCM was added MsCl (6.76 mL, 87 mmol) at 0 °C. The mixture was allowed to 
warm to ambient temperature and stirred for 2 h. DCM was added to the mixture and the product was washed 
with a 1M HCl solution. The aqueous phase was once extracted with DCM. The combined organic extracts were 
washed with brine, dried over MgSO4 and concentrated under reduced pressure, affording 11.4 g of a yellow oil 
(82 mmol, 94%). 
1
H NMR (300 MHz, CDCl3): δ = 4.92 (hept, J = 6.2 Hz, 1H), 2.96 (s, 3H), 1.39 (d, J = 6.3 Hz, 
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6H).
 13
C NMR (75 MHz, CDCl3): δ = 76.8, 38.7, 23.0. IR (ATR): 2984, 2941, 1342, 1324, 1173, 1095, 914, 879, 
810 cm
-1
. 
4-(Tetraethylene glycol) azido-4'-isopropoxy-2,2'-bipyridine (40): To a solution of i-PrOMs (39) (1.42 g, 
10.3 mmol, 1.05 equiv.), tetra(ethylene glycol) azido mesylate (35) (3.05 g, 10.3 mmol, 1.05 equiv.) in 110 mL 
acetone was added 2,2'-bipyridine-4,4'-diol (34) (1.84 g, 9.77 mmol, K2CO3 (3.38 g, 24.4 mmol, 2.5 equiv.) and 
18-crown-6 (258 mg, 0.98 mmol, 0.10 equiv.). The mixture was refluxed for 66h. The mixture was filtered and 
the solvent removed. A saturated NaHCO3 solution was added and the product was extracted with DCM (2×). 
The organic extracts were washed with brine, dried over MgSO4 and concentrated under reduced pressure. The 
compound was purified by column chromatography on silica (DME/DCM, 2:98 to 10:90). The fractions were 
analyzed by low resolution mass spectroscopy and only the pure ones were selected, yielding 1.34 g (3.10 mmol, 
32%) of the desired product as a yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 8.44 (dd, J = 7.8, 5.7 Hz, 2H), 7.94 
(dd, J = 10.6, 2.5 Hz, 2H), 6.85 (dd, J = 5.7, 2.6 Hz, 1H), 6.79 (dd, J = 5.7, 2.6 Hz, 1H), 4.80 (hept, J = 6.0 Hz, 
1H), 4.34–4.27 (t, J = 4.8 Hz, 2H), 3.94–3.84 (t, J = 4.4 Hz, 2H), 3.79–3.59 (m, 10H), 3.37 (t, J = 5.1 Hz, 2H), 
1.39 (d, J = 6.1 Hz, 6H). 
13
C NMR (75 MHz, CDCl3): δ = 165.9, 165.2, 158.1, 157.8, 150.3, 150.2, 112.1, 111.5, 
107.6, 106.7, 77.1, 71.0, 70.8, 70.1, 70.1, 69.5, 67.5, 50.8, 21.9. IR (ATR): 2971, 2872, 2098, 1584, 1549, 1454, 
1290, 1229, 1104, 996, 940 cm
-1
. HRMS (ESI): calcd. for C21H30N5O5 (M+H
+
) 432.2247, found 432.2257. 
4-(Tetraethylene glycol amino-4'-isopropoxy-2,2'-bipyridine (41): To azide 40 (1.14 g, 3.10 mmol) in 40 mL 
THF was added PPh3 (1.02 g, 3.87 mmol, 1.25 equiv.). The mixture was refluxed for 2.5 h, water (2.8 mL) was 
added and the mixture refluxed for 1 h. The mixture was allowed to cool to room temperature and concentrated 
in vacuo. A 0.25M HCl solution was added to the mixture and the aqueous layer was washed with DCM (5×). 
The aqueous phase was basified by adding a 2M NaOH solution which resulted in a cloudy mixture. The product 
was extracted six times with DCM. The combined organic extracts were dried over MgSO4 and concentrated in 
vacuo, giving 1.26 g (2.96 mmol, 96%) of a red oil. 
1
H NMR (300 MHz, CDCl3): δ = 8.44 (t, J = 5.6 Hz, 2H), 
7.94 (dd, J = 5.4, 2.5 Hz, 2H), 6.86 (dd, J = 5.7, 2.6 Hz, 1H), 6.79 (dd, J = 5.7, 2.6 Hz, 1H), 4.81 (hept, J = 6.0 
Hz, 1H), 4.31 (t, J = 4.8 Hz, 2H), 3.90 (t, J = 4.4 Hz, 2H), 3.79–3.60 (m, 8H), 3.52 (t, J = 4.2 Hz, 2H), 2.87 (t, J 
= 5.2 Hz, 2H), 1.96 (br s, 2H), 1.39 (d, J = 6.1 Hz, 6H). 
13
C NMR (75 MHz, CDCl3): δ = 165.9, 165.2, 158.1, 
157.8, 150.3, 112.1, 111.4, 107.7, 106.8, 77.1, 73.1, 71.0, 70.7, 70.4, 70.1, 69.5, 67.6, 41.8, 21.9. IR (ATR): 
3380 (br), 2971, 2867, 1584, 1558, 1458, 1290, 1238, 1113 cm
-1
. HRMS (ESI): calcd. for C21H32N3O5 (M+H
+
) 
406.2342, found 406.2342. 
Carbonyl-N-4-(tetraethylene glycol-4'-isopropoxy-2,2'-bipyridine-N-imidazole (42): To a solution of 1,1'-
carbonyldiimidazole (2.31 mL of a 0.4 M solution in DCM, 0.92 mmol, 1.5 equiv.) was added amine 41 (250 
mg, 0.62 mmol) in 5 mL DCM at 0 °C. The mixture was stirred at room temperature for 1h. The reaction was 
concentrated in vacuo and purified by column chromatography on silica gel (DCM/MeOH, 95:5), affording 298 
mg (0.60 mmol, 97%) of a colorless oil.
 1
H-NMR (CDCl3, 300 MHz): δ = 8.41 (dd, J = 10.4, 5.6 Hz, 2H), 8.21 
(s, 1H), 7.91 (s, 2H), 7.48 (s, 1H), 7.42 (br s, 1H), 7.01 (s, 1H), 6.80–6.75 (m, 2H), 4.78 (h, J = 6.0 Hz, 1H), 4.25 
(t, J = 4.8 Hz, 2H), 3.83 (t, J = 4.4 Hz, 2H), 3.72–3.53 (m, 12H), 1.37 (d, J = 6.0 Hz, 6H). 13C NMR (CDCl3, 75 
MHz): δ = 165.7, 165.3, 158.1, 157.7, 150.3, 150.2, 149.3, 136.3, 130.2, 116.3, 112.2, 111.3, 107.7, 106.7, 70.9, 
70.6, 70.5, 70.2, 70.1, 69.5, 69.4, 67.4, 40.9, 21.9. IR (ATR): 2975, 2923, 2876, 1713, 1579, 1562, 1294, 1104 
cm
-1
. HRMS (ESI): calcd. for C25H34N5O6 (M+H
+
) 500.2509, found 500.2508. 
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Cp*Ir(4,4’-dimethoxy-2,2’-bipyridine)Cl2 (43): To a solution of pentamethylcyclopentadienyliridium(III) 
chloride dimer (100 mg, 0.126 mmol, 1 equiv.) in 12mL MeOH was added 4,4’-dimethoxy-2,2’-bipyridine (33) 
(54 mg, 0.252 mmol). The mixture was stirred for 5 minutes, followed by evaporation of the volatiles under 
reduced pressure. The residue was dissolved in as less as possible DCM. The product precipitated after the 
addition of heptane. Filtration and washing with heptane afforded 155 mg (0.252 mmol, 100%) of 43 as a yellow 
solid. 
1
H NMR (400 MHz, CDCl3) δ = 9.25 (d, J = 2.7 Hz, 2H), 8.37 (d, J = 6.5 Hz, 2H), 7.08 (dd, J = 6.5, 2.7 
Hz, 2H), 4.42 (s, 6H), 1.65 (s, 15H).
 13
C NMR (75 MHz, CDCl3) δ = 169.4, 158.2, 149.9, 117.3, 111.5, 88.1, 
77.1, 59.5, 8.8, 1.1. 
Cu(4,4’-dimethoxy-2,2’-bipyridine)(NO3)2 (44): To a solution of 4,4'-dimethoxy-2,2'-bipyridine (33) (100 mg, 
0.462 mmol) in 20 mL MeOH was added Cu(NO2)2.3H2O (112 mg, 0.462 mmol, 1 equiv.). The mixture turned 
immediately blue and was concentrated in vacuo after 5 minutes, which afforded 186 mg (0.461 mmol, 100%) of 
a blue solid. ICP-MS: calcd copper content 35.69 mass%, found 35.88 mass%. 
4′-(1-ethoxy-2-(2-aminoethoxy))-2,2′:6′,2′′-terpyridine (46): To 2-(2-aminoethoxy)ethanol (0.098 g, 0.934 
mmol) in 4 mL DMSO was added powdered KOH (262 mg, 4.67 mmol, 5 equiv.). The mixture was stirred at 60 
°C for 30 min,  after which 4'-chloro-2,2':6',2''-terpyridine (45) (250 mg, 0.934 mmol) was added. The reaction 
was stirred at 60 °C for 6 h. After cooling to room temperature, an aqueous 0.25M HCl solution was added and 
the mixture was washed with CH2Cl2 (3×). An aqueous 1M NaOH solution was added, resulting in a cloudy 
mixture. The product was extracted with CH2Cl2 (5×). The combined organic phases were dried over MgSO4 and 
evaporated under vacuum to yield 294 mg of 46 as a yellow oil (0.874 mmol, 94%). 
1
H NMR (CDCl3, 300 
MHz): δ = 8.67 (ddd, J = 4.8, 2.4, 1.2 Hz, 2H), 8.60 (dt, J = 8.1, 1.2 Hz, 2H), 8.05 (s, 2H), 7.83 (dt, J = 7.5, 1.8 
Hz, 2H), 7.31 (ddd, J = 7.5, 4.8, 1.2 Hz, 2H), 4.42–4.38 (m, 2H), 3.91–3.88 (m, 2H), 3.60 (t, J = 5.1 Hz, 2H), 
2.89 (t, J = 5.1 Hz, 2H), 1.46 (br s, 2H). 
13
C NMR (CDCl3, 75 MHz): δ = 167.1, 157.2, 156.1, 149.1, 136.8, 
123.9, 121.4, 107.6, 73.9, 69.4, 67.8, 42.0. IR (ATR): 2928, 2863, 1580, 1558, 1407, 1204, 793 cm
-1
. HRMS 
(ESI): calcd. for C19H21N4O2 (M+H
+
) 337.1664, found 337.1665. 
Carbonyl-N-4′-(1-ethoxy-2-(2-aminoethoxy))-2,2′:6′,2′′-terpyridine-N-imidazole (47): To a solution of 1,1'-
carbonyldiimidazole (0.64 mL of a 0.4 M solution in DCM, 0.25 mmol, 1.5 equiv.) was added terpyridine 46 (57 
mg, 0.17 mmol) in 1.5 mL DCM at 0 °C. The mixture was stirred at room temperature for 1.5h.  Afterwards, the 
reaction was concentrated in vacuo and purified by column chromatography on silica gel (DCM/MeOH, 9:1), 
affording 64 mg of the desired compound (0.15 mmol, 88%). 
1
H NMR (CDCl3, 300 MHz): δ = 8.64 (ddd, J = 
5.4, 1.8, 0.9 Hz, 2H), 8.59 (dt, J = 7.8, 0.9 Hz, 2H), 8.11 (t, J = 0.9 Hz, 1H), 8.06 (s, 2H), 7.85 (dt, J = 7.5, 1.8 
Hz, 2H), 7.33 (ddd, J = 7.5, 4.8, 1.2 Hz, 2H), 7.28 (t, J = 1.5 Hz, 1H), 6.95 (dd, J = 1.5, 0.9 Hz, 1H), 4.41–4.38 
(m, 2H), 3.90–3.87 (m, 2H), 3.75–3.70 (m, 2H), 3.67–3.60 (m, 2H). 13C NMR (CDCl3, 75 MHz): δ = 167.1, 
157.3, 156.1, 149.1, 149.0, 137.1, 136.3, 130.5, 124.1, 121.6 115.8, 107.8, 70.0, 69.8, 68.0, 50.8, 40.9. IR 
(ATR): 3127, 3049, 2941, 1718, 1588, 1553, 1398, 1290, 1212 cm
-1
. HRMS (ESI) calcd. for C23H23N6O3 
(M+H
+
) 431.1831, found 431.1833. 
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3. Aqueous reductive amination using a dendritic 
metal catalyst in a dialysis bag 
 
Abstract 
Water soluble dendritic iridium catalysts were synthesized by attaching a reactive metal 
complex to third and fourth generation poly(propylene imine) (DAB-Am) dendrimers via an 
adapted asymmetric bipyridine ligand. These dendritic catalysts were applied in the aqueous 
reductive amination of valine while contained in a dialysis bag. Comparable conversions were 
observed as for the non-compartmentalized counterparts, albeit with somewhat longer 
reaction times. The successful compartmentalization was demonstrated by removal of the 
dialysis bag and reusage in a next reaction for several cycles. Catalytic activity was still 
observed, showing that the catalyst was successfully kept in the compartment. However, after 
extended reaction times the reaction rates decreased, probably due to leakage and inactivation 
of the iridium catalyst. 
 
3.1 Introduction 
Cascade catalysis, a bioinspired strategy to conduct multiple consecutive catalytic steps in one 
pot, is attracting the attention of an increasing number of chemists.
[1],[2]
 Advantages of 
cascade processes include a reduction in the number of workup and purification steps, but also 
the fact that unstable intermediates can be immediately further reacted, or that unfavorable 
equilibria can be driven to the desired product. An obvious drawback of such a strategy may 
be the often intrinsic incompatibility of the catalysts and/or enzymes involved, which will 
lead to incomplete conversions. Incompatible catalysts can be physically separated in various 
ways e.g. by applying biphasic reaction conditions,
[3]
 membrane reactors
[4]
 or sol-gels.
[5]
 
Another way to circumvent incompatibility problems is to achieve compartmentalization by 
attaching the actual catalyst to larger particles and contain them in an environment that is 
accessible for the substrate molecules, but impermeable to the macromolecular catalyst. Such 
‘pseudo-homogeneous catalysts’ can amongst others be created by immobilizing soluble 
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metal complexes on nanoparticles, either non-magnetic
[6],[7]
 or magnetic ones,
[8],[9]
 which can 
be contained in semi-permeable membranes and hence be physically separated from other 
catalysts. Nanoparticles may be unstable and stabilizers which might affect the catalyst 
behavior, are often necessary to prevent aggregation.
[10],[11]
 
Dendrimers can also be used as scaffolds for creating macromolecular catalysts,
[12]
 which 
generally show only a limited loss in activity compared to their ‘non-expanded’ 
congeners.
[13],[14]
 This might be a result of the comparable properties of these materials 
regarding solubility and electronegativity. Such dendritic catalysts can be kept in a 
compartment due to the macromolecular nature of these polymers, and have been utilized for 
purification purposes after the reaction
[15]
 and in continuous flow reactors during reaction.
[16]
 
Dendritic catalysts have also been applied while enclosed in commercially available dialysis 
bags.
[17],[18],[19]
 The latter examples, however, were conducted in organic, environmentally 
unfriendly solvents. As part of a research program, in which we focus on conducting cascade 
reactions catalyzed by the joint action of organometallic catalysts and enzymes, we studied 
possibilities to compartmentalize metal catalysts in an aqueous environment. Inspired by the 
aforementioned dendrimer examples, we decided to design a metallodendrimer that would 
show catalytic activity under compartmentalized, aqueous conditions. To this end, an iridium-
catalyst was selected that was known to be suitable for reductive amination in an aqueous 
environment. We showed that by applying a dendritic analogue in a dialysis device we were 
able to successfully drive the aqueous reductive amination of an unprotected amino acid to 
completion, despite the unfavorable equilibria for iminium ion formation in water. Since the 
dendrimer remains inside the dialysis bag due to its size, the catalyst can also be easily 
removed from the reaction mixture after the reaction has been completed and reused in a next 
reaction (Figure 3.1). 
 
Figure 3.1 General approach for the use of dendritic catalysts in a dialysis bag. 
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3.2 Dendritic catalyst formation  
To study this approach, we selected iridium catalyst 3, which has been previously successfully 
applied in aqueous reductive aminations.
[20]
 The catalyst is based on related iridium 
complexes that are capable of performing transfer hydrogenation reactions as has been 
documented by Fukuzumi et al.
[21],[22],[23] 
The water soluble iridium catalyst 3 was prepared 
according to a procedure of Francis
[20]
 in high yield (Scheme 3.1). Starting material is 
[Cp*IrCl2]2 which readily coordinates to bipyridine 1 to form iridium complex 2. Subsequent 
abstraction of the chloride ion in the presence of Ag2SO4 afforded the active species 3 in 
excellent yield. 
 
Scheme 3.1 Synthesis of water soluble iridium catalyst 3. 
Ligand 7 (synthesis described in chapter 2) was connected to water soluble third and fourth 
generation poly(propylene imine) (DAB-Am) dendrimers via a protocol described by 
Peerlings and Meijer (Scheme 3.2).
[24]
 First, a multi-isocyanate was prepared in situ using di-
tert-butyl tricarbonate (6). After the addition of pyridine to quench the excess of tricarbonate 
6, ligand 7 was added, leading to the formation of dendrimers 8 and 9 in good yields. The 
products were completely characterized by 
1
H and 
13
C NMR, thereby confirming that all 
amines had been reacted. Furthermore, IR spectroscopy showed signals at 1580 and 1640 cm
-1
 
derived from the newly formed urea functionalities. The next reaction, coordination of iridium 
to the dendritic ligands in methanol, afforded the corresponding iridium complexes 10 and 11 
in quantitative yield. In the final step, the complex was converted into the water soluble 
dendritic catalysts 12 and 13 by overnight treatment with Ag2SO4 in 46 and 47% yield, 
respectively.
[20]
 During the removal of AgCl by centrifugation, some dendritic material was 
probably lost in the pellet, explaining the rather moderate yield of the final step. Dendrimers 
12 and 13 were purified by aqueous dialysis. Unfortunately, the NMR spectra of dendrimers 
10-13 could not be completely resolved due to the broad peaks observed, and the low 
intensity of the resonances in the 
13
C NMR measurements. However, each transformation was 
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accompanied by a clear and complete change in chemical shift of the aromatic bipyridine 
peaks. 
Scheme 3.2 Attachment of the adapted ligand 7 to the dendrimers via a multi-isocyanate 
coupling, followed by iridium coordination. 
 
3.3 Dendrimer catalysis  
The reactivity of macromolecular catalysts 12 and 13 was examined in the aqueous reductive 
amination of valine (14, Scheme 3.3). This reaction is in fact a multistep process, in which the 
in water unfavorable equilibria for the formation of hemiaminal 16 and iminium ion 17 are 
compensated by the iridium-catalyzed reduction to form the benzylated amino acid 15. 
Iridium complexes 3, 12 and 13 were capable of reducing the intermediate imine in the 
presence of HCO2K, which acted as the hydride source. The reaction was monitored by 
analysis via HPLC of aliquots of the reaction mixture. An excess of benzaldehyde was used, 
because it was also partially reduced to benzyl alcohol in a side reaction. The optimal pH 
appeared to be 5, comparable with a similar catalyst published by Fukuzumi.
[22],[23]
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Scheme 3.3 Catalytic reductive amination of valine (14) via (unfavorable) equilibrium 
reactions in water. 
In the presence of the non-dendritic catalyst 3, formation of the N-alkylated amino acid 15 
proceeded considerably faster than in the dendrimer-supported reductive aminations (Figure 
3.2). However, after longer reaction times the yields were only slightly lower for the dendritic 
catalysts. 
 
Figure 3.2 Formation of 15 catalyzed by the three iridium catalysts. 
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3.4 Dendrimer catalysis inside a dialysis bag 
In order to study the same reaction with the dendritic catalysts 12 and 13 in a dialysis bag, a 
setup was used as depicted in Figure 3.3. This consisted of a closed cup containing a dialysis 
membrane with a molecular weight cut-off value of 2,000 (Figure 3.3). We assumed that all 
reaction components except the catalyst would be able to pass the membrane, turning the 
dialysis tube into a compartment suitable for catalysis. To verify this hypothesis, catalyst 12 
was injected in the dialysis device and the reductive amination of valine (14) was performed 
under otherwise identical conditions as for the non-compartmentalized catalysts (Figure 3.4). 
HPLC analysis showed that the reaction rate and conversion were fairly similar to the non-
compartmentalized aqueous reaction (Figure 3.2). Similar experiments were conducted with 
the G4 dendrimer 13 (Figure 3.4). The graph shows that the reaction rate was somewhat 
lower, but that the conversion was comparable to the ´free´ dendritic catalyst.  
 
Figure 3.3 Reaction setup to perform compartmentalized catalysis. 
 
Figure 3.4 G3 Catalyst 12 and G4 catalyst 13 activity in dialysis device. 
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3.5 Catalyst recovery 
After demonstrating that the dendritic catalysts 12 and 13 were still active when injected in a 
dialysis bag, we wanted to investigate the possibilities of catalyst recovery and reuse by 
means of a dialysis device. Thus, the dialysis tube with either catalyst 12 or 13 was removed 
after performing the reaction depicted in Scheme 3.3, dialyzed in buffer to remove all the 
other reaction contents and added to a fresh reaction mixture. Retaining the catalytic activity 
in subsequent runs would prove that the macrocatalysts stayed in the compartment and that 
recovery was possible. 
In the second run, the recovered G3 dendrimer 12 still showed catalytic activity (Figure 3.5), 
albeit that a distinct decrease in reaction rate was observed. In the third run, hardly any 
catalysis was observed. This phenomenon may be attributed to leakage of the catalyst through 
the dialysis membrane. In contrast to the smaller G3 dendrimer 12, the G4 catalyst 13 was 
equally active in a second run, clearly demonstrating the viability of containment of the 
catalyst in the dialysis bag (Figure 3.6). Prolonged usage, however, also resulted in a 
significant decrease in activity (runs 3 and 4). The activity loss can be most likely explained 
by decomposition of the catalyst under the relatively harsh reaction conditions, in which 
coordination between iridium and the ligands was lost and iridium is able to diffuse through 
the membrane.  
 
Figure 3.5 G3 Catalyst 12 activity in subsequent runs. 
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Figure 3.6 G4 Catalyst 13 activity in subsequent runs. 
ICP-MS measurements confirmed the loss of metal, since significant amounts of iridium were 
detected outside the dialysis cup (Table 3.1). After the third and fourth cycle of the G3- and 
G4-dendritic catalyzed reactions, virtually no iridium could be detected in the inner solution 
of the dialysis device, while in the outer volumes up to 34 and 27% of the initial amount of 
iridium was measured. We assume that the rest of the iridium precipitates in the dialysis 
device. The decrease in activity also correlates reasonably well with the leakage of iridium as 
determined by ICP-MS.  
 
 
 
 
 
 
 
 
 
0
25
50
75
100
0 25 50 75 100
C
o
n
v
er
si
o
n
 (
%
) 
Reaction time (h) 
1st run 2nd run 3rd rund 4th rund
- 67 - 
 
Table 3.1 Iridium loss during the dendrimer-supported catalytic reactions, measured by 
ICP-MS. 
Entry Catalyst Reaction cycle 
Reaction yield 
(%)
a
 
Ir content (% of 
initial amount)
b
 
1 12 1 87 33.6 
2 12 2 88 15.9 
3 12 3 13 5.1 
4 12 dialysis cup – 12.9 
5 13 1 85 27.0 
6 13 2 81 26.0 
7 13 3 37 4.7 
8 13 4 9 2.0 
9 13 dialysis cup – 4.2 
a
Reaction times vary. 
b
Samples were taken of the outer volume, except for entries 4 and 9 in 
which the content of the dialysis cup was analyzed. 
To confirm that the catalyst slowly decomposes, the G4 catalyst 12 was stirred in the presence 
of one equivalent HCO2K at 50 ºC for 12 days prior to the reductive amination. Indeed, no 
formation of N-benzyl valine (15) was observed upon use in the reductive amination reaction. 
The same phenomenon was observed for catalyst 3. After an incubation period of 10 days at 
50 ºC, the reductive amination depicted in Scheme 3 took 30 hours to reach completion, while 
the reaction with the active catalyst 3 succeeded in only 2 hours. 
 
3.6 Conclusion 
Dendritic catalysts were successfully synthesized by connecting Ir-bipyridine complexes to 
third and fourth generation DAB-Am dendrimers. The dendritic catalysts 12 and 13 showed 
good activity in the reductive amination of a free amino acid in water, albeit that prolonged 
reaction times as compared to the free catalyst were required. Due to the size of the 
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macromolecular catalysts, it was possible to employ them in a dialysis device for conducting 
reductive aminations of free amino acids in water. The G4 catalyst 13 showed the same 
reaction rate in a second run, which validates the concept of maintaining the macromolecular 
catalyst in the compartment. Facile separation of catalyst and product was possible using this 
approach. Furthermore, this shows that compartmentalization of the metal catalyst is in 
principle possible in an aqueous medium, although leakage of the metal ion outside the 
compartment of the metal was a major problem in our system. A more stable, water soluble 
metal complex should be used to ensure prolonged catalyst usage. However, this work implies 
that the compartmentalized catalyst should be applicable in cascade reactions with reagents 
that are normally incompatible with the iridium complex. Since our process was successfully 
conducted in water, combinations with enzymes should also be possible. 
 
3.7 Experimental section 
General information: Can be found in chapter 2. The picture in Figure 3.3 was taken by Dr. H.A. Van Kalkeren 
with an I-Phone (type unknown). Dendrimers 4 and 5 were a kind donation by SymoChem. Dendrimers 12 and 
13 were purified with Spectrumlabs Spectra/Por Dialysis Membrane 2 with a MWCO of 3.500. The aqueous 
reductive aminations were performed in Slide-A-Lyzer MINI dialysis units of Thermo Scientific with a MWCO 
of 2,000. The reductive aminations were monitored with an Agilent 1120 Compact LC equipped with an Agilent 
Eclipse Plus C18 column.  
General procedure for the reductive amination of valine: The appropriate catalyst (0.05 equiv.), L-valine 
(0.50 mg, 4.27 μmol) and HCO2K (3.59 mg, 43 μmol, 10 equiv.) were added via a stock solution to citric 
acid/Na citrate 25 mM buffer pH 5.0. Benzaldehyde (4.34 μL, 43 μmol, 10 equiv.) was directly added. The total 
reaction volume was 1.000 mL. The mixture was stirred at 50 °C open to the atmosphere (see Figure 3.3).  
General procedure for the reductive amination in a dialysis cup: A solution of the catalyst (0.05 equiv.) in 
0.500 mL citric acid/Na citrate 25 mM buffer pH 5.0 was added to the dialysis cup, while L-valine (5.00 mg, 
42.7 μmol), HCO2K (35.9 mg, 0.427 mmol, 10 equiv.) and benzaldehyde (43.4 μL, 0.427 mmol, 10 equiv.) were 
added to 9.500 mL citric acid/Na citrate 25 mM buffer pH 5.0. The dialysis cup was placed in this solution. The 
mixture was stirred at 50 °C open to the atmosphere (see Figure 3.3). 
Preparation ICP-MS samples: To 25 μL of the solution was added 500 μL concentrated HNO3. The mixture 
was heated to 80 °C for 3 h. After the mixture was cooled to room temperature, 0.250 mL of a 89.0 mg/L InBr3 
solution in 3% HNO3 and 9.225 mL MilliQ were added. 
Cp*Ir(4,4’-dimethoxy-2,2’-bipyridine)Cl2 (2): A procedure described by Francis
[20]
 was used and yielded 
100% of the desired product. To a solution of pentamethylcyclopentadienyliridium(III) chloride dimer (100 mg, 
0.126 mmol, 0.5 equiv.) in MeOH (12 mL) was added 4,4’-dimethoxy-2,2’-bipyridine (1) (54 mg, 0.252 mmol). 
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The mixture was stirred for 4 h, followed by evaporation of the volatiles under reduced pressure. The residue 
was dissolved in as less as possible DCM. The product precipitated after the addition of heptane. Filtration and 
washing with heptane afforded 155 mg (0.252 mmol, 100%) of 2 as a yellow solid. 
1
H NMR (400 MHz, CDCl3) 
δ = 9.25 (d, J = 2.7 Hz, 2H), 8.37 (d, J = 6.5 Hz, 2H), 7.08 (dd, J = 6.5, 2.7 Hz, 2H), 4.42 (s, 6H), 1.65 (s, 15H). 
13
C NMR (75 MHz, CDCl3) δ = 169.3, 158.1, 149.9, 117.3, 111.5, 88.1, 77.1, 59.5, 8.8, 1.1. 
Cp*Ir(4,4’-dimethoxy-2,2’-bipyridine)SO4 (3): A procedure described by Francis
[20]
 was used and afforded 
96% of the desired compound. To complex 2 (165 mg, 0.27 mmol) in 20 mL water was added Ag2SO4 (85 mg, 
0.27 mmol, 1.01 equiv.). The mixture was stirred at ambient temperature overnight. The mixture was filtered and 
concentrated under reduced pressure, yielding 165 mg (0.26 mmol, 96%) of a yellow solid. 
1
H NMR (400 MHz, 
D2O) δ = 8.88 (d, J = 6.6 Hz, 2H), 7.97 (d, J = 2.7 Hz, 2H), 7.41 (dd, J = 6.6, 2.7 Hz, 2H), 4.11 (s, 6H), 1.66 (s, 
15H).
 13
C NMR (CDCl3, 75 M z): δ = 168.4, 156.8, 151.8, 114.1, 110.1, 87.6, 56.3, 7.2. 
Di-tert-butyl tricarbonate (6): An adapted version of the procedure described by Pope was used.
[25]
 To a 
solution of potassium tert-butoxide (25 mL of a 1.0M solution in THF, 25 mmol) was added 10 mL THF and 
through this solution was slowly passed CO2 at 0 °C for 30 minutes. Diphosgene (0.905 mL, 12.5 mmol, 0.5 
equiv.) in 8 mL THF was added dropwise at 0 °C and the mixture stirred at 0 °C for 1 h. The mixture was 
partially concentrated by a rotary evaporator equipped with a cold trap with the reaction flask on an ice bath. 
Salts were removed by filtration and the residue was extensively rinsed with pentane. A large amount of pentane 
was removed by rotary evaporation at 0 ºC and the mixture cooled to -15 °C. A white product crystallized and 
was obtained by filtration. The filtrate was removed in vacuo at 0 °C and the white solid that remained was 
crystallized in pentane, yielding an off-white solid. The pentane was concentrated in vacuo at 0 °C and the 
remaining solid was again dissolved in a minimal amount of pentane, affording some more off-white solid. The 
residues were combined, resulting in 1.95 g (7.44 mmol, 60%) of the desired product. 
1
H NMR (300 MHz, 
CDCl3): δ = 1.56 (s, 18H). 
13
C NMR (75 MHz, CDCl3): δ = 144.7, 143.4, 87.4, 27.4. IR (ATR): 1860, 1782, 
1069 cm
-1
. 
DAB-G3-(bpy)16 (8):  To a solution of di-tert-butyl tricarbonate (6) (90 mg, 0.343 mmol, 1.5 equiv.) in 2.5 mL 
DCM was added dropwise a solution of DAB-Am-16 (4) (24.1 mg, 14.29 μmol) in 1.5 mL DCM at room 
temperature. Gas production was observed. After 45 minutes, a drop pyridine was added to quench the 
tricarbonate, followed by the addition of 4-(tetra(ethylene glycol) amino-4'-isopropoxy-2,2'-bipyridine (7) (139 
mg, 0.343 mmol, 1.5 equiv.) in 2.5 mL DCM after 10 minutes. The mixture was stirred for 2h and concentrated 
in vacuo. The mixture was dissolved in a minimal amount of DCM and heptane was added. The precipitate was 
removed by centrifugation. The filtrate was concentrated in vacuo and the procedure repeated, which resulted in 
some more precipitation. The solid material was dissolved in DCM and concentrated under reduced pressure, 
giving 80 mg of a sticky white oil (9.31 μmol 65%). 1H NMR (400 MHz, CDCl3): δ = 8.42 (dd, J = 9.2, 5.7 Hz, 
32H), 7.92 (dd, J = 6.8, 2.3 Hz, 32H), 6.83 (dd, J = 5.6, 2.5 Hz, 16H), 6.77 (dd, J = 5.6, 2.5 Hz, 16H), 6.20 (br s, 
16H), 5.94 (br s, 16H), 4.83–4.73 (m, 16H), 4.28–4.22 (m, 32H), 3.88–3.82 (m, 32H), 3.76–3.43 (m, 160H), 
3.36–3.28 (m, 32H), 3.14 (br s, 32H), 2.46–2.22 (m, 84H), 1.63–1.46 (m, 60), 1.37 (d, J = 6.1 Hz, 96H). 13C 
NMR (75 MHz, CDCl3): δ = 165.8, 165.2, 159.4, 158.0, 157.7, 150.2, 112.1, 111.4, 107.6, 106.7, 70.9, 70.6, 
70.2, 70.1, 69.4, 67.5, 52.2, 51.0, 40.0, 38.1, 27.8, 22.2, 22.0, 21.6. IR (ATR): 3347, 2923, 2863, 2789, 1636, 
1579, 1562, 1450, 1285, 1108 cm
-1
. 
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DAB-G4-(bpy)32 (9): The method for the G3 analogue was followed with the same amounts of starting 
materials, except DAB-Am-32 (5) (25 mg, 7.11 μmol) and yielded 95 mg of a sticky white oil (5.48 μmol 77%). 
1
H NMR (400 MHz, CDCl3): δ = 8.43–8.40 (m, 64H), 7.94–7.92 (m, 64H), 6.84–6.76 (m, 64H), 6.29 (br s, 
32H), 6.00 (br s, 32H), 4.81–4.75 (m, 32H), 4.31–4.20 (m, 64H), 3.88–3.80 (m, 64H), 3.72–3.53 (m, 256H), 
3.52–3.46 (br s, 64H), 2.47–2.21 (br s, 184H), 1.66–1.46 (m, 124H), 1.37 (d, J = 6.0 Hz, 192H). 13C NMR (75 
MHz, CDCl3): δ = 165.9, 165.2, 159.5, 158.0, 157.8, 150.3, 112.1, 111.4, 107.6, 106.7, 70.9, 70.6, 70.3, 70.1, 
69.4, 67.5, 40.0, 38.2, 22.2, 22.0. IR (ATR): 3343, 2928, 2859, 2802, 1640, 1588, 1558, 1281, 1229, 1108 cm
-1
. 
DAB-G3-(Cp*Ir(bpy)Cl2)16 (10): To a solution of DAB-G3-(bpy)16 (8) (60 mg, 6.98 μmol) in 5 mL MeOH was 
added dichloro(pentamethyl-pentadienyl)iridium (III) dimer (44.5 mg, 55.8 μmol, 1 equiv.). The orange mixture 
turned yellow within a few minutes. After 1 hour, the reaction mixture was concentrated in vacuo. The residue 
was dissolved in a minimal amount of DCM and heptane was added until a suspension was formed. The solid 
was removed by centrifugation, after which the residue was rinsed with heptane, affording 104 mg (6.95 μmol, 
100%) of a yellow solid. 
1
H NMR (400 MHz, CD3OD): δ = 8.69–8.64 (m, 32H), 8.10–7.97 (m, 32H), 7.35–7.25 
(m, 32H), 5.02 (hept, J = 6.0 Hz, 16H), 4.51–4.31 (m, 32H), 3.95–3.88 (m, 32H), 3.75–3.69 (m, 32H), 3.70–3.65 
(m, 32H), 3.65–3.62 (m, 32H), 3.60–3.56 (m, 32H), 3.49–3.43 (m, 32H), 3.26–3.21 (m, 32H), 3.16–3.09 (m, 
32H), 2.76–2.50 (m, 84H), 1.70–1.66 (m, 300H) 1.46–1.39 (m, 96H). 13C NMR (75 MHz, CD3OD): δ = 169.0, 
168.3, 161.0, 158.3, 158.2, 153.7, 153.6, 117.0, 116.6, 112.6, 111.5, 90.0, 74.0, 71.9, 71.8, 71.6, 71.4, 71.1, 70.5, 
70.3, 70.2 52.7, 41.0, 39.1, 21.9, 8.9, 8.6. IR (ATR): 3377 (br), 2936, 2867, 1605, 1562, 1493, 1428, 1229, 1104 
cm
-1
. 
DAB-G4-(Cp*Ir(bpy)Cl2)32 (11): The method for the G3 analogue was followed with DAB-G4-(bpy)32 (9) (60 
mg, 3.46 μmol) and pentamethylpentadienyliridium(III) chloride dimer (44.2 mg, 55.4 μmol, 1 equiv.) as starting 
materials and yielded 103 mg (3.42 μmol, 99%) of a yellow solid. 1H NMR (400 MHz, CD3OD): δ = 8.70–8.64 
(m, 64H), 8.10–7.97 (m, 64H), 7.34–7.24 (m, 64H), 5.03 (hept, J = 6.0 Hz, 32H), 4.50–4.32 (m, 64H), 3.95–3.88 
(m, 64H), 3.76–3.71 (m, 64H), 3.71–3.66 (m, 64H), 3.66–3.61 (m, 64H), 3.61–3.56 (m, 64H), 3.50–3.44 (m, 
64H), 3.27–3.21 (m, 64H), 3.17–3.10 (m, 64H), 2.70–2.44 (m, 184H), 1.70–1.66 (m, 604H), 1.47–1.39 (m, 
196H). 
13
C NMR (75 MHz, CDCl3): δ = 168.9, 168.2, 160.9, 158.1, 153.6, 116.9, 116.7, 112.5, 112.4, 89.9, 74.0, 
71.8, 71.7, 71.6, 71.5, 71.4, 71.3, 22.3, 22.1, 8.8. IR (ATR): 3381 (br), 2936, 2889, 1614, 1549, 1497, 1445, 
1225, 1104 cm
-1
.   
DAB-G3-(Cp*Ir(bpy)SO4)16 (12): To a solution of DAB-G3-(Cp*Ir(bpy)Cl2)16 (10) (94 mg, 6.28 μmol) in 5 
mL water was added Ag2SO4 (31.3 mg, 101 μmol, 1 equiv.). The mixture was stirred at ambient temperature 
overnight, after which it was centrifuged to (partially) remove the fine white particles, filtered over a 0.2 μm 
syringe filter and concentrated to dryness, yielding a dark red solid. The catalyst was dissolved in water and 
purified by dialysis (MW 3.500), affording 44 mg (2.86 μmol, 46%) of a dark red solid after concentration. 1H 
NMR (300 MHz, CD3OD): δ = 8.98–8.64 (m, 32H), 8.20–7.96 (m, 32H), 7.41–7.24 (m, 32H), 5.12–4.95 (m, 
16H), 4.56–4.30 (m, 32H), 3.98–3.87 (m, 32H), 3.78–3.53 (m, 128H), 3.52–3.41 (m, 32H), 3.28–2.60 (m, 
152H), 2.32–1.80 (m, 60H), 1.71–1.52 (m, 240H), 1.49–1.34 (m, 96H). 13C NMR (125 MHz, CD3OD): δ = 
169.1, 168.3, 161.2, 158.2, 153.6, 116.5, 116.4, 112.5, 111.6, 89.9, 74.0, 71.8, 71.5, 71.4, 71.3, 70.6, 70.3, 69.9, 
22.0, 21.8, 8.6. IR (ATR): 3364 (br), 2971, 2936, 2863, 1618, 1562, 1489, 1441, 1100 cm
-1
.   
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DAB-G4-(Cp*Ir(bpy)SO4)32 (13): The method for the G3 analogue was followed with DAB-G4-
(Cp*Ir(bpy)Cl2)32 (11) (90 mg, 2.99μmol)  and Ag2SO4 (29.87 mg, 95.8 μmol, 1 equiv.) as starting materials and 
afforded 43 mg (1.39 μmol, 47%) of a dark red solid. 1H NMR (300 MHz, CD3OD): δ = 8.96–8.84 (m, 64H), 
8.09–7.98 (m, 64H), 7.36–7.27 (m, 64H), 5.08–4.96 (m, 32H), 4.54–4.25 (m, 64H), 3.97–3.86 (m, 64H), 3.77–
3.58 (m, 256H), 3.50–3.43 (m, 64H), 3.28–2.92 (m, 280H), 2.40–1.76 (m, 180H), 1.69–1.65 (m, 480H), 1.47–
1.41 (m, 196H). 
13
C NMR (125 MHz, CD3OD): δ = 169.0, 168.3, 161.1, 158.2, 153.6, 116.8, 116.6, 112.5, 
111.5, 89.9, 74.0, 71.8, 71.6, 71.5, 71.5, 71.3, 70.8, 70.2, 22.0, 21.8, 8.7. IR (ATR): 3386, 2975, 2923, 2872, 
1614, 1562, 1484, 1454, 1100 cm
-1
. 
N-benzyl L-valine (15): Synthesis for HPLC analysis was performed according to a literature description.
[26]
 
Benzaldehyde (2.04 mL, 20 mmol, 1 equiv.) was added to a solution of L-valine (14) (2.34 g, 20 mmol) in 10 mL 
2M NaOH. The mixture was stirred for 90 minutes, after which NaBH4 (0.227 g, 6.00 mmol, 0.3 equiv.) was 
gradually added at 0 °C. The mixture was allowed to warm to room temperature and another portion of 
benzaldehyde (2.04 mL, 20 mmol, 1 equiv.) was added after 90 minutes. The mixture was cooled to 0 °C and 
NaBH4 (0.227 g, 6.00 mmol, 0.3 equiv.) was portion wise added after 45 minutes. The mixture was stirred for 2h 
at room temperature, diluted with 10 mL water and washed twice with DCM (10 mL). The aqueous phase was 
acidified until a neutral pH was achieved. The white precipitate was isolated by filtration and washed with water 
and acetone, yielding 3.65 g (17.6 mmol, 88%) of a white powder. 
1
H NMR (400 MHz, D2O + NaOH): δ = 
7.58–6.88 (m, 5H), 3.69–3.59 (m, 1H), 3.46–3.59 (m, 1H), 2.93–2.48 (m, 1H), 1.96–1.37 (m, 1H), 0.99–0.40 (m,  
6H). 
13
C NMR (75 MHz, D2O + NaOH) δ = 181.2, 138.4, 128.1, 128.0, 126.7, 68.3, 50.9, 30.1, 18.2, 17.9. IR 
(ATR): 3420 (br), 3040, 2962, 2872, 1605, 1571, 1437, 1406, 1320, 1221 cm
-1
. 
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4. Towards homogeneous metal catalysis in a 
polymersome nanoreactor 
 
Abstract 
Incompatible one-pot cascade reactions may well be successfully performed if both reactions 
are compartmentalized. In this chapter, our efforts to compartmentalize a homogeneous metal 
catalyst in a polymersome nanoreactor are described. This nanoscale vesicle can protect the 
catalyst from inactivation by other catalysts. To this end, a metal complex was immobilized 
on a large carrier molecule, which was subsequently used for encapsulation. Two different 
supports were chosen, dendrimers and proteins. Dendrimers were used because they are large, 
well-defined and extensively investigated macromolecular materials. The preparation of an 
active dendritic iridium catalyst was described in chapter 3. We also explored the possibility 
of using proteins as support because a wide variety of proteins have been encapsulated with 
high efficiencies in polymersomes before. To this end, a copper complex was functionalized 
and reacted with the free amines of BSA and lysozyme. The resulting macrocatalysts showed 
comparable reactivity in an aqueous oxa-Michael addition when compared to the non-adapted 
native catalyst. Next, attempts were undertaken to encapsulate the supported catalysts in two 
types of polymersomes. Polymersomes prepared from PS-PIAT block-copolymers were tested 
because their membrane had been shown to be highly permeable towards small substrates. On 
the other hand, PS-PEG polymersomes were used, which are only permeable in the presence 
of organic co-solvents, but are also more robust. Due to an insufficient stability of the protein-
supported catalyst-loaded PS-PIAT polymersomes, no catalytic Michael addition could be 
performed with these vesicles. Formation of catalyst-loaded PS-PEG polymersomes on the 
other hand succeeded and catalytic activity was observed.  
   
4.1 Introduction  
The advantages of cascade chemistry, such as less waste, fewer purification steps and more 
efficient transformations, have been recognized by scientists a long time ago and numerous 
examples of cascade reactions have appeared in literature.
[1],[2],[3],[4]
 Various reactions can be 
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combined in a single vessel without any problems. However, performing multiple reactions in 
one-pot is generally problematic as reagents of one reaction can negatively affect the other 
ones. In addition, the optimal reaction temperature, pH and solvent may be different for the 
separate reactions involved. Considering this, the combination of an enzymatic reaction and a 
homogeneous metal-catalyzed reaction is a real challenge. Firstly, enzymes are usually not 
active in organic solvents, while only a minor part of homogeneous metal catalysts show 
catalytic activity in aqueous media. Secondly, metal complexes can coordinate to proteins, 
which can lead to inactivation of both catalysts.
[5]
 However, examples of combined enzyme-
and metal-catalyzed cascade reactions do exist. The major part of these compatible 
combinations are dynamic kinetic resolutions or related procedures: only one enantiomer is 
enzymatically converted into a desired enantiopure product, while the remaining starting 
material is racemized by a metal catalyst.
[2],[6],[7],[8],[9]
 In another example, a palladium-
mediated Suzuki coupling is combined with an enzymatic ketone reduction.
[10],[11]
  
In order to obtain a broader scope in cascade chemistry, in particular concerning the 
combination of enzymes with metal catalysts, individual reactions must be made compatible. 
One approach, inspired by nature, is to use a compartmentalization strategy which prevents 
the undesired interactions of different catalysts or reagents with each other. In the living cell, 
high reaction efficiencies are obtained due to well-tuned cascade reactions. Here, normally 
incompatible reactions can be performed simultaneously by applying compartmentalization 
techniques. Cell membranes form compartments, which can protect enzymes from 
inactivation by separation from harmful chemical processes. Substrates and reaction 
intermediates are able to reach each necessary biocatalyst in the different compartments by 
crossing semi-permeable membranes.
[12]
 For example, peroxisomes encapsulate harmful 
oxidation reactions in which H2O2 is liberated or consumed to prevent damage to the cell.
[13]
 
Inspired by the efficient examples nature provides, scientists have compartmentalized 
reactions via several techniques. Macroscopic compartmentalization examples are biphasic 
reaction systems,
[14],[15],[16]
 membrane reactors,
[17],[18]
 and sol-gels,
[19],[20]
 while 
compartmentalization on a nanoscale has been realized via application of layer-by-layer (LbL) 
particles,
[21],[22],[23],[24] 
lipid vesicles or liposomes,
[25],[26]
 and virus-like particles, capsules 
prepared from multiple protein subunits.
[27],[28]
   
Vesicles can also be prepared from polymeric amphiphiles.
[29],[30],[31]
 These so-called 
polymersomes are generally more robust than liposomes and their properties can be readily 
tuned by adapting the synthetic building blocks. Enzyme-filled polymersomes of which the 
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membrane is semipermeable have been extensively used as nanoreactors.
[32],[33]
 In these cases, 
the enzymes were too large to escape the vesicle, whereas the substrate and product were able 
to pass the membrane. Thus, the polymersomes protected the enclosed enzymes from the 
environment by the stable membrane.  
If homogeneous metal catalysts are enclosed in polymersomes, physical interaction with other 
catalytic species can be prevented, which contributes to an improved compatibility. Hence, 
metal catalyst-loaded polymersomes are highly interesting for cascade chemistry where 
compartmentalization is required. Until now, only a few examples exist in which metal-
containing compounds were encapsulated in polymersomes or the closely related 
liposomes
[34],[35],[36]
 and in none of these examples a homogeneous metal catalyst was 
involved. The lack of homogeneous metal catalyst encapsulation can be attributed to two 
main problems. First, polymersomes are usually prepared in water, whilst homogeneous metal 
catalysts are generally unstable and not reactive under aqueous conditions. Secondly, regular 
homogeneous metal catalysts would escape from the semipermeable compartment due to the 
small dimensions of these catalysts. Therefore, they should be immobilized on a support prior 
to encapsulation to prevent leakage. Immobilization on dendrimers would allow keeping the 
catalyst inside the vesicles, as diffusion through the membrane is hampered due to their large 
dimensions. Poly(propylene imine)-based (DAB-Am) dendrimers were chosen as support, as 
these well-defined macromolecules are water soluble, easy to adapt and commercially 
available. The preparation of water-soluble dendrimer-supported catalysts was described in 
chapter 3. These catalysts showed catalytic activity in an aqueous reductive amination.      
Additionally, proteins should be suitable supports as well, because these molecules are 
generally water soluble, commercially available and because proteins have been successfully 
enclosed in polymersomes before. Formation of metal complex-enzyme conjugates have been 
previously described, for example in order to obtain a chiral environment for enantioselective 
catalysis.
[37]
 In some cases, the metal complexes were functionalized with biotin, which is 
strongly bound by streptavidin,
[38],[39],[40]
 while another approach involved covalent 
attachment via cysteine conjugation.
[41]
 The role of the protein in our approach differs from 
the examples mentioned above. The protein is used as a support rather than as protection or a 
chiral agent; protection in our case is achieved via the polymeric vesicles.  
In this chapter, we present our attempts to encapsulate immobilized metal catalysts inside a 
polymersome nanoreactor. We initially investigated the possibility of encapsulating the 
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metallodendrimer 4 inside a polymersome. Formation of this catalyst has been described in 
chapter 3 and was based on iridium catalyst 3, a water-soluble complex which is highly active 
in aqueous reductive aminations.
[42]
 The enlarged dimensions of catalyst 4 were envisaged to 
retain the metal complex in the polymersome compartment, as diffusion over the membrane 
would be prevented (Scheme 4.1). In a second approach, proteins were used as support to 
prevent leakage from the polymersome compartment. For this purpose the covalent 
attachment of activated copper-bipyridine complex 6 to a protein was investigated, thereby 
creating an active, homogeneous macrocatalyst. The related copper-bipyridine complex 5 is 
known to catalyze aqueous oxa-Michael additions.
[43],[44]
  
 
Scheme 4.1 Homogeneous metal catalysis inside a polymersome nanoreactor. 
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4.2 Preparation of protein-metal catalyst conjugates 
4.2.1 Bipyridine attachment to BSA and lysozyme 
The protein carrier in this research should be robust, easy to decorate with functional ligands 
and readily available. The metal complexes should be connected in a covalent fashion, as this 
would result in a stable macrocatalyst. To this end, the nucleophilic amine groups of the 
lysine residues in the protein can be used in a reaction with ligands equipped with 
electrophilic groups. We started with the widely applied and cheap protein Bovine Serum 
Albumin (BSA), which contains 59 lysine residues of which 35 are approximately accessible 
for modification, for example with isocyanates,
[45]
 or organic acid anhydrides.
[46]
 Next, we 
explored the possibility to decorate lysozyme with the catalyst, which has 6 lysines in total.
[47]
 
We chose to install a carbonyl imidazole rather than an isocyanate onto the bipyridine ligand, 
as this electrophilic group has a higher stability, which allowed isolation and purification of 
the reactive ligand 7 (see Chapter 2). Thus, a solution of ligand 7 in acetone was added to a 
buffered aqueous solution of BSA and the mixture was stirred overnight (Scheme 4.2). After 
purification by dialysis, the number of attached ligands to the protein was estimated by 
MALDI-TOF measurements (Figure 4.1). We aimed at a high number of attached ligands per 
protein as this would result in a high catalyst loading in the polymersome nanoreactor. To this 
end, the pH and reagent concentrations were varied (Table 4.1, entries 1-5). The optimal pH 
for the installation of the ligands appeared to be 9.0 (entry 4). At a lower pH, more amines 
were inactivated by protonation while at a higher pH, decomposition of the reactive carbonyl 
imidazole occurred due to attack of OH
-
. A lower amount of attached ligands was observed 
when the reaction was performed at a two-fold diluted protein concentration while keeping 
the concentration of ligands constant (entry 6). More concentrated reactions (entries 7 and 8) 
yielded more attached ligands per protein. Changing the acetone/buffer ratio or the addition of 
DMAP to promote the reaction did not have a major influence on the outcome of the reaction. 
Applying the optimal conditions depicted in Table 4.1, entry 8, to lysozyme resulted in 5 
bound ligands, as was observed by MALDI-TOF. There was no change in molecular weight 
of the modified proteins after storing the solutions at 5 °C for several months, showing the 
stability of these ligand-protein conjugates.      
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Scheme 4.2 Ligand attachment to proteins via modification of lysines. 
Table 4.1 Optimization of ligand attachment to BSA.
a
 Different amounts of ligand 7 were 
tested for the attachment to the protein support. 
Entry Concentration 
BSA (mg/mL)
a
 
Amount of 
ligand 7 (equiv.) 
pH # of attached 
ligands 
1 0.50 100 6.1 2.2 
2 0.50 100 7.2 6.4 
3 0.50 100 7.9 12 
4 0.50 100 9.0 15 (Fig. 4.1) 
5 0.50 100 11.0 6.3 
6 0.25 200 9.0 12 
7 1.00 100 9.0 23 
8 2.00 100 9.0 32 
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Figure 4.1 MALDI-TOF spectra of ligand-protein conjugates. Both conjugates are formed 
under the reaction conditions depicted in Table 4.1, entry 8. 
4.2.2 Copper introduction to ligand-protein conjugates 
To prepare the catalytically active copper complex, the obtained ligand-protein conjugates 
were stirred with 1 equivalent Cu(NO3)2. Unfortunately, the modified BSA precipitated at 
various pH-values during the complexation. Even when BSA with only a few attached ligands 
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was used, precipitation of the protein was observed. Probably the presence of bound copper 
has an influence on the tertiary structure of the protein, thereby changing its solubility. This 
result shows that BSA is an inappropriate protein for our purpose, as only protein-supported 
catalysts in solution can be used for the encapsulation in polymersomes.   
After stirring the ligand-modified lysozyme with the copper salt, no precipitation occurred 
and a clear mass increase was observed with MALDI-TOF. However, after purification by 
dialysis, only a minor increase with respect to the value found for the ligand-protein conjugate 
was observed. This result shows that copper was removed during dialysis. Inductively 
coupled plasma mass spectrometry (ICP-MS) confirmed the loss of copper, as only 23% was 
left of the copper that was initially present after complexation. We hypothesize that most of 
the copper ions were weakly coordinated to the protein in an unselective manner and not 
coordinated to the bipy ligand, and thus were removed upon dialysis. 
To ensure successful copper binding, the process was reversed; copper nitrate was first 
coordinated to bipyridine 7 in MeOH, which was in turn added to lysozyme in buffer pH 7.9 
yielding ligand-protein conjugate 8 (Scheme 4.3). MALDI-TOF analysis revealed an average 
of about 2 attached metal complexes per lysozyme (Figure 4.2).      
 
Scheme 4.3 Cu-bpy complex immobilization on lysozyme. 
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Figure 4.2 Cu-bpy complex 6 immobilization on lysozyme. 
As leakage of Cu-ions from the complex was considered a risk, also the more strongly 
coordinating terpyridine ligand was used.
[48]
 Complex 9 was activated in an analogous manner 
as for the bipyridine catalyst (described in chapter 2), giving rise to complex 10 (Scheme 4.4). 
After addition to lysozyme, an average of 2 bound metal complexes per protein was observed 
(Figure 4.3).  
 
Scheme 4.4 Copper-terpyridine complex. 
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Figure 4.3 Cu-bpy complex 10 immobilization on lysozyme. 
 
4.3 Catalytic activity protein-supported metal catalysts in the aqueous 
oxa-Michael addition 
The catalytic activities of the two different Cu-lysozyme conjugates 8 and 11 were compared 
to the non-immobilized analogues 5 and 9 in a benchmark Michael addition using 10 mol% 
catalyst in all reactions (Scheme 4.5 and Graph 4.1).
[44] 
The copper complex acts as a Lewis 
acid, rendering the unsaturated ketone more susceptible to nucleophilic attack of water. The 
uncatalyzed reaction also takes place, albeit at a low reaction rate.   
 
Scheme 4.5 Cu-catalyzed aqueous oxa-Michael addition. 
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Graph 4.1 Reaction rates of the oxa-Michael addition of water to ketone 1. 
Reactions with catalyst 5, Cu-bpy-lysozyme 8 and the uncatalyzed reaction were at least two 
times performed and yielded comparable results, reactions with catalyst 9 and Cu-tpy-
lysozyme 11 were performed once. A clear trend can be observed from Graph 4.1. Although 
the small Cu-tpy 9 catalyst did show a moderate activity, no reactivity in the presence of the 
immobilized Cu-tpy 11 was observed. Apparently the presence of the bulky protein hampered 
catalysis. In contrast, the immobilization of the somewhat smaller Cu-bpy complex on 
lysozyme did not significantly affect the catalytic activity, which can be deduced from the 
small difference in conversion rate between 8 and 5. This might be explained by the presence 
of the peptide residues in close proximity of the copper center. The amino acids may interact 
with the substrate or the copper, thereby increasing the reactivity of the substrate. 
Immobilization can even have a positive effect on the rate, as was demonstrated by the group 
of Roelfes with copper complexes immobilized on DNA: the presence of DNA substantially 
improved the catalytic activity.
[43]
  
In order to investigate whether it was possible to recycle the ligand-protein complex 8, spin 
filtration (with a MWCO 3.000) was applied as it was shown in previous experiments that 
lysozyme could be successfully isolated via this method. Indeed, bicinchoninic acid 
(BCA),
[49]
 revealed that 99% of the protein was retained after spin filtration. However, the 
isolated protein conjugate failed to show catalytic activity in a second run. ICP-MS indicated 
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that leakage of copper had occurred. Approximately 50% of all copper was lost after one day, 
showing that the copper was only bound with moderate strength to the ligand-protein material 
in water. Although the protein could be kept in the spin filter during purification, the metal 
was washed away. Therefore, the protein-metal complex 8 conjugate was considered 
unsuitable for catalyst recovery purposes.  
 
4.4 Macrocatalyst encapsulation in polymersomes 
Two types of polymersomes were used for the encapsulation of dendrimer 4 and the ligand-
protein conjugate 8. PS-PIAT polymersomes have an intrinsically porous membrane, while 
PS-PEG polymersomes are not permeable in water so that 25 volume% THF should be 
present to induce permeability.  
4.4.1 PS-PIAT polymersomes 
Polymersomes prepared from the diblock copolymer polystyrene40-b-poly(lisocyanoalanine( 
2-thiophen-3-yl-ethyl)amide)50 (PS-PIAT) (Scheme 4.6) have an intrinsically porous 
membrane. Hence, these vesicles are suitable for application as nanoreactors without any 
modification of the membrane.
[50],[51],[52]
 Encapsulation of dendritic catalyst 4 was performed 
by addition of the polymers in an organic solvent to an aqueous solution of the supported 
catalyst. However, polymersomes could not be observed by Transmission Electron 
Microscopy (TEM). It was concluded that aggregation of the polymers was disturbed in the 
presence of the dendrimers.  
 
Scheme 4.6 PS-PIAT diblock polymer. 
As a second macrocatalyst Cu-lysozyme 8 was used for encapsulation in polymersomes by 
the addition of a solution of the PS-PIAT polymers in THF to an aqueous solution of the 
modified protein in milliQ. However, again no polymersomes were observed by TEM. When 
the experiment was repeated with unmodified lysozyme encapsulation was achieved neither, 
showing that lysozyme itself hampered polymersome formation. In contrast to for example 
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BSA and Horse Radish Peroxidase (HRP), which were successfully encapsulated in other 
studies, lysozyme is positively charged at physiological pH. The isoelectric point, the point at 
which the net charge is zero, of this protein is 11.35. Presumably the charge on lysozyme 
hampered polymersome formation. To investigate this further, the encapsulation of 
unmodified lysozyme in PS-PIAT polymersomes was performed in buffered solutions of pH 
9, 10, 11 and 12. The experiments at pH 9 and 10 did not show any polymersomes with TEM. 
At pH 11, besides precipitated material a turbid mixture was obtained, which suggests the 
formation of colloids. By further increasing the pH to 12, vesicles with a diameter of 150-200 
nm were observed by TEM. Repeating the experiment at this pH with the Cu-complex 
conjugated lysozyme 8 yielded polymersomes as well (Figure 4.4). Thus, encapsulation of 
lysozyme in PS-PIAT polymersomes is believed to only proceed above pH 11. 
 
Figure 4.4 Cu-lysozyme encapsulated polymersomes at pH 12. 
As the uncatalyzed oxa-Michael addition occurs rapidly at pH 12 due to the high hydroxide 
concentration, dialysis against milliQ was performed to lower the pH to conditions under 
which catalysis could be investigated. The polymersomes were thus dialyzed, which however 
unexpectedly led to the disappearance of the vesicles after 2 days, as was observed by TEM. 
Lowering the pH below the isoelectric point of the lysozyme resulted apparently in an 
unstable polymersome membrane and consequently in the loss of the supramolecular, 
polymeric structure.     
4.4.2 Crosslinked PS-PEG polymersomes 
Because lysozyme-loaded PS-PIAT polymersomes seemed to be unstable in the pH regime 
required for the oxa-Michael addition, polymersomes were used which were prepared from 
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PS-PEG. The polymers were equipped with isocyanate functionalities, which could be cross-
linked by treatment of hexylmethylene diamine (Scheme 4.7).
[53],[54]
 Hence, the stability of 
these vesicles could be further increased after aggregation by creating covalent bonds between 
the individual polymers.  
 
 
Scheme 4.7 Crosslinkable amphiphilic PS-PEG polymers. 
 
The PS-PEG polymersome membrane is not porous in pure water. However, porosity of the 
membrane is achieved by the addition of 25 volume% THF, which swells the membrane and 
thus allows transport of organic molecules over the polymer bilayer. To investigate whether 
the presence of THF was tolerated in combination with the Michael addition, the reaction was 
first performed in a 3:1 buffer pH 6.5/THF mixture (Scheme 4.8) with the unmodified metal 
complex 5. A conversion of 59% after 3 days was observed. This shows that the equilibrium 
of the reaction is more directed towards the unsaturated ketone 1 in THF, but still sufficiently 
efficient to be performed in the solvent required for application of the PS-PEG polymersome 
nanoreactors.   
 
 
Scheme 4.8 Oxa-Michael addition in the presence of 25% THF. 
 
PS-PEG polymersomes were prepared by the addition of an aqueous Cu-lysozyme 8 solution 
to a solution of polymers in THF. Next, 6 equiv. hexamethylenediamine were added to 
crosslink the polymers. The disappearance of the isocyanate moieties after 2 h reaction was 
confirmed by IR spectroscopy. After dialysis in a buffer/THF mixture to wash away all non-
encapsulated catalyst, vesicles were observed by TEM (Figure 4.5). We demonstrated that all 
non-incorporated protein was washed away during dialysis by stirring pre-formed 
polymersomes with protein conjugate 8. After dialysis of this mixture, no catalytic activity 
was observed.  
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Figure 4.5 Crosslinked PS-PEG polymersomes. 
Next, the catalytic Michael addition depicted in Scheme 4.8 was performed with the copper- 
bearing polymersome nanoreactors in a 3:1 buffer/THF mixture and in buffer only. A 
remarkable difference in reaction rate was observed. No catalysis was observed in case of the 
membrane-swollen polymersomes, in 3:1 buffer/THF mixture. Contrarily, in the case of 
‘closed’ polymersomes, in the absence of T F and with the same batch of PS-PEG 
polymersomes, a clear enhancement in the reaction rate was observed (Graph 4.2).  
 
Graph 4.2 Reaction rates of oxa-Michael additions with the copper-bearing PS-PEG 
polymersomes. 
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This result shows that the catalyst is not active in the presence of THF. In case of pure water, 
when the membrane is believed to be impermeable to organic substrates, catalytic activity was 
observed. The observed catalytic activity might have taken place at the surface of the 
polymersomes (Scheme 4.9). Because all protein material which did not have an interaction 
with the polymersomes was washed away during dialysis, the catalytic activity originates 
from these polymeric vesicles. In addition, because the substrate was not able to diffuse 
through the lipophilic membrane, catalysis took presumably place outside the vesicle. 
Unfortunately however, we are unable to prove this explanation with the results described in 
this chapter.  
 
Scheme 4.9 Catalysis at the surface of a polymersome nanoreactor. 
 
4.5 Conclusion 
To broaden the scope of cascade chemistry, it was attempted to compartmentalize 
homogeneous metal catalysts in polymersome nanoreactors. To this end, metal catalysts were 
immobilized on either a dendritic support (chapter 3) or a protein carrier. No polymersomes, 
however, could be formed in the presence of the dendritic catalyst. In a next attempt, two 
identical copper complexes were immobilized per lysozyme. The resulting protein conjugate 
8 showed a good activity in an aqueous oxa-Michael addition of water to ketone 1 with a 
comparable efficiency as the free catalyst 5. Lysozyme-loaded PS-PIAT polymersomes 
appeared to be only stable above pH 11, which was not compatible with the Michael addition. 
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Contrarily, formation of PS-PEG polymersomes in the presence of Cu-lysozyme was possible. 
In pure water, catalytic activity was observed, while the membrane of the vesicle was 
impermeable to organic substrates. We therefore hypothesize that catalysis took place at the 
surface of the polymersome.  
Further research to prove this idea would consist of showing the location of the protein. Using 
a fluorescently labeled lysozyme during polymersome formation will cause a fluorescent 
signal at the location of the protein. Fluorescent microscopy will show whether the protein is 
located at the polymersome surface, inside the membrane or in the lumen of the vesicle.    
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4.7 Experimental section 
General information: Can be found in chapter 2. MALDI-TOF mass spectroscopy was performed on a Bruker 
BIFLEX-TOF machine, samples were measured on an MTP 384 ground steel target plate. The oxa-Michael 
addition were monitored with an Agilent 1120 Compact LC equipped with an Agilent Eclipse Plus C18 column. 
Transmission electron microscopy (TEM) pictures were obtained using a JEOL 1010 TEM. The synthesis of 
ligand 5 is described in chapter 2, of dendrimer 4 in chapter 3 and of 1, 2 and 3 in chapter 5. PS-PIAT polymers 
were purchased from Encapson, PS-PEG polymers were kindly provided by dr. S. A. Meeuwissen and M. C. M. 
van Oers. 
Preparation MALDI-TOF samples: The matrix was prepared by combining 20 mg/mL sinapinic acid in 
acetonitrile and 0.1% TFA in MilliQ in a 1:1 ratio. Next, 10 µL SA matrix was mixed with 10 µL 0.1-10 mg/mL 
protein solution and 1 µL was applied onto the plate. After drying, another 1 µL was applied. 
Preparation ICP-MS samples: To 25 μL of the used solutions was added 500 μL concentrated HNO
3
. The 
concentration of protein differs but was known in each case.  The mixture was heated to 80 °C for 3h. After the 
mixtures were cooled to room temperature, 0.250 mL of a 89.0 mg/L InBr
3
 solution in 3% HNO3 and 9.225 mL 
MilliQ were added. 
Formation of ligand-protein conjugates (Table 4.1): A stock solution of the protein in the indicated buffered 
solution was made. Next, the indicated amount of 3.50 mg/mL ligand in acetone was added. The mixture was 
shaken at 37 °C overnight. Afterwards, the sample was purified either by dialysis in milliQ or buffer for 2 days 
thereby replacing the solvent 5 times. Afterwards, the amount of attached ligands was determined by MALDI-
TOF. 
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Catalytic Michael reaction (Graph 4.1 and Graph 4.2): To a solution of 0.641 mg substrate 1 (4.27 µmol) in 
1.00 mL buffer pH 6.5 was added the indicated copper catalyst (0.427 µmol, 0.10 equiv.). The mixture was 
shaken at rt. For Graph 4.2, the water/THF experiments were performed in a 3:1 buffer pH 6.5/THF mixture. 
PS-PIAT polymersome formation: A solution of 0.50 mL 1.00 mg/mL PS-PIAT in THF was added drop wise 
to 2.50 mL of a 0.20 mg/mL aqueous protein 25 mM buffer solutions without stirring. The sample was shaken 
carefully for 5 seconds, after which the sample was set to rest for 2 hours. Samples were purified by dialysis 
(MWCO 1,000,000). 
PS-PEG polymersome formation: To 2.00 mL of a stirring 2.00 mg/mL solution of PS-PEG polymers in THF 
was added 0.50 mL of a 5.0 mg/ml protein solution using a syringe pump in a period of 0.5h. Next, 1.50 mL 
milliQ was added over 1.5h under stirring, followed by the addition of hexamethylene diamine (2.1 mg, 18.1 
µmol, 6.0 equiv.). The mixture was stirred for 2h, after which IR confirmed the disappearance of the isocyanate 
functionalities. The polymersomes were purified by dialysis (MWCO 1,000,000).  
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5. Potassium formate as a small molecule switch: 
controlling oxidation/reduction behaviour in a two-
step sequence 
 
Abstract 
A one-pot reaction sequence is described in which the addition of one compound allowed 
switching between competing oxidation and reduction reactions. First, anisyl alcohol was 
oxidized by Laccase and TEMPO, and the oxidized product was subsequently reacted in an 
iridium-complex catalyzed aqueous reductive amination with valine. Competition 
experiments revealed that it was impossible to perform both reactions simultaneously, as the 
desired product was more easily oxidized than the starting material. Therefore, the one-pot 
process was sequentially conducted. After completion of the oxidation reaction, HCO2K was 
added. This reagent stopped the oxidation by enzyme inhibition, while it started the reduction 
at the same time.  
 
5.1 Introduction 
In the past decade, multi-step one-pot procedures have attracted an increasing interest of the 
chemical community.
[1],[2]
 Combining multiple transformations in one reaction vessel renders 
sequences more cost-effective as fewer work-up and purification steps are required. Multistep 
one-pot procedures are therefore considered to contribute to a more sustainable way of 
producing chemicals. A major challenge in the design of multi-step sequences is the 
compatibility of the involved substrates, intermediates and reagents or catalysts. 
Compatibility issues can be prevented by compartmentalization strategies. However, another 
approach to successful combine incompatible reactions is by performing the reactions 
subsequently. After completion of the first reaction, the second reaction is started by adding a 
catalyst or reagent.   
A particular challenge is seen in reactions in which opposing or counteracting reagents or 
catalysts (acid/base, oxidator/reductor) are used simultaneously.
[3]
 Incompatibilities between 
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opposing catalysts have been resolved by immobilization on insoluble polymers
[4]
 or 
encapsulation in sol-gels.
[5],[6],[7]
 Such behaviour is advantageously used in for example 
dynamic kinetic resolutions and related procedures
[8] 
in which secondary alcohols are 
racemized via the corresponding ketone through a redox equilibrium induced by a single 
catalyst. A remarkable case has been described by Kroutil et al., in which racemization and 
reduction were performed stepwise by a single alcohol dehydrogenase (ADH). Switching 
between non-selective oxidation and enantioselective reduction occurred by removal of the 
co-substrate acetone and addition of i-propanol.
[9]
  
In a different strategy, enantioselectivity has been achieved via chemical oxidation by a 
metal-catalyst, and simultaneous reduction by ADH in the same reaction vessel.
[10]
 As shown 
in this approach, performing multistep reactions in a consecutive manner does not per se 
require the adaptation of the catalysts or reactants used.  
In this chapter, we describe a model one-pot reaction system with counteracting catalysts, in 
which the oxidant acts on the starting compound and the final product, while the reductant 
acts on the intermediate product leading to both starting material and final product. We have 
shown that by introducing a specific reagent, the reaction can be efficiently steered into one 
direction by ‘switching-off’ the oxidation and simultaneously ‘switching on’ the reduction, 
with all other reagents present from the start of the reaction. This is the first example of a 
reagent-mediated switch between two counteracting catalytic systems, which can now be 
efficiently performed in one pot in the desired sense.  
The two-step sequence involves the aqueous enzymatic oxidation of p-methoxybenzyl alcohol 
(1) to anisaldehyde (2), which in the presence of valinamide (3) is in equilibrium with 
iminium intermediate 4 (Scheme 5.1). For the enzymatic oxidation laccase was selected 
because of its outstanding oxidative performance on benzylic systems and its broad substrate 
selectivity.
[11],[12],[13]
 The iminium ion 4 reacts further in an iridium-catalyzed reductive 
amination with formate as the hydride source to yield amine 5. However, since the latter 
product is readily oxidized by laccase, and benzaldehyde is also prone to reduction by the 
iridium catalyst, this process does not lead to any product formation when carried out in a 
single vessel. The major challenge therefore was to limit the undesired reverse reactions. 
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Scheme 5.1 One-pot oxidation/reduction sequence. 
 
5.2 Optimization of the separate oxidation and reduction reactions 
In order to tackle the problem, we initially analyzed the partial reactions involved in more 
detail. Laccase belongs to the class of oxidoreductases and is capable of performing 
oxidations at the expense of O2 with water as the only by-product. Because of its stability and 
non-toxic waste, laccase is also widely applied in industry.
[14],[15]
 Laccase readily oxidized 
anisyl alcohol (1) to aldehyde 2 in oxygenated citric acid buffer at pH 5 in 92% yield (Scheme 
5.2). We selected an activated alcohol
[16]
 to keep the reaction times short. In addition, 0.3 
equivalents of TEMPO were used as electron carrier, which appeared crucial for the oxidation 
to proceed.
[16],[17],[18]
 
 
Scheme 5.2 Laccase-mediated oxidation of anisyl alcohol (1). 
The reducing agent in our sequence was iridium complex 6 (Scheme 5.3), which has been 
successfully applied in aqueous reductive amination reactions.
[19]
 The catalyst is based on 
related iridium complexes which catalyze transfer hydrogenation reactions as has been 
documented by Fukuzumi et al.
[20],[21],[22]
 The reductive amination of 2 with (S)-valinamide 
(3) to the stable product 5 proceeded in 92% yield under similar conditions in buffer pH 5 at 
40 °C (Scheme 3). Thus, iridium complex 6 was capable of reducing the intermediate 
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iminium ion 4 in the presence of HCO2K as the hydride source. An excess of anisaldehyde (2) 
was used, because it was partially reduced to anisyl alcohol (1) in a competing reaction. 
 
Scheme 5.3 Aqueous reductive amination of anisaldehyde (2). 
 
5.3 Compatibility between the oxidation and reduction reaction  
In the following step to obtain a successful one-pot process, the compatibility of the oxidation 
conditions with each of the reactants of the reductive amination was examined (Table 5.1). 
The presence of either valinamide (3) (entry 2) or iridium complex 6 (entry 3) was tolerated. 
Contrarily, a 64 mM concentration of HCO2K (1 equiv) almost completely inhibited the 
enzymatic activity, while 32 mM HCO2K (0.5 equiv) resulted in only a small decrease in 
yield. To investigate whether this inhibition is reversible, we removed the HCO2K by 
filtration over a spin-filter, after which the recovered laccase was tested in the oxidation of 
alcohol 1. Formation of aldehyde 2 was indeed observed, showing that laccase is only 
reversibly inactivated by HCO2K.  
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Table 5.1 Compatibility of the enzymatic oxidation of 1 with the reactants of the 
reductive amination depicted in Scheme 5.3. Conditions: 25 U Laccase, 0.3 equiv. TEMPO. 
Entry Additive Conversion after 8h (%)
a 
1 – 92 
2 valinamide (3) (0.66 equiv) 91 
3 iridium complex 6 (5 mol%) 96 
4 HCO2K (64 mM) 2 
5 HCO2K (32 mM) 84 
a
Conversions determined by RP-HPLC. 
The same approach was used for the reductive amination (Table 5.2), which revealed that the 
reaction was not hampered by TEMPO (entry 2). The presence of laccase (entry 3) did have a 
tolerable negative influence on the yield. Work of Arends et al. revealed that the rhodium 
analogue of complex 6 shows a significant decrease in activity in the presence of various 
enzymes due to complexation of the metal center.
[23]
 In our hands the activity loss was 
limited, probably because a higher complex/enzyme ratio was used. In the presence of both 
laccase and TEMPO (entry 4), an initial yield of 8% was observed after 4h, which gradually 
decreased to provide only traces of product 5 after 8h, indicating that the product had reacted 
to another compound.  
Table 5.2 Compatibility of the reductive amination with the reactants of the oxidation.
 
Conditions: 5 equiv. 2, 10 equiv. HCO2K, 0.05 equiv. 6. 
Entry Additive Conversion after 8h (%)
a 
1 – 100 
2 TEMPO (0.3 equiv) 100 
3 laccase (25.0 U) 64 
4 laccase (25 U) + TEMPO (0.3 equiv) 3 
a
Conversions determined by RP-HPLC. 
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Fabbrini and coworkers showed that benzylic amines can be oxidized to iminium ions by the 
oxidized TEMPO species, resulting in the corresponding aldehydes in aqueous media.
12
 
Likewise, the alkylated valinamide 5 may be rapidly oxidized via the iminium intermediate to 
aldehyde 2 and valinamide 3 in the presence of laccase and TEMPO. For a successful cascade 
reaction with a simultaneous reduction and oxidation step, the alcohol must be easier oxidized 
than the amine. A competition experiment with alcohol 1 and amine 5 confirmed that the 
amine is more prone to oxidation at pH 5.0 to aldehyde 2 than anisyl alcohol (1) (Scheme 
5.4). At the time that amine 5 was fully oxidized to aldehyde 2, 63% of anisyl alcohol (1) was 
still left. 
 
 
Scheme 5.4 Competitive oxidation of amine 5 and alcohol 1. 
We assumed that at lower pH the alkylated valinamide 5 was less prone to oxidation as more 
amine was protonated. However, the p-methoxybenzyl group might be unstable under these 
conditions, as valinamide turns into a better leaving group if the amine is protonated. 
Therefore, we first tested the stability of p-MeOBnValNH2 (5) at pH values between 5 and 
2.5. No decomposition of compound 5 was observed under any of these pH values. Next, the 
experiment described in Scheme 5.4 was repeated under pH conditions between 4.5–2.5. 
Indeed, the relative rate of oxidation became more favorable at decreasing pH values (Figure 
5.1), and at pH 2.5, more benzylic alcohol was oxidized than amine 5, which is a prerequisite 
for a successful transformation (Scheme 5.5) However, below pH 3 no full oxidation was 
observed. This can be explained by inactivation of the laccase, whose pH-window for these 
kinds of reactions is around 3.5–5.0.[16],[17],[18] Hence, it was not possible to perform both 
transformations at the same time, as either the target compound was more reactive than the 
starting alcohol (> pH 3) or the enzyme was rapidly inactivated (< pH 3). 
- 99 - 
 
  
  
  
 
Figure 5.1 Competitive oxidation between alkylated valinamide 5 and anisyl alcohol (1) 
under different pH values. 
 
Scheme 5.5 pH Dependent competitive oxidation. 
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The latter results underline that it is impossible to conduct both transformations 
simultaneously, and that in a one-pot system the products revert to the starting materials. 
 
5.4 One-pot two-step reaction in sequential fashion 
We then chose to adjust the procedure, prompted by the observed inhibition of laccase by 
HCO2K (Table 5.1, entry 4). To test whether laccase could be inactivated and oxidation of 
amine 5 would be suppressed, the reductive amination was performed in the presence of 
laccase, TEMPO and 25 equivalents HCO2K. Indeed, 88% of the desired product was formed, 
showing that HCO2K could be used as a switch between the oxidation and the reduction. 
After establishing the possibility to switch between the two different reactions, we set out to 
optimize the one-pot oxidation/reduction process (Scheme 5.6).  
 
Scheme 5.6 One-pot two-step sequence with opposing catalysts. 
A reaction in the absence of laccase (Table 5.3, entry 1) did not lead to any product formation. 
Without inhibition of laccase – in the presence of small amounts of HCO2K – no desired 
product was formed either (entry 2). If 100 equivalents of HCO2K were added, laccase was 
successfully inhibited (entry 3) albeit that only 18% of the desired compound was obtained. 
The low yield was the result of a second, fast competing reduction, being the aldehyde 
reduced to alcohol 2. The iminium ion 4 is formed in an unfavorable equilibrium reaction in 
water, and a fast reduction mainly results in aldehyde reduction. Decreasing the reduction rate 
should afford larger amounts of product 5 because more time is available to set the 
equilibrium. Indeed, when 25 equivalents HCO2K were used (entry 4), the yields significantly 
increased. A further enhancement was achieved by using 10 equivalents of HCO2K (entry 5). 
In this case, a ten-fold lower amount of laccase was used as otherwise the enzyme would not 
be inhibited efficiently and oxidation of compound 5 would occur. Remarkably, the oxidation 
of the alcohol was only slightly slower in entry 5 compared to entries 2-4. When HCO2K was 
added in two portions of 2.5 equivalents a yield of 64% was observed. To summarize, by 
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using the appropriate amount of the ‘switching’ compound, the yield was increased from 
traces to 64%. 
We continued the optimization by varying the amount of catalyst 6 (entries 7-9). The presence 
of 0.5 or 1 mol% catalyst gave high yields of 70 and 80%, respectively, while 0.2 mol% 
catalyst led to a disagreeable reaction time of 136 h and a lower yield. In entry 10, both 
optimized amounts HCO2K (2.5 equiv.) and iridium complex 6 (1 mol%) were used. 
However, a comparable yield was obtained to the example in which the HCO2K was added in 
one batch (entry 7). 
A final strategy involved using more concentrated reactions, thereby increasing the 
concentration of iminium ion 4. Indeed, a high yield of 91% (entry 11) was obtained if the 
reaction was performed twice as concentrated. Contrarily, 78% (entry 12) was found with a 
four times more concentrated reaction mixture. In the latter case, the enzymatic oxidation 
appeared to be slow and far from completion, explaining the lower yield. Probably the high 
concentration of reagents hampered the laccase activity.   
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Table 5.3 One-pot two-step sequence optimization. 
Entry Laccase 
(U) 
Ir-cat 6 
(mol%) 
HCO2K 
(equiv) 
Time 
oxidation 
(h) 
Alcohol 1 
conversion 
(equiv)
a,b
 
Total 
reaction 
time (h) 
Conversion 
(%)
a 
1 0.0 5 10 10 0.00 10 0 
2 25.0 5 0.5 24 5.00 24 0 
3 25.0 5 100 12.5 4.46 20 18 
4 25.0 5 25 12.5 4.61 20 29 
5 2.50 5 10 13 4.44 20 32 
6 2.50 5 2 × 2.5 16.5 4.32 65 64 
7 2.50 1 10 22 3.67 50 80 (40)
c 
8 2.50 0.5 10 23 3.78 71 70 
9 2.50 0.2 10 17 4.50 136 61 
10 2.50 1 3 × 2.5 23 3.78 88 81 
11
d 
5.00 1 10 41 3.51 65 91(50)
c
 
12
e 
10.00 1 10 22 2.36 41 78 (62)
c
 
a
Conversions determined by RP-HPLC. 
b
With respect to valinamide 3. 
c
Isolated yields 
between brackets. Isolated yields were lower due to losses during the extraction procedure.
 
d
Two times more concentrated. 
e
Four times more concentrated. 
This new approach shows the concept of ‘switching’ between two counteracting reactions. 
The same strategy was also used for the less-reactive benzyl alcohol and resulted in a 
comparable yield of 75% of the desired benzylated valinamide 9 (Scheme 5.7). However, the 
oxidation proceeded only slowly. The reaction started with 5 equiv. of alcohol 7 and only 2.25 
equiv. (45%) of aldehyde were formed after 89h, showing the poor reactivity of non-activated 
benzylic alcohols in the laccase/TEMPO oxidation reaction. 
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Scheme 5.7 One-pot two-step sequence with benzyl alcohol (7). Reaction conditions: 2.50 
U laccase, 1 mol% Ir-cat 6, 10 equiv. HCO2K 
 
5.5 Conclusion 
A successful two-step reaction sequence with counteracting catalysts in water was performed. 
An enzymatic oxidation was combined with a reducing metal catalyst in one-pot. First, anisyl 
alcohol (2) was oxidized to anisaldehyde (3), which reacted in a reductive amination with 
valinamide (4). It appeared impossible to perform both transformations simultaneously, as the 
desired product 5 was more easily oxidized than anisyl alcohol (2) above pH 3 and below that 
value, poor conversions were observed due to inactivation of the enzyme. Hence, the reaction 
sequence was performed subsequently in which it was crucial to inhibit the laccase with an 
excess of HCO2K. At the same time, the reductive amination started. The reaction conditions 
were fine-tuned and led to a maximum conversion of 91% and a maximum isolated yield of 
62%. This is the first example in which a compound acts as switch between two opposing 
reactions in a one-pot procedure. 
 
5.6 Experimental section 
General information: Can be found in chapter 2. Laccase from Trametes Versicolor (12.6 U/mg) was 
purchased from Sigma-Aldrich. The oxidations and reductive aminations were monitored with an Agilent 1120 
Compact LC equipped with an Agilent Eclipse Plus C18 column. The synthesis of catalyst 6 can be found in 
chapter 3. 
General procedure for the oxidation: Laccase (25.0 U) and TEMPO (3.00 mg, 19.2 µmol, 0.3 equiv) were 
added via a stock solution in oxygenated citric acid/Na citrate 25 mM buffer pH 5.0. Anisyl alcohol (1) (7.97 µL, 
64 µmol) was directly added via a pipette. The total reaction volume was 10.000 mL. The mixtures were shaken 
at 40 °C. 
General procedure for the reductive amination: Iridium complex 6 (0.143 mg, 0.213 μmol, 0.05 equiv.), 
valinamide hydrochloride (3) (0.652 mg, 4.27 μmol), and HCO2K (3.59 mg, 0.043 mmol, 10 equiv.) were added 
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via a stock solution in oxygenated citric acid/Na citrate 25 mM buffer pH 5.0. Anisaldehyde (2) (5.14 μL, 0.043 
mmol, 10 equiv.) was directly added via a pipette. The total reaction volume was 1.000 mL. The mixtures were 
shaken at 40 °C. 
General procedure for the oxidation/reduction sequence: The amounts of the reagents differ and are stated in 
Table 3. Laccase, TEMPO, iridium complex 6 and valinamide hydrochloride (3) were added via a stock solution 
in oxygenated citric acid/Na citrate 25 mM buffer pH 5.0. Anisyl alcohol (1) (26.69 μL, 0.214 mmol, 5 equiv.), 
was directly added via a pipette. The total reaction volume was 10.000 mL. The alcohol conversion was 
followed with HPLC and after the conversion reached about 80%, HCO2K was added via a stock solution in 
oxygenated citric acid/Na citrate 25 mM buffer pH 5.0. 
Optimized procedure for the oxidation reduction sequence (Table 3, entry 11):  Laccase (5.0 U), TEMPO 
(6.00 mg, 38.4 µmol, 0.3 equiv), iridium complex 6 (0.58 mg, 0.86 μmol, 0.01 equiv.) and valinamide 
hydrochloride (3) (13.04 mg, 85.4 μmol) were added via a stock solution in oxygenated citric acid/Na citrate 25 
mM buffer pH 5.0. Anisyl alcohol (1) (15.94 µL, 0.128 mmol) was directly added via a pipette. The total 
reaction volume was 10.000 mL. The mixtures were shaken at 40 °C. After 40h, 3.51 equiv. anisaldehyde (2) 
were formed. Next, HCO2K (71.8 mg, 0.854 mmol, 10 equiv.) was added and the mixture was shaken at 40 °C. 
A conversion of 91% was observed after a total reaction time of 65h. Afterwards, a saturated NaHCO3 solution 
was added and the product extracted with DCM (3×). The combined organic extracts were dried over MgSO4, 
concentrated and purified by column chromatography on silica (DCM/MeOH, 99:1 to 97:3), affording 10.0 mg 
(42.3 µmol, 50%) of the desired product.     
Synthesis for HPLC analysis: 
N-4-Methoxybenzyl-(S)-valinamide (5): To vacuum-dried 3Å molecular sieves was added 5 mL MeOH (S)-
valinamide hydrochloride (3) (250 mg, 1.64 mmol) and anisaldehyde (2) (0.197 mL, 1.64 mmol, 1 equiv.). The 
mixture was stirred at ambient temperature for 1.5h, after which NaBH4 (248 mg, 6.55 mmol, 4 equiv.) was 
added. Gas formation was observed. The mixture was heated to 50 °C after 2.5h, but no further conversion was 
observed after 4h. More NaBH4 (248 mg, 6.55 mmol, 4 equiv.) was added. Still, starting material was observed 
after a total reaction time of 6h. The mixture was filtered and concentrated in vacuo. Purification by column 
chromatography on silica yielded 83 mg (0.35 mmol, 21%) of a white solid. 
1
H NMR (400 MHz, CDCl3): δ = 
7.21 (d, J = 8.8 Hz, 2H), 7.03 (br s, 1H) 6.86 (d, J = 8.8 Hz, 2H), 5.74 (br s, 1H), 3.80 (s, 3H), 3.76 (d, J = 12.8 
Hz, 1H), 3.59 (d, J = 13.2 Hz, 1H), 2.95 (d, J = 4.8 Hz, 1H), 2.07 (dh, J = 7.2, 4.4 Hz, 1H), 0.97 (d, J = 6.8 Hz, 
3H), 0.93 (d, J = 6.8 Hz, 3H). 
13
C NMR (75 MHz, CDCl3): δ = 176.9, 158.9, 131.9, 129.4, 114.0, 67.9, 55.4, 
52.9, 31.4, 19.6, 18.1 IR (ATR): 3360, 3256, 2941, 1666, 1614, 1523, 1251, 806 cm
-1
. HRMS (ESI): calcd. for 
C13H20N2O2Na (M+Na
+
) 259.1422, found 259.1421. 
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6. A one-pot oxidation/enantioselective oxa-
Michael cascade 
 
Abstract 
A laccase/TEMPO-mediated oxidation was combined with an aqueous, enantioselective 
copper-catalyzed Michael addition of water in one pot. The copper catalyst was also 
immobilized onto DNA to induce an enantioselective reaction. However, low conversions 
were observed when the reactions were performed simultaneously, which could be explained 
by an undesired reaction of the intermediate product with an oxidized intermediate of 
TEMPO. We were able to enhance the conversions by using a stepwise approach. Thus, after 
completion of the oxidation, the first reaction was stopped by inhibiting the enzyme with 
HCO2K. Next, the Michael addition was started by adding the Cu-catalyst. Following this 
strategy, the conversion of the two-step one-pot sequence was increased by approximately 
20% while a similar enantioselectivity was observed. 
 
6.1 Introduction 
One-pot multistep synthesis procedures have much potential to contribute to a more 
environmentally friendly fine chemical industry. As only one workup and one purification 
step are required, less waste is produced as compared to the corresponding sequential separate 
steps. Furthermore, reactive intermediates can be more efficiently transformed into the desired 
end products (generating less byproducts) and unfavorable equilibria can be overcome if the 
end state of the product is the thermodynamically most favored situation. Based on an 
increasing societal demand for using greener chemistry, it is no surprise that catalytic one-pot 
procedures have attracted the interest of the chemical community. As a result, over the years 
various single-pot reaction sequences have been developed based on combinations of non-
catalyzed, enzymatic and metal-catalyzed transformations.
[1],[2],[3]
  
The major challenge in combining reactions in one pot lies in finding compatible reagents or 
reaction conditions. Incompatibility issues as a result of adverse interactions of molecular 
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components from different reaction steps – catalysts, reagents or products – can in some cases 
be overcome by compartmentalization strategies. This approach has been successfully 
pursued by applying for example membrane reactors,
[4],[5],[6]
 sol-gels,
[7],[8]
 polyelectrolyte 
vesicles
[9],[10]
 and polymeric vesicles.
[11],[12],[13]
 Another approach is to perform the multiple 
steps consecutively in a one-pot procedure. Thus, after completion of the first step, the next 
step is started by adding one of the reagents of the second reaction or by changing the reaction 
conditions.
[14],[15]
 An example of the latter strategy was recently reported by us, in which the 
first reaction was stopped and the next reaction was started by adding one single small 
molecule that acted as a reaction switch.
[16]
  
Combining enzymatic steps with metal-catalyzed reactions is a particular challenge. Metals 
can coordinate to proteins, leading to inactivation of one or even both of the catalyts.
[17],[18]
 
Furthermore, the majority of biocatalysts are only active in water, while for metal complexes 
this is quite often the opposite. During the last decades, however, a range of metal catalysts 
have been adapted or specially designed for reactions in water.
[19],[20],[21]
 This has resulted in 
several examples of aqueous metal complex-enzyme one-pot combinations, of which a few 
are cascade reactions;
[22],[23],[24],[25]
 and the major part are one-pot procedures in which the 
steps are performed consecutively.
[26],[27],[28],[29],[30]
  
We now present an aqueous one-pot two-step synthetic procedure involving the combined 
action of a biocatalyst and a metal catalyst. We selected a copper catalyst which catalyzes the 
oxa-Michael addition of water to enones.
[31]
 We aimed to explore the possibility of combining 
this oxa-Michael reaction with a laccase/TEMPO-mediated oxidation such that allylic 
alcohols in one pot are transformed into the corresponding chiral β-hydroxyketones (Scheme 
6.1). In addition, a DNA-based copper catalyst (Figure 6.1) was applied to investigate whether 
combining the previously reported enantioselective Michael addition would result in an 
enantioenriched product 4. Furthermore, we hypothesized that the presence of the bulky DNA 
might decrease undesired catalyst-catalyst interactions. First, incompatibility issues between 
the reactions were investigated and secondly, the one-pot sequence was studied. 
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Scheme 6.1 One-pot process involving laccase-mediated allylic oxidation and copper-
catalyzed oxa-Michael addition. 
 
Figure 6.1 DNA-bound copper catalyst 5. The copper coordinates to the three nitrogens 
which are not part of the acridine moiety.  
 
6.2 Examination of the separate reactions  
We first investigated the enzymatic reaction leading to Michael acceptor 2. The powerful 
oxidation behavior of laccase
[32],[33],[34]
 led us to explore the reactivity of this enzyme on 
allylic alcohol 1. Laccase belongs to the class of oxidoreductases and is capable of performing 
oxidations at the expense of O2 with water as the only byproduct. Because of its stability and 
non-toxic waste, laccase is widely applied in industry.
[35],[36]
 To facilitate the oxidation and 
hence broaden the substrate scope, substoichiometric amounts of mediators are used in 
combination with laccase in cases where substrates are incapable of entering the active site of 
the enzyme. Thus, in the presence of O2, laccase readily oxidizes the mediator TEMPO to 
oxoammonium species 6,
[37]
 which in turn is capable of oxidizing alcohol 1 (Scheme 6.2). The 
resulting hydroxylamine 7 is reoxidized by the enzyme to regain the reactive intermediate 6.  
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Scheme 6.2 Laccase-mediated oxidation with TEMPO acting as a mediator. 
The allylic alcohol 1 was readily oxidized under conditions which were previously reported as 
being optimal for the subsequent Michael addition. At room temperature in buffer pH 6.5, 
92% of the α,β-unsaturated ketone 2 was formed in 4.5 hours. After that time, the reaction 
yield slowly decreased due to a slow, uncatalyzed Michael-addition of water to unsaturated 
ketone 2. In the absence of either laccase or TEMPO only traces of product 2 were observed, 
showing the necessity of the combination of laccase plus mediator. 
The second step of the sequence involved the aqueous copper-catalyzed Michael addition of 
water to ketone 2 at pH 6.5 (Scheme 6.3). This reaction was performed in the presence of 
either complex 3, Cu-5 or the immobilized Cu-5-DNA. Satisfyingly, in the presence of 
catalyst 3, 81% conversion into the desired β-hydroxyketone 4 was reached in 31 h. The 
presence of DNA had a dramatic effect on the reaction rate of the Michael addition resulting 
in a considerably shorter reaction time, which is in line with previous observations.
[38]
 The 
slow change in ee of product 4 (Figure 6.3) while the reaction proceeded was also in good 
agreement with previous work. This had shown that the ee over time slowly decreases due to 
an equilibrium between ketone 2 and alcohol 4 under the reaction conditions.
[31]
 
 
Scheme 6.3 Copper-catalyzed oxa-Michael addition of water. 
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Figure 6.2 Aqueous oxa-Michael additions in the presence of various copper catalysts. 
 
Figure 6.3 Development of enantiomeric excess during the oxa-Michael addition 
catalyzed by Cu-5-DNA. 
 
6.3 Oxidation/oxa-Michael cascade  
After establishing that both the enzymatic oxidation and the oxa-Michael addition resulted in 
good conversions at the same pH and temperature, we performed both transformations within 
one reaction vessel. Thus, the cascade reaction was performed in the presence of laccase, 
TEMPO and either catalyst 3, Cu-5 or the immobilized Cu-5-DNA catalyst (Scheme 6.1, 
Figure 6.1). In the case of catalyst 3, a maximum yield of 54% of ketone 2 and only 5% of the 
desired compound 4 were observed by HPLC after 23 h, which increased further to 30% after 
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4 days (Figure 6.4). Remarkably, the cascade reaction in the presence of the Cu-5-DNA 
catalyst gave the lowest conversion. Thus, the presence of DNA did not increase the overall 
yield of the two-step reaction to 4. More specifically, a rather low reaction rate of the 
oxidation towards ketone 2 was observed in the presence of the DNA-based catalyst. This 
result implies that the incompatibility of both reactions cannot be avoided by the presence of 
DNA.  
The incompatibility of the cascade reaction was investigated in more detail. Thus, the aqueous 
Michael addition depicted in Scheme 6.3 was performed in the presence of copper complex 3 
and either laccase or TEMPO or both laccase and TEMPO (Figure 6.5). The presence of 
laccase led to a slight decrease in reactivity, while TEMPO did not have an influence on the 
reaction at all. The addition of both laccase and TEMPO, however, significantly hampered the 
reaction. We reasoned that the oxoammonium species 6, which was only formed with both 
laccase and TEMPO present, was responsible for the low yield. The Michael addition took 
also place in the absence of Cu-catalyst, albeit at a significantly lower reaction rate. 
 
Figure 6.4 Cascade reactions depicted in Scheme 6.1 in the presence of laccase/TEMPO 
and various copper catalysts. 
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Figure 6.5 Influence of the oxidation reagents on the Cu-catalysed oxa-Michael addition 
using complex 3. 
We then analyzed more closely how the oxidized TEMPO species 6 could disturb the Michael 
addition. High resolution mass spectrometry of the reaction mixture showed the occurrence of 
a product which exactly corresponded to the sum of the masses of the oxidized TEMPO 
species 6 and product 4. Since starting material 1 appeared to be stable towards 
oxoammonium intermediate 6, the newly formed alcohol might have reacted with it (Scheme 
6.4). Because compound 8 is the anticipated intermediate of the regular oxidation and 
diketone 9 was not observed, we hypothesized that N-oxide 8 may have reacted irreversibly to 
the more stable cyclic hemiacetal 10. The idea of a stoichiometric reaction between alcohol 4 
and oxoammonium species 6 was supported by an experiment in which the pure alcohol 4 was 
subjected to laccase and different amounts of TEMPO. The conversion of the starting material 
did exactly match the amount of mediator added (Figure 6.6). These results in our view show 
that the desired product 4 of the reaction sequence reacts with the oxidized TEMPO 
intermediate 6 in a stochiometric fashion. Elimination of the TEMPO moiety of either 8 or 10 
to afford the corresponding diketone 9 did not happen spontaneously. Surprisingly, formation 
of diketone 9 was neither observed in the presence of 0.5M NaOH nor by heating the reaction 
mixture to 80 °C by mass spectrometry or HPLC, showing that the proposed product 10 has a 
considerable stability. These observations also explain the relatively poor yield in the two-step 
one-pot sequence with Cu-5-DNA compared to catalysts 3 and Cu-5: due to the rapid 
formation of Michael product 4, TEMPO was quickly consumed and hence the oxidation 
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stopped at an early stage. 
 
Scheme 6.4 Proposed side-reaction during the cascade reaction. 
 
Figure 6.6 Conversion of alcohol 4 in the presence of laccase and various amounts of 
TEMPO. 
Laccase-mediated oxidations have also been described with other mediators.
[39]
 Unlike 
TEMPO, these mediators could be unreactive towards the secondary alcohol in the desired 
product 4 and thus be more useful in our reaction sequence. To this end, violuric acid (11), N-
hydroxybenzotriazole (12) and N-hydroxy-phthalimide (13) (Scheme 6.5) were also used as 
mediators under reaction conditions identical to the TEMPO-mediated oxidation (Scheme 
6.2). Unfortunately, only traces of the desired product were observed, showing that mediators 
11–13 were not as useful for the oxidation of allylic alcohol 2. Remarkably, the cascade 
reaction in the presence of the Cu-5-DNA catalyst gave the lowest conversion. The presence 
of DNA thus did not increase the overall yield of the two-step reaction to 4. More precisely, a 
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poor reaction rate in the oxidation towards ketone 2 was observed in the presence of the 
DNA-based catalyst. This result implies the incompatibility of both reactions cannot be 
avoided by the presence of the DNA. 
 
Scheme 6.5 Alternative mediators used in combination with laccase. 
 
6.5 Two-step one-pot sequence with a potassium formate switch  
Because TEMPO intermediate 6 was required for the first step, but hampered the second one, 
we concluded that the sequence had to be performed in consecutive steps in order to obtain 
acceptable yields. More importantly, the reactive intermediate 6 should be efficiently removed 
from the reaction mixture to prevent undesired reaction with the enone. In previous research 
we discovered that HCO2K could act as a ‘switch’ in a one-pot reaction sequence containing a 
laccase-mediated oxidation by efficiently inhibiting the enzyme.
[16]
 In addition, we 
hypothesized that HCO2K would also be able to in situ reduce the oxoammonium 
functionality in compound 6, thereby effectively preventing formation of hemiacetal 8. To 
verify the hypothesis, the laccase/TEMPO-mediated reaction was conducted and stopped 
upon completion by HCO2K, followed by addition of copper complex to start the Michael 
addition.  
This formate-induced two-step one-pot sequence was performed in the presence of metal 
complex 3, Cu-5, and Cu-5-DNA (Scheme 6.6, Table 6.1) under various conditions. After 
formation of ketone 2, which generally proceeded in 80-90% in 5 h, 10 equiv. of HCO2K 
were added to stop the oxidation and quench oxoammonium species 6. The indicated copper 
catalyst was then added to start the oxa-Michael addition. In the absence of laccase, no 
oxidation occurred and no Michael product 4 was formed (entry 1). The reactions with the 
different catalysts resulted in comparable conversions of about 65% (entries 2, 5 and 8), albeit 
with different reaction times. In these cases, the second reaction proceeded slower and less 
efficient than the single Michael addition, which can be attributed to the presence of reagents 
and the enzyme of the oxidation reaction. In the sequence with the DNA-based Michael 
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addition, reaction times were substantially shorter and an ee of 20% was obtained, which was 
in agreement with the separate oxa-Michael addition. This result showed that the presence of 
neither laccase nor TEMPO disturbed the enantioselectivity of the Michael addition. As 
expected, the yields of the two-step sequences were higher than the cascade reactions (entries 
3, 6 and 9) since the undesired side-reaction did not take place. The crucial role of HCO2K 
was demonstrated in entries 4, 7 and 10. When the oxidation was not stopped and the oxidized 
TEMPO species 6 was not quenched, approximately 20% less product was observed which 
again can be attributed to formation of undesired product 10. If the copper catalyst was added 
at the start of the reaction, formation of the Michael product 4 was accelerated, which trapped 
the TEMPO species during the oxidation. As a consequence, the oxidation reaction stopped at 
an early stage as all TEMPO was scavenged. These experiments clearly demonstrate that it is 
essential to apply the HCO2K-switch between the two single reactions to obtain acceptable 
overall conversions. 
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Table 6.1 One-pot two-step reaction sequence under different conditions. 
 
a
Sequential two-step process, performed without laccase. 
b
Performed as cascade process with 
all reagents added simultaneously. 
 
6.6 Conclusion 
A laccase/TEMPO-mediated oxidation was combined with an aqueous copper-catalyzed oxa-
Michael addition in one pot. The copper complex was immobilized onto DNA, which resulted 
in the catalyzed addition of water to an unsaturated ketone in 20% ee. We found that the 
combination of TEMPO and the desired Michael product led to low conversions, as they 
reacted into an undesired compound that was stable under the reaction conditions. The overall 
Entry Catalyst HCO2K (equiv) Reaction time 
(h) 
Conversion to 4 (%) 
1
a 
3 – 32 0 
2 3 10 95 61 
3
b 
3 – 95 33 
4 3 – 95 37 
5 Cu-5 10 32 64 
6
b 
Cu-5 – 32 36 
7 Cu-5 – 32 48 
8 Cu-5-DNA 10 24 65 (20% ee) 
9
b 
Cu-5-DNA – 24 17 
10 Cu-5-DNA – 24 46 
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conversion, however, could be increased by changing to a stepwise approach. Thus, after 
laccase/TEMPO-mediated oxidation, the enzyme was inhibited and TEMPO was quenched by 
addition of HCO2K. In the same pot, the catalyzed Michael addition was started by adding a 
copper catalyst. Following this strategy, the conversion of the two-step one-pot sequence was 
increased to approximately 65%, while by employing a DNA-immobilized Cu-catalyst a 
similar enantioselectivity was observed as for the separate Michael addition. 
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6.8 Experimental section 
General information: Can be found in chapter 2. Laccase from Trametes Versicolor (12.6 U/mg) was used for 
enzymatic oxidations and purchased from Sigma-Aldrich. DNA was obtained as DNA sodium salt from salmon 
testes from Sigma-Aldrich. The enzymatic oxidations and Michael additions were monitored with an Agilent 
1120 Compact LC equipped with an Agilent Eclipse Plus C18 column or a Shimadzu 10AD-VP equipped with 
an Agilent Eclipse xDB C18 column. A method was used which started with an 9:1 MilliQ/MeCN eluens and 
shifted to 3:2 MilliQ/MeCN in 10 minutes. Next, this eluens  changed to 9:1 MilliQ/MeCN in 2 minutes and 
remained constant for 2 minutes. Ketone 2 has a retention time of 3.40 minutes and alcohol 4 2.28 minutes.  The 
enantiomeric excess of product 4 was determined after extraction of the crude reaction mixture by Et2O, 
concentration in vacuo and addition of isopropanol by a Shimadzu 10AD-VP equipped with a Chiralpak-AD 
column. An isocratic method with 97:3 n-heptane/i-PrOH for 60 minutes was used The retention times of 28.6 
and 33.3 minutes were identical to a racemic reference compound which was  separately prepared according to a 
method described in this section.  
General procedure for the enzymatic oxidation: Laccase (2.50 U), TEMPO (0.200 mg, 1.28 µmol, 0.3 equiv) 
and alcohol (1) (0.65 mg, 4.27 µmol) were combined via stock solutions with an appropriate concentration in 
oxygenated buffer. The total reaction volume was adjusted to 1.000 mL and the mixtures were shaken at rt. 
Michael addition catalyzed by Cu-catalyst 3: Substrate 2 (0.641 mg, 4.27 µmol) and copper catalyst 3 (0.172 mg, 
0.427 µmol, 0.10 equiv.) were combined via stock solutions with an appropriate concentration in buffer. The 
total reaction volume was adjusted to 1.000 mL and the mixtures shaken at rt.  
Michael addition catalyzed by Cu-5 or Cu-5-DNA: A stock solution of 0.741 mg/mL 5 in buffer was 
combined with a 0.535 mg/mL Cu(NO3)2 solution in buffer in a 1:1 volume ratio. If a DNA-based Michael 
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addition was performed, 1.400 mL of this solution was added to 1.000 mL of a 6.00 mM DNA (in base pairs) 
solution in buffer. Otherwise, 1.400 mL of the Cu-5 solution was diluted to 2.400 mL with buffer pH 6.5. The 
resulting solution was added to substrate 2 in such a way that a concentration of 0.641 mg/mL of 2 was achieved. 
General procedure for the oxidation/oxa-Michael addition sequence with catalyst 3: Laccase (2.50 U) and 
TEMPO (0.200 mg, 1.28 µmol, 0.3 equiv) and alcohol 1 (0.650 mg, 4.27 µmol) were added via a stock solution 
in oxygenated 25 mM buffer pH 6.5. The total reaction volume was adjusted to 1.000 mL and the mixtures were 
shaken at rt. After full conversion into the desired ketone 2, HCO2K (3.59 mg, 42.7 µmol, 10 equiv.) and catalyst 
3 (0.172 mg, 0.427 µmol, 0.10 equiv.) were added via stock solutions with an appropriate concentration in 
oxygenated 25 mM buffer pH 6.5, resulting in a total reaction volume of 1.440 mL. The mixtures were shaken at 
rt. 
General procedure for the oxidation/oxa-Michael addition sequence with Cu-5 or Cu-5-DNA: Laccase 
(25.0 U) and TEMPO (2.00 mg, 12.8 µmol, 0.3 equiv) and alcohol 1 (6.50 mg, 4.27 µmol) were added via a 
stock solution in buffer. The total reaction volume was adjusted to 10.00 mL and the mixtures were shaken at rt. 
After full conversion into the desired ketone 2, HCO2K (35.9 mg, 0.42 mmol, 10 equiv.) was added and 10.00 
mL of a pre-formed Cu-5 or a Cu-5-DNA solution: 0.741 mg/mL 5 in buffer pH 6.5 was combined with a 0.535 
mg/mL Cu(NO3)2 solution in buffer pH 6.5 in a 1:1 ratio. When a DNA-based Michael addition was performed, 
1.4 mL of this solution was added to 1.000 mL of a 6 mM DNA (in base pairs) solution  in buffer pH 6.5. 
Otherwise, 1.400 mL of the Cu-5 solution was diluted to 2.400 mL with buffer pH 6.5. 
(E)-1-(1-methyl-1H-imidazole-2-yl)but-2-en-1-ol (1): To a solution of N-methylimidazole (2.91 mL, 36.5 
mmol) in THF (100 mL) was added dropwise n-BuLi (1.6M in hexanes, 22.8 mL, 36.5 mmol, 1 equiv.) at -78 °C 
in a period of 15 minutes. The cooling bath was removed and the reaction allowed to warm to rt for 30 minutes, 
after which the mixture was cooled to -78 °C again and crotonaldehyde (3.73 mL, 45.7 mmol 1.25 equiv.) was 
added dropwise. The mixture was allowed to warm to room temperature after 3 h and saturated aqueous NH4Cl 
(8 mL) was added. The volatiles were removed in vacuo, saturated aqueous NaHCO3 was added and the product 
extracted with DCM (2×50 mL). The organic fractions were dried over MgSO4, concentrated and purified by 
column chromatography on silica gel (DCM/MeOH, 95:5), yielding 4.55 g (29.9 mmol, 91%) of 1 as a yellow 
oil. 
1
H NMR (CDCl3, 300 MHz): δ = 6.82 (d, J = 1.2 Hz, 1H), 6.75 (d, J = 1.2 Hz, 1H), 5.75–5.71 (m, 2H), 5.18 
(d, J = 4.8 Hz, 1H), 3,63 (s, 3H), 1.73 (dd, J = 4.8, 0.9 Hz, 3H). 
13
C NMR (CDCl3, 75 MHz): δ = 148.7, 130.5, 
128.0, 126.5, 121.8, 68.0, 33.1, 17.7. IR (ATR): 3111, 1496, 968, 743 cm
-1
. HRMS (ESI) calcd. for C8H13N2O 
(M+H
+
) 153.1027, found 153.1028. 
(E)-1-(1-methyl-1H-imidazole-2-yl)but-2-en-1-one (2): To a solution of alcohol 1 (500 mg, 3.29 mmol) in 
DCM (20 mL) was added MnO2 (2.86 g, 32.9 mmol, 10 equiv.). The mixture was stirred at ambient temperature 
for 1.5 h. It was filtered over Celite and concentrated in vacuo, affording 430 mg (87%, 2.86 mmol) of 2 as a 
colorless oil. 
1
H NMR (CDCl3, 300 MHz): δ = 7.41 (dq, J = 15.6, 1.5 Hz, 1H), 7.16 (s, 1H), 7.14 (dq, J = 15.3, 
6.9 Hz, 1H), 7.03 (s, 1H), 4.03 (s, 3H), 1.98 (dd, J = 6.9, 1.5 Hz, 3H). 
13
C NMR (CDCl3, 75 MHz): δ = 180.8, 
144.0, 143.8, 129.3, 128.0, 127.1, 36.4, 18.5. IR (ATR): 1666, 1618, 1445, 1415, 1290, 1039, 914 cm
-1
. HRMS 
(ESI) calcd. for C8H11N2O (M+H
+
) 151.0871, found 151.0874. 
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Cu(4,4’-dimethoxy-2,2’-bipyridine)(NO3)2 (3): To a solution of 4,4'-dimethoxy-2,2'-bipyridine (100 mg, 0.462 
mmol) in MeOH (20 mL) was added Cu(NO2)2•3 2O (112 mg, 0.462 mmol, 1 equiv.). The mixture turned blue 
immediately and was concentrated in vacuo after 5 minutes, which afforded 186 mg (0.461 mmol, 100%) of 3 as 
a blue solid. The material was used without further characterisation. 
1-(1-methyl-1H-imidazol-2-yl)ethanone (4a) (structure not shown in text): This material was prepared as 
reference material for HPLC analysis. To a solution of N-methylimidazole (1.46 mL, 18.3 mmol) in THF (50 
mL) was added dropwise n-BuLi (1.6M in hexanes, 11.42 mL, 18.3 mmol, 1 equiv.) at -78 °C in a period of 15 
minutes. The cooling bath was removed and the reaction allowed to warm for a period of 30 minutes, after which 
the mixture was cooled to -78 °C again. Ethyl acetate (2.24 mL, 22.8 mmol, 1.25 equiv.) was added dropwise 
and the mixture was allowed to warm to room temperature after 3 h. To the mixture was added saturated aqueous 
NH4Cl (2 mL) and the volatiles were removed in vacuo. Saturated aqueous NaHCO3 was added and the product 
was extracted with DCM (2×50 mL). The organic fractions were dried over MgSO4, concentrated and purified 
by distillation, yielding 1.73 g (8.54 mmol, 76%) of 4a a colorless oil. 
1
H NMR (CDCl3, 400 M z): δ = 7.10 (s, 
1H), 6.99 (s, 1H), 3.97–3.95 (m, 3H), 2.63–2.61 (m, 3H). 13C NMR (CDCl3, 75 M z): δ = 190.8, 129.1, 127.0, 
36.3, 27.2. IR (ATR): 1679, 1406 cm
-1
. HRMS (ESI) calcd. for C6H9N2O (M+H
+
) 125.0714, found 125.0723. 
3-hydroxy-1-(1-methyl-1H-imidazol-2-yl)butan-1-one (4): To a solution of diisopropylamine (325μL, 2.32 
mmol, 1.15 equiv.) in THF (3.5 mL) was added n-BuLi (1.6M in hexanes, 1.32 mL, 2.12 mmol, 1.05 equiv.) at -
78 °C. The mixture was allowed to warm to 0 °C after 10 minutes and re-cooled to -78 °C. A solution of 4a (250 
mg, 2.01 mmol) in THF (4 mL) was added dropwise. The reaction mixture was allowed to warm to -7 °C and 
stirred for 2 h. The mixture was then cooled to -78 °C and acetaldehyde (449 μL, 8.06 mmol, 4 equiv.) was 
added. The mixture was allowed to warm to -50 °C (MeCN/CO2(s)) and stirred for 1.5 h. The reaction was 
quenched by adding saturated aqueous NH4Cl, diluted with water and extracted with DCM (2 ×). The mixture 
was dried over Na2SO4 and concentrated. Purification by column chromatography on silica gel (EtOAc) yielded 
242 mg (1.44 mmol, 71%) of 4 as a colorless oil. 
1
H NMR (CDCl3, 300 M z): δ = 7.14 (d, J = 0.9 Hz, 1H), 7.04 
(d, J = 0.3 Hz, 1H), 4.34–4.23 (m, 1H), 4.14 (br s, 1H), 4.00 (s, 3H), 3.28 (dd, J = 16.2, 2.7 Hz, 1H), 3.13 (dd, J 
= 16.2, 8.7 Hz, 1H), 1.28 (d, J = 6.3 Hz, 3H).
 13
C NMR (CDCl3, 75 M z): δ 192.5, 143.1, 129.3, 127.3, 64.5, 
48.6, 36.3, 23.1. IR (ATR): 3204, 3122, 3109, 1657, 1406, 1121, 1013 cm
-1
. HRMS (ESI) calcd. for C8H13N2O2 
(M+H
+
) 169.0977, found 169.0979. 
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7. Summary and perspectives 
 
7.1 Summary 
In nature, complex molecules are prepared via well-developed enzymatic cascade reactions. 
An excellent control on the order of reactions and the movement of the substrates, 
intermediate structures and products within the cell is achieved via compartmentalization of 
the different reactions. This approach enables to perform incompatible reaction in one system 
as catalysts or reagents that hamper each other are separated. Thus, reactions that cannot be 
combined normally are successfully performed by the creation of compartments around the 
specific reaction sites. Scientists have used this knowledge to develop systems that mimic the 
natural way of compartmentalizing reactions. A selection of these are summarized in chapter 
one. A general approach to compartmentalize a reaction is by enclosing the (bio)catalyst or 
reagent inside a space surrounded by a semi-permeable membrane. The substrate and product 
are able to diffuse through the membrane, whereas the catalyst is not and remains inside. If 
two incompatible reagents or catalysts are physically separated in this fashion, cascade 
chemistry with incompatibility issues should be possible. In this thesis, the work to achieve 
compartmentalized catalytic reactions is described.  
Homogeneous metals catalysts are powerful tools to prepare a wide variety of functional 
molecules. However, only a small part of all reported compartmentalized catalytic reactions 
use homogeneous metal complexes. The major problem is that the normal metal complex is 
generally able to diffuse through the membrane as well due to the limited dimensions. 
Therefore, it should be immobilized on a large support to prevent leakage. In chapter two, the 
adaption of three important ligands in catalysis is described which enables immobilization on 
a support: N-heterocyclic carbene (NHC), bipyridine and terpyridine ligands, all able to form 
active catalysts after coordination to a metal.  
Another general problem of homogeneous metal catalysts is that they usually cannot be used 
in water, while many compartmentalized catalysis is often performed under aqueous 
conditions. Many metal catalysts are not soluble in water, inactive or even decompose. The 
functionalized ligands described in chapter two can be easily decorated with polar groups, 
which enhance the water solubility of the metal catalysts and makes aqueous 
compartmentalized catalysis possible.  
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To show the possibility of keeping a large homogeneous metal catalyst inside a compartment, 
an adapted bipyridine ligand was connected to a star-shaped, water soluble polymer, a 
dendrimer, and iridium was coordinated. The dendrimer-supported catalyst was supposed to 
remain in a dialysis bag due to its size, while all other reaction ingredients were able to pass 
the membrane. Catalytic activity in an aqueous reductive amination was observed in these 
dialysis bags, showing that the enlarged catalysts were still active. In a next step, the dialysis 
bags were removed from the reaction mixture and used in a next reaction. The catalyst could 
be used for three cycles before the catalytic activity disappeared. This was explained by loss 
of the metal due to leakage outside the bag.  
Chapter four describes the immobilization of a copper complex, known for catalyzing an 
aqueous oxa-Michael addition, to a protein support. Approximately two metal complexes 
were connected to each protein molecule and catalytic activity of the macrocatalyst was 
observed. Efforts to enclose the adapted protein in a PS-PIAT polymersome, a vesicle with a 
bilayer membrane of amphiphilic polymers, failed. Most likely, the polymersomes were only 
stable when the protein was not charged, above pH 12. However, this is an unsuitable pH for 
the metal catalyzed reaction. With another type of polymersomes, crosslinkable PS-PEG 
polymersomes, catalysis was observed. However, due to the intrinsic impermeability of the 
polymersome membrane in pure water, we hypothesize that catalysis took place at the outer 
surface of these vesicles.  
In the next chapter, the non-expanded iridium catalyst from which the dendritic iridium 
catalyst was derived was used in an aqueous one-pot two-step reaction protocol. We 
combined two opposing reactions in one-pot: a laccase/TEMPO mediated oxidation and an 
iridium complex catalyzed reduction. After establishing that both reactions could not be 
performed simultaneously, it was shown that switching from the oxidation to the reduction 
reaction was possible by the addition of HCO2K. The same trick in a different one-pot two-
step sequence was applied in chapter six. In the first step, an unsaturated ketone was formed 
after a laccase/TEMPO mediated oxidation of the corresponding allylic alcohol. Next, this 
intermediate product was reacted in a copper catalyzed oxa-Michael addition. First attempts to 
perform the two-step sequence simultaneously resulted in a poor product formation. As 
catalyst deactivation could be the reason for the poor conversion, we immobilized the metal 
complex onto DNA. We hypothesized that catalyst interaction would be prevented due to 
shielding of the DNA. Unfortunately, this strategy did not work and a more detailed 
investigation into this incompatibility revealed that a side-reaction of the β-hydroxyketone 
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with the oxidize TEMPO species occurred. Therefore, the two steps were performed 
consecutively: After a full conversion of the first step, the enzyme was inhibited and the 
reactive oxidized TEMPO species quenched by adding HCO2K. After addition of the metal 
catalyst, the deseired product was obtained in improved yields. 
 
7.2 Perspective 
Compartmentalized catalysis is an important topic in organic chemical resesearch. The 
efficient processes in nature can be imitated by the application of separated catalyzed 
reactions. Only a few strategies are applicable on a large, industrial scale. For example, 
compartmentalized cascade catalysis can be achieved with membrane reactors or under 
biphasic reaction conditions. Many other strategies to compartmentalize reactions can be 
classified as fundamental research, with as major focus the creation of an artificial cell. Much 
work has been published about the creation of nanoreactors, which are often loaded with 
active enzymes. Research to obtain more complex and better cell-mimics will continue in the 
future. For example, the reaction sequences within one single particle will be obviously 
expanded with more enzymatic steps. Furthermore, substrates selective membranes can be 
incorporated to prevent the presence of undesired, harmful molecules inside the catalytic 
compartment. Also the in-situ removal of waste products inside these compartmentalized 
systems would be beneficial. Another interesting approach would be to connect different 
compartments with protein channels to obtain a faster and more efficient transport of the 
intermediates.  
Homogeneous metal catalysis did not play an important role in compartmentalized cascade 
catalysis so far, although various chemical transformations can be only catalyzed by metal 
complexes. A main problem is that (nano)compartmentalized systems are generally used in an 
aqueous medium, while most metal complexes are not active, not soluble or even decompose 
in water. The water solubility of the catalysts can be increased by adaptions of the ligands, but 
it also has an impact on the reactivity. Another problem with homogeneous metal catalysts in 
water is leakage of the metals. This is also supported by observations during the execution of 
the work described in this work. Leakage and inactivation of the catalyst makes recovery of 
the catalyst impossible. Probably the dissociation of a metal complex in water is promoted by 
the excellent stability of metal ions in aqueous solution.  
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In conclusion, the development of more aqueous stable, soluble, and active metal catalysts is 
highly desirable. Proteins can be an inspiration here, as biocatalysts exist with a metal in the 
active site and leakage of the metal from these materials is not plausible to occur. However, 
biocatalysts generally have a limited substrate scope and work only under specific reactions 
conditions (e.g. solvents, pH, temperature). The development of a catalyst which has the 
advantages of both homogeneous and biocatalysts is required but will be a real challenge.  
 
7.3 Samenvatting 
In de natuur worden complexe moleculen gemaakt door middel van geëvolueerde, 
enzymatische cascade reacties. Binnen de cel is er een goede controle op het verloop van de 
reacties en het transport van beginproducten, intermediaren en eindproducten. Dit wordt 
bereikt door het laten verlopen van de verschillende reacties in verschillende 
celcompartimenten. Deze aanpak maakt het mogelijk om onverenigbare reacties in één 
systeem plaats te laten vinden doordat katalysatoren of reagentia die elkaar negatief 
beïnvloeden gescheiden zijn. Reacties die normaal niet te combineren zijn kunnen dus  
plaatsvinden door aparte compartimenten te creëren rondom de reacties. Wetenschappers 
hebben deze kennis gebruikt om systemen te ontwikkelen die deze natuurlijke wijze van het 
scheiden van reacties nabootsen. Hiervan is een selectie samengevat in hoofdstuk één. Een 
algemene aanpak om reacties te scheiden wordt bereikt door een (bio)katalysator of reagens in 
te sluiten in een ruimte omsloten door een semi-permeabel membraan. Het beginproduct en 
het product zijn in staat het membraan te passeren, terwijl de katalysator dit niet kan. Als zo 
incompatibele reagentia of katalysatoren fysiek gescheiden worden, zouden cascade reacties 
met anders onverenigbare stappen te combineren moeten zijn. In dit proefschrift zijn de 
behaalde resultaten met het doel katalytische cascade reacties in verschillende 
compartimenten plaats te laten vinden beschreven. 
Homogene metaalkatalysatoren zijn veelzijdige hulpmiddelen om een breed scala aan 
functionele moleculen te verkrijgen. Echter wordt in maar een beperkt gedeelte van alle 
beschreven katalytische reacties in een compartiment een homogeen metaalcomplex gebruikt. 
Het voornaamste probleem is dat normale metaalcomplexen kunnen diffunderen door het 
membraan dankzij hun kleine afmetingen. Het is daarom van belang om de metaalcomplexen 
vast te maken aan grotere materialen om lekkage te voorkomen. De aanpassing van drie 
belangrijke liganden die het vastmaken op een drager mogelijk maakt staan beschreven in 
- 127 - 
 
hoofdtuk twee. Het gaat hierbij om N-heterocyclische carbenen (NHC), bipyridine en 
terpyridine liganden, die alledrie in staat zijn om een actieve katalysator te vormen na 
coördinatie van een metaal.  
Een ander veelvoorkomend probleem van homogene metaalkatalysatoren is dat ze meestal 
niet te gebruiken zijn in water, terwijl het vormen van compartimenten voor katalyse vaak in 
water plaatsvindt. Veel metaalkatalysatoren zijn niet oplosbaar in water, inactief of vallen 
zelfs uit elkaar. De functionele liganden beschreven in hoofdstuk twee kunnen makkelijk 
uitgerust worden met polaire groepen. Hierdoor is de wateroplosbaarheid van de 
metaalcomplexen groter en wordt katalyse in gescheiden compartimenten in water mogelijk. 
Een aangepast bipyridine ligand is aan een stervormig, wateroplosbaar polymeer vastgezet en 
vervolgens aan iridium gecoördineerd om zo een macrokatalysator te verkrijgen. Dit om aan 
te tonen dat een grote homogene katalysator binnenin een compartiment zou blijven. Het idee 
was dat de aangepaste katalysator in een dialysezak zou blijven dankzij zijn afmetingen, 
terwijl alle andere ingrediënten van de reactie het membraan konden passeren. Activiteit van 
deze vergrote katalysatoren werd waargenomen in een reductieve aminering binnenin deze 
dialysezak. Vervolgens werd deze zak verwijderd uit het reactiemengsel en succesvol 
gebruikt in een volgende reactie. De katalysator kon drie reacties gebruikt worden voordat de 
katalytische activiteit duidelijk verminderde. Dit kan verklaard worden door verlies van het 
metaal dankzij lekkage uit de zak. 
Hoofdstuk vier beschrijft het vastzetten van een kopercomplex die een waterige oxa-Michael 
additie katalyseert, op een eiwit. Ongeveer twee metaalcomplexen werden er op elk eiwit 
vastgezet, die vervolgens katalytische activiteit vertoonden. Pogingen om het materiaal in te 
sluiten in PS-PIAT polymersomen, een blaasje met een dubbelzijdig membraan van amfifiele 
polymeren, waren zonder succes. De polymersomen waren waarschijnlijk slechts stabiel 
indien het eiwit ongeladen was, boven pH 12. Dit is echter een ongeschikte zuurtegraad voor 
de metaalgekatalyseerde reactie. Katalyse werd wel waargenomen met een ander type, PS-
PEG polymersomen. Wij vermoeden dat katalyse aan het oppervlak plaatsvond vanwege het 
ondoordringbare karakter van het membraan in puur water.  
Het volgende hoofdstuk beschrijft het gebruik van een iridium complex in een synthese van 
twee stappen in één pot in water. We combineerden twee tegenwerkende reacties in één 
reactievat: een laccase/TEMPO versnelde oxidatie en een iridium complex gekatalyseerde 
reductie. Nadat bleek dat beide reactie niet tegelijkertijd plaats konden vinden, werd 
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aangetoond dat er geschakeld kon worden van de oxidatie- naar de reductiereactie door 
toevoeging van HCO2K. Dezelfde truc werd toegepast in hoofdstuk zes. In de eerste stap werd 
een onverzadigd keton gevormd na een laccase/TEMPO gekatalyseerde oxidatie van het 
overeenkomstige allylische alcohol. Vervolgens werd dit tussenproduct gereageerd in een 
koper gekatalyseerde oxa-Michael additie. Eerste pogingen om deze tweestaps sequentie 
tegelijkertijd te laten plaatsvinden resulteerden in een slecht verloop van de reactie. Omdat dit 
zou kunnen komen door de deactivatie van de katalysator hebben we het metaal complex 
vastgemaakt aan DNA. We veronderstelden dat de interactie met de katalysator wellicht 
voorkomen kon worden door een afschermend effect van het DNA. Deze strategie werkte 
helaas niet en de deactivatie van de meerstapsreactie werd verder onderzocht. Dit liet zien dat 
een zijreactie plaatsvond van het ß-hydroxyketon met de geoxideerde TEMPO verbinding. De 
twee stappen werden vervolgens na elkaar uitgevoerd. Na volledige omzetting in de eerste 
stap werd het enzym geremd en de reactieve geoxideerde TEMPO verbinding afgebroken 
door HCO2K toe te voegen. Na toevoeging van de metaalkatalysatot startte de tweede stap. 
Deze aanpak zorgde voor een verbeterde opbrengst van het gewenste product.   
                      
7.4 Visie 
Het uitvoeren van katalyse in een compartiment is een belangrijk onderwerp in organisch 
chemisch onderzoek. De efficiënte processen in de natuur kunnen nagebootst worden door de 
toepassing van gescheiden gekatalyseerde reacties. Slechts enkele strategieën kunnen gebruikt 
worden op een grote industriële schaal. Hiervan zijn membraanreactors of biphasische 
condities voorbeelden waarbij gescheiden compartimenten worden bereikt. Veel andere 
voorbeelden om individuele reacties te scheiden kunnen gezien worden als fundamenteel 
onderzoek. Hierbij ligt de nadruk vooral op het maken van een kunstmatige cel. Veel werk is 
gepubliceerd over de vorming van nanoreactors die vaak gevuld kunnen worden met actieve 
enzymen. Onderzoek om nog complexere en betere imitaties van cellen te krijgen zal zich 
verder ontwikkelen in de toekomst. De reactiesequenties binnen een enkel deeltje zullen 
logischerwijs worden uitgevoerd met meer enzymatische stappen. Bovendien zullen 
membranen die specifieke substraten doorlaten gebruikt worden om de aanwezigheid van  
ongewenste, schadelijke moleculen te voorkomen. Verder zal het in situ verwijderen van 
afvalproducten in deze systemen met meerdere compartimenten voordelen bieden. Een andere 
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interessante aanpak is om verschillende compartimenten te verbinden met eiwitkanalen om 
een sneller en efficiënter transport van tussenproducten te krijgen. 
Homogene metaalkatalyse heeft tot nog toe geen grote rol gespeeld in cascade chemie in 
compartimenten, ondanks dat sommige chemische conversies alleen gekatalyseerd kunnen 
worden door metaalcomplexen. Een groot probleem is dat systemen met compartimenten in 
het algemeen worden gebruikt in water, terwijl de meeste metaalcomplexen hierin niet actief 
zijn, niet oplosbaar of zelfs uiteenvallen. De wateroplosbaarheid kan vergroot worden door de 
liganden aan te passen. Dit heeft echter ook een invloed op de reactiviteit. Een ander 
probleem met homogene metaalkatalyse in water is lekkage van de metalen. Dit punt wordt 
onderschreven door observaties die gedaan werden bij het uitvoeren van dit onderzoek. 
Lekkage en deactivatie van de katalysator maken hergebruik onmogelijk.  
De ontwikkeling van meer metaalkatalysatoren die stabiel, oplosbaar en actief zijn in water is 
noodzakelijk. Eiwitten kunnen een bron van inspiratie zijn, aangezien er biokatalysatoren 
bestaan met een metaal in hun reactieve centrum. Lekkage van deze metalen zal niet 
plaatsvinden. Echter accepteren biokatalysatoren normaal gesproken een beperkte groep 
substraten en ze werken slechts onder specifieke omstandigheden (bijvoorbeeld oplosmiddel, 
pH, temperatuur). De ontwikkeling van katalysatoren die de voordelen van zowel homogene 
katalysatoren als enzymen hebben zal een serieuze uitdaging zijn.        
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